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Abstract
There is substantial evidence to suggest that the sympathetic nervous system is
intimately involved in the development of ventricular arrhythmias during acute
myocardial ischaemia. Nevertheless factors controlling myocardial noradrenaline
(NA) release during ischaemia are only partly understood. Therefore, the effect of
duration and severity of ischaemia on neuronal NA release (left stellate ganglion
stimulation, 5Hz) was studied using a perfused, innervated rat heart model. The
effect of ischaemia on presynaptic inhibition by a-adrenergic, muscarinic and
purinergic receptors was also examined. There is higher density of a-adrenoceptors
in female tissues but it is not clear whether there is a gender difference in
presynaptic inhibitory mechanisms.
NA overflow progressively declined during 10 min stop-flow ischaemia, but was
maintained for up to 60 min during less severe ischaemia (95% flow reduction ). a-
Adrenergic or purinergic antagonists increased NA overflow during low-flow but not
stop-flow ischaemia. In normoxic hearts, neuronal NA overflow was inhibited by
vagal nerve stimulation (15 Hz) but not after 10 min low-flow or 1-5 min stop-flow
ischaemia. The loss of VS-induced inhibition of NA overflow during ischaemia may
be due to enhanced a-adrenergic presynaptic inhibition of acetylcholine release, since
an a-adrenoceptor antagonist could restore this effect. The inhibitory effect of the
muscarinic agonist methacholine on NA overflow was also attenuated by low-flow or
stop-flow ischaemia, indicating a dysfunction of muscarinic presynaptic receptors.
The effect of gender on a2-adrenergic presynaptic inhibition of neuronal NA
release was also studied. In normoxic hearts, NA overflow by control nerve
stimulation was similar. The a2-adrenergic inhibitor rauwolscine potentiated NA
overflow more in female than in male hearts, both during normoxia and ischaemia.
Ovariectomy attenuated a-adrenergic presynaptic inhibition of NA overflow. During
normoxia, presynaptic inhibition of neuronal NA overflow by vagal nerve stimulation
was greater in female than in male hearts, but methacholine-reduced NA overflow
equally in female and male hearts.
The postsynaptic, heart rate-lowering response to vagal nerve stimulation, but not
to methacholine, was more marked in female than male hearts. Castration potentiated,
and ovariectomy attenuated the effect of vagal nerve stimulation on heart rate.
iv
Sympathetic nerve stimulation during 10 mins low-flow ischaemia increased the
incidence of ventricular fibrillation during early reperfusion (from 8% to 55%).
Simultaneous vagal nerve stimulation or pretreatment with methacholine prevented
reperfusion ventricular fibrillation without a reduction in neuronal NA release. No sex
difference was found in the severity of ischaemic arrhythmias after coronary ligation
in vitro or in vivo without nerve stimulation.
Feeding rats n-3 or n-6 polyunsaturated fatty acids changed myocardial fatty acid
composition without changing neuronal NA overflow and its adrenergic presynaptic
modulation either during normoxia or during ischaemia.
In conclusion, sympathetic nerve stimulation leads to ischaemic-reperfusion
arrhythmias. The antiarrhythmic effect of vagal nerve stimulation and of dietary
polyunsaturated fatty acids cannot be explained by presynaptic modulation of NA
release. Cardiac neuronal function, especially sympathetic neurotransmitter release
and presynaptic modulation, is affected by the severity of ischaemia, parasympathetic
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Introduction and Literature Review
1.1 Sudden Cardiac Death: Challenge to Modern Cardiology
Sudden cardiac death (SCD) continues to be a major problem in current cardiac
medicine. In the western world, about 50% of all coronary deaths are in the form of
SCD constituting the leading cause of death among men aged 30-65 years [Kannel
and Schatzkin 1985, Oliver 1982, Gillum 1989]. It is estimated that each month there
will be about 100 SCD events per million population in western society. Most SCD
victims (80-90%) have no prodromes within days or horns prior to the fatal event and
only a minority recently consult with their doctors presenting vague symptoms
[Oliver 1982]. In fact, in a high proportion of victims, SCD is the first and only
manifestation of coronary artery disease (CAD) [Kannel and Schatzkin 1985].
Furthermore, most SCDs occur outside hospital [Fraser 1986, Gillum 1989]. These
facts imply that subjects with high risk of SCD are not properly identified and
therefore do not receive proper medical advice, treatment and monitoring.
1.1.1 The Pathology of SCD
Autopsy and angiographic studies have demonstrated that extensive and severe
CAD is the major underlying etiology in over 80% of SCD cases. Significant
coronary artery stenosis (>75%) could be identified in 70-90% of cases, and multiple
coronary stenoses in about half of all cases [Davies and Thomas 1984, Liberthson et
al 1974, Baroldi et al 1979, Davies and Popples 1979]. Scattered myofibrillar
degeneration, coagulative myocytolysis, healed myocardial infarction and myocardial
hypertrophy are other common findings [Baroldi et al 1979, Liberthson et al 1974,
Davies and Popples 1979]. The reported frequency of coronary artery thrombosis is
not constant, varying from 15% to 74% [Baroldi et al 1979, Lovegrove and
Thompson 1978, Davies and Thomas 1984, Liberthson et al 1974]. However, this
figure may not be a true reflection of the nature of the acute ischaemic event due to
spontaneous thrombolysis. Coronary spasm may also cause serious arrhythmias and
SCD with or without concomitant coronary stenosis [Miller et al 1982].
Morphological changes of acute myocardial infarction (MI) are less common (20-
35%) [Baroldi et al 1979, Lovegrove and Thompson 1978, Liberthson et al 1974].
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This is in agreement with the finding that about 40% of patients resuscitated from a
cardiac arrest have enzymatic evidence of acute myocardial necrosis and only 20%
show electrocardiographic (ECG) evidence of a transmural infarction [Greene 1990a].
Some autopsy data suggest a relationship between random damage to the specialized
conducting tissue or cardiac nerves and the risk of SCD [Rossi 1985, James 1983].
But because of the difficulties in carrying out detailed investigations and the limited
number of cases, it is not possible to come to a definitive conclusion.
A number of other causes or factors also contribute to SCD [Myerburg 1987].
Ventricular hypertrophy is an important and independent risk factor for ventricular
arrhythmias and SCD [Kannel and Schatzkin 1985]. Heart failure is another
syndrome with a high risk of SCD. According to recent reports, about 40-50% of
deaths in patients with heart failure are categorized as SCD [Kannel et al 1988,
Bigger 1987]. Myocarditis and valvular disease may also be associated with SCD
though less frequently. Disorders of the nervous system may predispose the heart to
lethal arrhythmias [Oppenheimer etal 1990].
Thus, it can be concluded that SCD does not possess a distinctive entity of
pathomorphological lesions and a spectrum of minor to extensive myocardial lesions.
Therefore, it is difficult to explain the mechanism of SCD by pathological
observations alone.
1.1.2 Electrophysiological Substrate of SCD
Ventricular tachycardia (VT) and fibrillation (VF) are the most common electrical
disturbances leading to SCD. VF is recorded in 95% of SCD victims attended to
within minutes after collapse [Cobb 1988, Hallstrom et al 1983]. Similarly, the
occurrence of VT and VF is documented in the vast majority of SCD cases (83%)
using Holter monitoring [de Lune et al 1989]. The average time for VT to degenerate
into VF is 96 seconds [Milner et al 1985]. Bradyarrhythmia and asystole were seen in
10-20% of patients [de Lune 1989, Milner et al 1985, Kempf and Josephson 1984].
Data from Holter monitoring show that VF may be preceded by a sudden increase in
HR [Adgey et al 1982, McAreavey et al 1989].
An inherent ventricular electrical instability in SCD victims is suggested by
several observations. About 30% of resuscitated subjects die of another episode of VF
within weeks [Greene 1990a]. Men or acute MI patients who have exercise-induced
ischaemic ventricular arrhythmias or frequent and complex ventricular premature
beats (VPB) during ECG monitoring are at higher risk of SCD [Kannel and Schatzkin
1985, Moss et al 1987, Bigger et al 1984]. Furthermore, inducibility of VT and VF
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by programmed electrical stimulation is high (68-75%) in survivors of cardiac arrest
[Horowitz et al 1982, Freedman et al 1988].
1.1.3 Factors Influencing SCD
A number of factors are associated with increased risk of SCD. Here, only those
which have been proved to be important and/or linked to the subject of the thesis are
briefly reviewed.
1) CAD risk factors and SCD
The Framingham Study indicates an important relationship between classical risk
factors for CAD and the probability of SCD over a 26-year follow-up period (Figure
1.1) [Kannel and Schatzkin 1985]. This emphasizes the importance of underlying
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DECILE OF MULTIVARIATE RISK
Figure 1.1 Risk of SCD by decile of multivariate risk: 26-year follow-up, the Framingham Study
[Kannel and Schatzkin 1985],
2) Ventricular dysfunction and extent ofmyocardial ischaemia
After acute MI, clinical variables reflecting the degree of ventricular dysfunction
or ischaemic/infarct size (IS) correlate with frequency and repetitivity of VPB
[Coromilas et al 1985] and incidence of SCD [Schulze et al 1977]. Patients with
acute MI requiring early treatment for VT or VP1 exhibit higher peak plasma creatine
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phosphokinase than those without these serious arrhythmias [Abraham et al 1989].
Congestive heart failure is also associated with 5-9 fold increase in the risk of SCD
[Kannel et al 1988]. In animals with experimental MI time of onset and severity of
arrhythmias are closely related to IS [Lepr&i et al 1983, Curtis et al 1987]. In dogs,
frequency of VPBs, incidence of VT, reduction of VF threshold, and the inducibility
of VT are all IS-dependent [Coromilas et al 1985, Gang et al 1982]. Large IS is
associated with an increased incidence of VF [Sheehan and Epstein 1983, Bolli et al
1986].
3) Ventricularpremature beats
Relationship between frequency or type of VPB and risk of SCD has been well
defined. The occurrence of VPB during 24 hour ECG monitoring is associated with
an increased risk of SCD in men [Kannel and Schatzkin 1985]. In male patients with
recent MI, complex (frequent and repetitive) VPB is a strong predictor of SCD during
the follow-up period (Figure 1.2) [Moss et al 1987, Bigger et al 1984, Lown 1979,
Ruberman et al 1981, Surawicz 1987].
Frequency Repetitivity
Ventricular premature beats
Figure 1.2 Frequency (per hour) and repetitivity of VPBs during 24 hour Hotter monitoring and the
incidence ofSCD during 2 year follow-up [Bigger et al 1984]
4) Gender
It is well-known that middle-aged women have a lower risk of CAD, MI, and
mortality due to ischaemic heart attack than men. After the menopause, this gender-
gap narrows but male dominance persists. As there is a delay of 10-15 years in the
development of atherosclerotic lesions in coronary arteries in women in comparison
to men, it is impossible to directly compare the incidence of SCD between the sexes
on a population basis. However, epidemiological, clinical and experimental data
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suggest a gender difference in SCD. In the Framingham cohort, the proportion of
SCD out of total coronary deaths during a 30 year follow-up period tends to be higher
in men than in women (46% vs 34%) [Kannel et al 1988]. Recently, a similar gender
difference in out-of-hospital deaths as a percentage of total coronary deaths is also
indicated by the FINMONICA Study (68% vs 56% during 1982-1987) [Romo et al
1990] and a national survey in the United States (68.2% vs 54.7% in 45-54 age group
during 1980-1985) [Gillum 1989]. In survivors of cardiac arrest or patients with
recent VT/VF, male gender is one of the strongest and independent predictor for the
inducibility of VT and VF by programmed premature electrical stimulation
[Freedman et al 1988, Schoenfeld et al 1985]. Interestingly, women do not share the
increased risk that men demonstrate when VPBs exist [Moss et al 1987, Kannel and
Schatzkin 1985, Dittrich et al 1988]. In anaesthetized or conscious rats, severity of
ventricular arrhythmias and early mortality after coronary ligation is higher in males
than in females (Figure 1.3) [Siegmund et al 1979, Lu et al 1984, Du et al
unpublished]. In a well-designed study the risk for VF during acute coronary
occlusion is found to be higher in male than female dogs [Puddu et al 1988], although
this difference was not observed in another study [Trolese-Mongheal et al 1985].





Figure 1.3 Gender difference in the early mortality induced by left coronary artery occlusion (CAO)
in anaesthetized (left panel) [Siegmund et al 1979] and conscious rats (right panel) [Lu et al 1984].
5) Severity of ischaemia and collateral circulation
Pathological studies show that IS is usually smaller after acute coronary occlusion
if functional collaterals are present [James 1978, Baroldi 1970]. In patients with acute
MI, well-developed collaterals are accompanied by preserved ventricular function,
perhaps due to a reduced IS [Williams et al 1976, Nohara et al 1983, Rentrop et al
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1988], and the association of the likelihood of SCD and IS or ventricular dysfunction
has been documented. In a group of patients with variant angina, increased severity of
ischaemia, estimated by ECG ST-segment elevation, is related to early onset of lethal
arrhythmias and subsequent SCD [Miller et al 1982]. A postmortem study suggested
that a poor pre-existing collateral network increased the risk of SCD [Spain et al
1963]. In patients with matched severity of CAD, the presence of a collateral
circulation significantly reduces mortality rate during follow-up [Webster et al 1974].
Experimental studies also show that severity of ischaemia and collateral
circulation influence the vulnerability of the heart to lethal arrhythmias [Meesmann
1982, Bolli et al 1986, von Mutins et al 1988]. After acute coronary occlusion, dogs
with an adequate collaterals had a significant higher VF threshold and were less likely
to develop fatal arrhythmias [Garza et al 1974]. Bolli and colleagues found in dogs
that residual coronary flow of >8% of normal level (vs <8%) substantially reduced the
incidence of VT (17% vs 87%) and VF (0% vs 57%) [Bolli et al 1986]. Therefore,
severity of ischaemia and the status of collateral circulation is a critical factor in the
development of SCD.
6) Dietary fat
The strongest evidence suggesting an effect of dietary fat on SCD comes from
experimental studies. Incidence of VF and mortality following acute coronary
occlusion are reduced by dietary supplementation with polyunsaturated fatty acids for
2-6 months [McLennan et al 1985 and 1989, Hock et al 1987 and 1990, Riemersma
et al 1988, Culp et al 1980], although the mechanism of this protection remains
unclear.
Data from the Framingham Study suggest a plausible and weak relation of serum
total cholesterol on the long-term risk of SCD [Kannel and Schatzkin 1985, Kannel et
al 1988]. Dietary saturated fats have been related to the incidence of CAD [Keys
1980]. Recently, an inverse relation has been demonstrated between dietary
polyunsaturated/saturated fatty acid ratio or linoleic acid level in adipose tissue and
the relative risk of CAD [Wood et al 1987]. Whether a similar relation exists between
dietary fat and SCD in man remains to be seen. In patients with acute MI saturated
fatty acids in adipose tissue are significantly higher in those with serious ventricular
arrhythmias than those without [Abraham et al 1989].
1.1.4 Prevention and Prediction of SCD
In the recent two decades, extensive resources and research have been directed
towards prevention of SCD. As victims of SCD share most of the major risk factors
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for CAD [Kannel and Schatzkin 1985], it might be expected that lowering of these
risks could reduce the incidence of SCD. Unfortunately, none of the large scale
primary coronary disease prevention trials has led to a statistically significant
reduction in SCD [reviews see Oliver 1985, Roelandt and Hugenholtz 1986]. Current
emphasis has shifted to various types of secondary prevention. Patients with recent
MI or unstable angina are often prone to arrhythmias. Trials with these subjects aimed
to lower raised serum cholesterol, blood pressure, platelet aggregation or arrhythmias
(lidocaine) have yielded uncertain results on SCD as an endpoint [Oliver 1985,
Noneman and Rogers 1978, Furberg and Craver 1988]. Exceptionally, [3-adrenergic
blockade is effective in reducing the risk of SCD [Oliver 1985, Roelandt and
Hugenholtz 1986, Frishman et al 1984].
The failure to curb SCD in most primary and secondary prevention trials may be
due to the the difficulty to identify those at risk of SCD. Therefore, a large number of
studies have been conducted to find clinical variables, which are capable of predicting
the probability of subsequent SCD. These parameters, e.g., complex ectopics on ECG
Holter monitoring [Moss et al 1987, Ruberman et al 1981], ejection fraction [Bigger
et al 1984, Schulze et al 1977], inducibility at electrophysiological testing [Freedman
et al 1988], exercise test [Greene 1990b], R-R interval variability [Kleiger et al 1987]
and baroreflex sensitivity [Schwartz et al 1988a, La Rovere et al 1988], are of some
value to identify the subgroup at enhanced risk of SCD. But most of them do not have
the sensitivity nor the specificity to predict the risk of SCD for an individual.
In summary, since morphological lesions do not provide a simple explanation for
the occurrence of the lethal event, SCD is most probably a random event during a
short episode of myocardial ischaemia due to underlying CAD [Oliver 1986, Stone
1990]. Thus, questions remaining to be answered should be why some hearts are so
vulnerable to ischaemia and what the trigger(s) leading to VT and VF are. Among the
transcient and local factors that should be considered are those originating from
higher nervous centres or from peripheral neurons.
1.2 Neuronal Mechanisms of Ventricular Arrhythmias in
Myocardial Ischaemia
1.2.1 Neuronal Activation during Myocardial Ischaemia
Activation ofsympathetic nerve
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Within 30 min after the onset of anterior MI, 54% of patients show signs of
sympathetic activation, i.e., sinus tachycardia and transcient hypertension [Webb et al
1972]. In other patients who show signs of augmented vagal tone atropine treatment
may unmask underlying sympathetic activation [Webb et al 1972, Neufeld et al
1978]. During acute MI, a high level of circulating catecholamines is a common
finding in most patients apparently due to enhanced release from sympathetic nerves
and adrenal medulla [Goldstein 1981, Nadeau and de Champlain 1979, Bertel et al
1982, Karlsberg et al 1979, Schomig et al 1984b]. Using radiotracer kinetic
techniques, McCance and Forfar have reported enhanced spillover of cardiac
noradrenaline (NA) in patients with unstable angina or with exertion-induced
myocardial ischaemia [1989a and 1989b].
Autopsy studies of hearts from SCD victims show a typical coagulative
myocytolysis in 80% of the cases in comparison to 20% in accidental deaths [Baroldi
et al 1979]. This morphological change is similar to that in experimentally-induced
"catecholamine cardiomyopathy" [Rona 1985], thereby providing indirect evidence of
enhanced sympathetic activity and NA release.
Several lines of experimental evidence strongly suggest a sympathetic activation
during myocardial ischaemia. Direct recording of efferent sympathetic
nerve impulses shows a increased firing frequency immediately after coronary artery
occlusion [Lombardi et al 1984, Malliani et al 1980, Gillis 1971], which is
accompanied by reduced VF threshold [Lombardi et al 1983]. However, NA levels in
the ischaemic effluent were not measured in these studies. Increased circulating
catecholamine levels indicate an overall activation of sympathetic nervous system,
especially in conscious animals [Godin et al 1985, Forfar et al 1984, Karlsberg et al
1979].
An augmented catecholamine release in ischaemic myocardium is indirectly
supported by an enhanced NA overflow during ischaemic-reperfusion in vivo [Forfar
et al 1984, Godin et al 1985, Yamaguchi et al 1990], by increased cAMP levels
which is partly prevented by |3-blockade [Ohyanagi et al 1988, Lubbe et al 1981,
Thandroyen et al 1986], and by the histochemical finding that myocardial
catecholamine content is reduced after ischaemia [Abrahams son et al 1982,
Krivokapich et al 1987, McDonald et al 1986, Muntz et al 1984]. Usually, reduction
in intraneuronal NA (demonstrated by fluorescence method) precedes the drop in
myocardial NA content, indicating loss of NA from synaptic vesicles into ischaemic
regions [Abrahamsson 1982, Muntz et al 1984]. In pig and dog hearts, nearly 20-40%
of total myocardial NA may be lost after 5-20 min of ischaemia with or without
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reperfusion [McDonald et al 1986, Krivokepich et al 1987], although the magnitude
of this loss may be less according to others [Mukherjee et al 1979, Muntz et al 1984].
Activation ofparasympathetic nerve
Clinical and experimental data also suggest increased cardiac vagal activity (i.e.,
sinus bradycardia and hypotension) in 55% patients seen within 30 min after the onset
ofMI [Webb et al 1972]. Signs of vagal activation is more common in patients (75%)
or dogs with inferio-posterior infarction [Pantridge 1978, Neufeld et al 1978, Billman
and Marsh 1989]. In experimental studies, increased nerve impulses of afferent and
efferent vagal fibres are recorded shortly after ischaemia [Thordn 1976, Uchida and
Murao 1974, Corr and Gillis 1978]. Autonomic activation appears to be influenced by
the extent of myocardial ischaemia. In the cat, for instance, induction of a small
ischaemic area is accompanied by sympathetic activation only, and a large ischaemic
lesion results in an enhanced vagal tone overriding a sympathetic activation
[Lombardi et al 1984]. In man and dog, however, extent of sympathetic activation is
proportional to infarct size [Karlsberg et al 1979, Goldstein 1981, Bertel et al 1982].
Mechanism ofneural activation by myocardial ischaemia
In the setting of acute myocardial ischaemia, neuronal activation may occur via 1)
exciting impulses from high centres to the heart due to pain, anxiety and fear, 2)
neuronal reflexes induced by activation of pressor and volume receptors following a
decrease in blood pressure and cardiac output [Schomig et al 1984b, Karlsberg et al
1979], and 3) cardio-cardiac reflexes that are activated by afferents from the
ischaemic area. For activation of the cardio-cardiac reflexes, ischaemia-induced
chemical (e.g., increase in H+, K+, bradykinin, prostaglandins, serotonin) and
functional changes (such as left ventricular dilatation, dyskinesis, increased
ventricular volume and wall stress) may be important [Shepherd 1985]. Various
reflex routes either via central nervous system or spinal cord may be activated
simultaneously leading to enhanced neuronal tone to the heart [Lombardi et al 1983].
Complexity of pathways by which autonomic nerves are activated may constitute the
anatomic background of sympatho-vagal interactions and of the simultaneous
activation of both branches. Afferent receptors are not evenly distributed in the
ventricle, which could explain the observed patterns of autonomic activation in
relation to location of ischaemia [Webb 1972, Perez-Gomez et al 1979, Thomas et al
1978].
1.2.2 Neuronal Activity and Ischaemic Arrhythmias
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Effect ofenhanced adrenergic activity
Direct clinical evidence documenting a causal relation between sympathetic
activation and ischaemic arrhythmias is still rare, but a great amount of indirect data
have been accumulated. Increased plasma catecholamines significantly correlate with
the severity of ischaemic arrhythmias in some, but not all studies [Nadeau and de
Champlain 1979, Karlsberg et al 1979, Bertel et al 1982, Goldstein 1981]. However,
this correlation is only moderate and could be partly explained by a larger ischaemic
area and more severe ventricular dysfunction (Section 1.1.3). In patients with unstable
angina, ischaemia of the anterior wall is coupled with a marked increase in HR, which
precedes the onset of VT (42%) and VF (37%). In contrast, patients with inferior
ischaemia show reduction in HR and infrequent onset of VT (8%) and VF (3%)
[Perez-Gornez et al 1979]. Similarly, increase in HR during ECG monitoring
precedes VF in patients with acute MI [Adgey et al 1982, McAreavey et al 1989].
Psychological stress is associated with increased propensity of sudden cardiac
death [Brackett and Powell 1988, Kuller et al 1987, DeSilva 1982].
Socioenviromental stress and type A behaviour may be associated with long-term
high sympathetic activity which reduces the electrical stability of the heart [Lown
1987, Dimsdale et al 1987]. Indeed, mental stress can induce discernable
electrophysiological changes and ventricular arrhythmias in patients with
uncomplicated MI [Lown 1987]. It is estimated that about 20-40% of SCD events
were preceded by acute psychological disturbances [DeSilva 1982].
Detailed analysis of the frequency of SCD events or VT have disclosed a
circadian rhythm with significant excessive episodes between 9-12 am [Willich 1990,
Lucente et al 1988]. This diurnal pattern matches closely with the circadian variation
of plasma concentration of catecholamines [Stone 1990, Tofler et al 1987], and is
abolished by [3-blockade [Muller et al 1987, Fox and Mulcahy 1990]. A simultaneous
reduction in cardiac vagal tone may also be involved [Malpas and Purdie 1990].
The importance of sympathetic activity in the genesis of lethal arrhythmias is not
limited to ischaemic conditions. In patients with the long-QT syndrome, cardiac
sympathetic activity plays a key role in initiating VF and treatment with ^-blockade
reduces the incidence of SCD from 71% to 6% [Schwartz 1985]. Moreover,
neurogenic disorders are associated with increased risk of SCD [Oppenheimer et al
1990]. For example, increased plasma concentration of catecholamines and CK-MB
isoenzyme are common in head injury patients, who also show high incidence of
ventricular arrhythmias and cardiac mortality [Cruickshank 1989]. Furthermore,
during and shortly after vigorous exercise, ventricular arrhythmias and SCD may
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happen in apparently healthy subjects [Amsterdam 1990], perhaps due to sympathetic
overstimulation as a 10-fold increase in plasma NA level occurs during this
vulnerable period [Dimsdale et al 1984].
Three lines of experimental evidence strongly support the concept that enhanced
cardiac sympathetic activity is a trigger for ischaemic arrhythmias. Firstly, increased
sympathetic nerve firing during myocardial ischaemia coincides with the reduction of
VF threshold and the onset of VF [Lombardi et al 1983, Corr and Gillis 1978],
Secondly, electrical stimulation of central (hypothalamus) or cardiac sympathetic
nerves reduces electrical stability of the ischaemic and non-ischaemic heart in several
species [Corr and Gillis 1978, Schwartz et al 1976, 1985b, Johnasson et al 1974]. In
dogs, left stellate ganglion stimulation reduces the VF threshold and triggers
ventricular arrhythmias, which is in contrast to an antiarrhythmic effect by
stimulation of the right stellate ganglion [Schwartz et al 1976, Priori et al 1988, Corr
et al 1986]. This difference may be explained by findings that the afferent limbs of
most cardio-cardiac sympathetic reflexes may be preferentially distributed through
left sided nerves, hence making these reflexes largely dependent on an intact left
stellate ganglion [Schwartz et al 1976]. Subjecting animals to psychological and
physiological stress is also arrhythmogenic [Johnasson et al 1974, Verrier and Lown
1984]. Adaptation to these stressors reduces the vulnerability to arrhythmias during
ischaemia [Parker et al 1987, Billman et al 1984, Meerson and Malyshev 1989].
Thirdly, adrenergic agonists increase the incidence of ventricular arrhythmias during
ischaemia and reperfusion [Penny 1984, Yamada et al 1986, Kimura et al 1987,
Sheridan et al 1980].
Effect ofsuppressed adrenergic activity
Large amount of studies demonstrate an antiarrhythmic effect by depressing
sympathetic tone. Treatment with propranolol reduces the incidence of VF and
myocardial damage in the acute phase of MI [Norris et al 1984, Peter et al 1978]. In
patients after acute MI, treatment with ^-adrenergic blockers achieves an
antiarrhythmic effect with a 33% reduction in mortality due to SCD [Frishman et al
1984]. This salutary impact contrasts with the ineffectiveness of class I
antiarrhythmic drugs in similar subjects [Furberg 1983].
In experimental studies, a- and [3-blockade are effective in reducing the incidence
of ventricular arrhythmias either during ischaemia or reperfusion [Penny 1984,
Schwartz et al 1985, Benfey et al 1984, Sheridan et al 1980], although there is some
controversy [Williams et al 1987, Daugherty et al 1986]. Adrenergic antagonist may
be able to delay the onset of irreversible damage or limit the infarct size [Elson et al
Introduction and Literature Review 12
1981, Thandroyen et al 1990, Opie 1980], thereby providing another explanation for
the antiarrhythmic effect. An extreme way to attenuate adrenergic tone is sympathetic
denervation either surgically or chemically (pretreatment with 6-hydroxydopamine or
a-methylmetatyrosine) with a substantial reduction of cardiac NA content (<10% of
normal). Such treatment is associated with a reduction in the severity of
ischaemic/reperfusion arrhythmias and ischaemic damage ofmyocardium [Martin and
Meesmann 1985, Abrahamsson 1985, Jones et al 1978, Schwartz and Zuanetti 1988].
In dogs, chronic left stellectomy increases VF threshold and is highly protective
against ventricular arrhythmias, while right stellectomy may decrease the electrical
stability of non-ischaemic and ischaemic hearts [Schwartz et al 1976, Corr et al
1986]. However, others have reported both right and left stellectomy to be effective in
preventing VF during ischaemia in dogs [Puddu et al 1988]. In patients after acute
MI, left stellectomy achieved significant reduction in the incidence of SCD over 5-
year follow-up from 22% to 3.6% [Schwartz et al 1985]. In contrast, acute surgical
sympathectomy is usually less potent or ineffective [Schwartz et el 1976, Elson et al
1981, Euler et al 1985], This may indicate the importance of myocardial
catecholamine levels and/or associated changes, such as an increased glycogen
content [Daugherty et al 1986] in arrhythmogenesis during ischaemia.
Effect ofparasympathetic nerve system
Hypotension and bradycardia appearing during acute MI may coexist with
ventricular arrhythmias [Webb et al 1972, Epstein et al 1972]. However, those
patients showing signs of vagal activation usually have fewer ventricular arrhythmias
and better prognosis [Epstein et al 1972, Perez-Gomez et al 1979, Neufeld et al
1978]. Actually, administration of atropine for the treatment of bradycardia and
hypotension may unmask and enhance the effect of underlying sympathetic
activation, leading to the development of serious arrhythmias [Pantridge 1978,
Epstein et al 1972].
Vagal control of the heart may be assessed by measurement of R-R interval
variation or baroreflex sensitivity [Schwartz et al 1988a]. Those patients with the
greatest reduction in vagal activity, defined in the acute phase of MI, are at increased
risk of SCD [Kleiger et al 1987, La Rovere et al 1988]. In postinfarct patients chronic
exercise programmes may reduce the risk of ventricular arrhythmias and improve
prognosis [Furberg and Craver 1988], an effect possibly due to an improved vagal
tone as show in dogs [Billman et al 1984].
Experimental results also suggest a protective effect of enhanced vagal tone
during MI. In dogs with a healed MI, vagal activity assessed by baroreflex sensitivity
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was inversely related to the incidence of SCD triggered by exercise and acute
ischaemia (Figure 1.4) [Schwartz et al 1988a]. In conscious dogs exposed to an
adverse environment, vagal blockade by atropine leads to a substantial increase in
vulnerability to VF [Verrier and Lown 1984]. During ischaemia vagal activation,
either by electrical nerve stimulation or by enhanced baroreflex, attenuates ischaemia-
induced depression in VF threshold [de Ferrari 1987, Verrier 1988, Marshall et al
1981] and VF is delayed in onset or prevented [Zuanetti et al 1987, Marshall et al
1981, Myers et al 1974]. Enhanced cardiac vagal tone via baroreflex activation could
terminate sustained VT [Wexman and Wald 1977], Likewise, vagal tonic drugs
(cholinesterase inhibitors, cholinergic agonists or enzyme-resistant cGMP analogues)
are capable of increasing VF threshold and reducing the incidence of ventricular








Figure 1.4 Baroreflex sensitivity and sudden cardiac death in dogs after myocardial infarction
(p<0.001 for differences among the groups) [Schwartz et al 1988a]
Effect of vagotomy on ischaemic/reperfusion arrhythmias is uncertain [Schwartz
and Zuanetti 1988, Corr et al 1986]. It seems that the resultant influence of vagotomy
depends on the preexisting level of vagal tone and sympathetic activity [Verrier and
Lown 1984, Corr et al 1987, Bergamaschi 1978]. In the cat, coronary occlusion
results in a marked vagal activation and vagotomy leads to an increased incidence of
VF. In contrast, in conscious dogs with anterior ischaemia vagotomy is ineffective as
efferent vagal tone is not increased [Verrier 1988, Corr et al 1986].
However, there are some studies which did not find a protective effect of vagal
stimulation during myocardial ischaemia [Corr and Gillis 1978, Yoon et al 1977,
James et al 1977]. Some studies even showed a deleterious effect by cholinergic
stimulation [Bergamaschi 1978, Scherlag et al 1982]. It seems that vagally-mediated
>20 >15 9-15 <9 <4
Baroreflex sensitivity (msec/mm Hg)
Introduction and Literature Review 14
HR reduction per se may partly explain these conflicting results [Verrier 1988, James
et al 1977]. For instance, in dogs with myocardial ischaemia, vagal nerve stimulation
or vagomimetic drugs only provides partial protection if HR is kept constant by
pacing [Verrier 1988]. Detrimental effect of excessive vagal activation may be owing
to resultant hypotension which further reduces blood supply to the ischaemic heart,
and to bradycardia which favours arrhythmias due to enhanced automaticity.
1.2.3 Neuronal Influence on Electrophysiology of Ischaemic Myocardium
The electrophysiological substrate for arrhythmogenesis in the setting of
ischaemia has been reviewed [Janse and Kleber 1981, Surawicz 1985]. Briefly, they
are 1) slow conduction of electrical impulses in the ischaemic region due to reduced
action potential and damaged cell-cell coupling; 2) unidirectional block as a result of
dispersion in refractoriness and reexitability; and 3) enhanced automaticity partly due
to the late-potential-triggered activation. All these aspects are under adrenergic and
cholinergic influences.
The electrophysiological effects of adrenergic stimulation in the heart are
mediated mainly through ^-adrenoceptors. These effects include 1) accelerated
diastolic depolarization of sinus cells or potential pacemaker fibres; 2) increased
conduction velocity; 3) decreased refractoriness in the A-V junction and His-bundle;
and 4) shortened action potential duration of Purkinje fibres and working myocytes.
During myocardial ischaemia, ^-adrenergic stimulation activates the slow inward
current (Isi) and decreases exitatory threshold, thereby maintaining the slow
conduction [Spinelli and Rosen 1989]. Both changes are in favour of the
establishment and maintenance of reentry [Surawicz 1985]. p-Stimulation may also
induce and augment late-potentials and automaticity of Purkinje fibres in ischaemic
regions via an enhanced Ca2+ influx [Han and Cameron 1985, Kimura et al 1987, Wit
and Rosen 1986]. Purkinje fibres within the infarcted zone are more resistant than
working myocytes to ischaemia [Cox et al 1973, Rossi 1985, Le Marec et al 1985],
and may show diastolic depolarization and automaticity with an enhanced sensitivity
to adrenergic stimulation [Han and Cameron 1985]. Another possibility linking
sympathetic activation to the arrhythmogenesis is the hypokaelemic effect of (3-
adrenergic stimulation [Verrier 1988]. It is well known that hypokalemia increases
the ventricular vulnerability to arrhythmias both clinically and experimentally
[Nordrehaug and Vander-Lippe 1983, Curtis and Hearse 1989].
In the normal heart, stimulation of a-adrenoceptors opposes the effects of (3-
stimulation and therefore is antiarrhythmic. During ischaemia, however, a-agonists
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enhance inward Na+ and Ca2+ currents, hence accelerate the speed of phase-4
spontaneous depolarization. a-Stimulation may also increase the magnitude of after-
depolarization and the resultant triggered-activity [Yamada et al 1988]. This may be
partly due to the increased aj-adrenoceptor numbers in ischaemic myocardium [Corr
et al 1981]. During reperfusion a- but not ^-adrenoceptors contribute to the
arrhythmogenesis [Penny 1984, Sheridan et al 1980, Corr et al 1986].
Vagal activation shows profound effect on supraventricular tissues and conduction
system. Stimulation of muscarinic receptors decreases slow inward Ca2+ and Na+
currents and increases outward K+ conductance. As a result, acetylcholine (ACh)
exerts a negative chronotropic effect in SA and AV node cells and results in a reduced
conduction in the AV junction. In ventricular myocardium, direct electro¬
physiological effects of vagal stimulation are modest. This is in keeping with a sparse
cholinergic innervation of the ventricles [Loffelholz and Pappano 1985]. However, in
the presence of an enhanced adrenergic activity, vagal stimulation or ACh
antagonizes electrophysiological effects of p-adrenergic stimulation on Purkinje
fibres and ventricular myocytes [Corr et al 1987]. In intact dogs, vagal nerve
stimulation alone or in the presence of [3-blockade has no effect on VF threshold.
When sympathetic activity is augmented by thoracotomy or by adrenergic
stimulation, a definite antiarrhythmic effect is demonstrated [Kent 1982, Verrier and
Lown 1978]. It is believed that the protective influence of vagal tone during
ischaemia is largely mediated through its anti-adrenergic action, e.g., depressing or
abolishing Isi, lengthening the effective refractory period, and inhibiting automaticity
[Spinelli and Rosen 1989, Corr et al 1986]. Speculatively, this may be due to the
presynaptic inhibition of NA release and modulation of intracellular cAMP/cGMP
production [Loffelholz and Pappano 1985, Levy 1984, Corr et al 1986, Thandroyen
et al 1983].
Part of vagal protection against arrhythmias is mediated by a HR-lowering effect.
In normal and ischaemic dog hearts, VF threshold is inversely related to HR [James et
al 1977]. Although bradycardia may lengthen the vulnerable period and increase the
appearance of VPB by the removal of overdrive [Scherlag et al 1982], the
contribution of these effects to the onset of VF is considered to be small [Epstein et al
1972].
Sympathetic activation exacerbates ischaemia-induced metabolic derangement.
Increase in heart rate and contractility further deteriorates the relation of energy
supply/demand. Enhanced lipolysis of endogenous triglycerides may initiate an
energy wasting cycle [Riemersma 1986, Grong et al 1986]. Accumulation of lactate,
H+, loss of intracellular K+, and increased circulating free fatty acids, are also more
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marked under adrenergic stimulation [Opie 1985, Knopf et al 1988, Gettes et al
1986]. All these metabolic factors could interfere with the electrical stability of the
ischaemic heart. In contrast, vagal activation is expected to antagonize those changes
at different levels.
1.2.4 Autonomic Imbalance and Ischaemic Arrhythmias
It has been well known that inhomogenous changes in electrophysiology, i.e.,
desynchronized activation and dispersed refractoriness, are critical in the genesis of
VF [Surawicz 1985]. If the autonomic influences on these electrophysiological
substrates are heterogeneous, the heart would be vulnerable to fibrillate. This
possibility has recently gained considerable attention [Inoue and Zipes 1988, Zipes
1990, Gettes et al 1986, Verrier 1988, Schwartz et al 1988a].
The electrical stability of the heart is influenced by sympatho-parasympathetic
interactions which occur at different levels. Impulses from afferent sympathetic and
vagal neurons are centrally integrated, a process influenced by high neuronal
activities. At the level of the heart, sympathetic and vagal outputs exert opposite
effects. The final net response is not simply an algebraic one [Levy 1984].
Presynaptically, ACh released from vagal nerves diminishes NA release from
neighbouring sympathetic terminals, and the converse is also true (vide infra).
Moreover, interactions also take place at the levels of postsynaptic receptors and
intracellular biochemical consequences. [Roeske and Yamamura 1983, Levy 1984]. It
is believed that the local interactions are important in ischaemic arrhythmogenesis
[Corr et al 1986, Zipes et al 1987], but this aspect has been studied little.
In many cases, sympathetic and parasympathetic nerves are activated
simultaneously during myocardial ischaemia and stressful conditions. Disturbing this
balance through vagal efferent blockade by atropine or vagotomy may result in a
substantial increase in the incidence of arrhythmias [Verrier and Lown 1984, Corr et
al 1987, Schwartz and Stramba-Badiale 1988]. In contrast, left sided sympathectomy
is protective [Schwartz et al 1976, Puddu et al 1988], as a relatively vagal-dominant
seems to be antiarrhythmic [Schwartz et al 1988a, Kleiger et al 1987]. Indeed, a
sudden autonomic imbalance, due either to withdrawal of vagal tone and/or increase
in sympathetic output, precedes VF [McAreavey et al 1986, Perez-Gornez et al 1979,
Adgey et al 1982, Schwartz et al 1988a]. Intracardiac sympathetic and vagal nerves
differ in their routes through the ventricular wall [Barber et al 1985, Zipes 1990].
Thus, selective myocardial damage to epi- or endo-layers of the ventricular wall may
preferentially interrupt one of the autonomic afferent and efferent limbs.
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Asymmetry of sympathetic tone during early ischaemia may also occur due to
several mechanisms, such as uneven adrenergic innervation [Pierpont et al 1984],
perineuronal inflammation [Rossi 1985, James 1983], ischaemia-induced regional
denervation and resultant changes in adrenergic sensitivity [Zipes 1990, Inoue and
Zipes 1987], nonuniform nerve discharge [Lathers et al 1978, Neely and Hageman
1990], or selective increase in adrenoceptor numbers [Corr et al 1981, Mukherjee et
al 1982]. It is possible that the antiarrhythmic effects of adrenergic blockade are
achieved by a uniform decrease in adrenergic stimulation, thereby preventing the
manifestation of uneven neuronal influence.
It is widely assumed that an enhanced catecholamine release in ischaemic
myocardium mediates the arrhythmogenic influence of sympathetic activation [Corr
et al 1986, Schomig 1989]. Prior to a detailed description of local NA release in
myocardial ischaemia and the working hypothesis of the project, a brief review of
cardiac neurotransmission and its presynaptic modulation will be presented.
1.3 Neurotransmission in the Heart
1.3.1 Innervation of the Heart
The heart receives dual sympathetic and parasympathetic innervation and its
function is under constant neuronal control.
The sympathetic efferent limb passes through intermediolateral columns of the
upper segment of spinal cord and synapses with preganglionic cardiac sympathetic
axons in the lateral grey columns. Preganglionic axons form synapses in the cervical-
thoracic ganglia. The inferior cervical and the first thoracic ganglia are fused together
forming the stellate ganglion. Cardiac nerves, usually three bundles, arise from these
ganglia on each side and form the cardiac plexus at the base of the heart. After
leaving the plexus postganglionic sympathetic axons run parallel to the coronary
arteries. The SA node and atria are mainly innervated by axons from right
sympathetic nerves. In the other parts of the heart, left sided sympathetic innervation
is dominant. The density of innervation in atria is about twice of that in the ventricle
[Levy and Martin 1979, Pierpont et al 1984]. The sympathetic innervation in
ventricles is inhomogeneous with a decreasing gradient from base to apex [Pierpont et
al 1984].
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The parasympathetic innervation of the heart originates from the dorsal vagal
nuclei in the medulla and forms the cardiac branches on each side. Some axons
synapse with postganglionic neurons in the cardiac vagal plexus. Others continue
through the plexus and form synapses with postganglionic neurons mainly located
within the atrial wall [Loffelholz and Pappano 1985]. The postganglionic neurons
give rise to short axons supplying the SA node, atrial myocardium and AV junction.
Histological and functional studies demonstrate the presence of ventricular ganglia,
although few in numbers, and cholinergic innervation of the His bundle and bundle
branches [Levy 1984, Zipes 1990]. Acetylcholine (ACh), choline acetyltransferase
and muscarinic receptors all exist in the ventricular myocardium. Vagal nerve
stimulation has definite effects on ventricular electrophysiology and contractility,
especially when sympathetic tone is high [Levy 1984, Verrier 1988].
1.3.2 Adrenergic Neurotransmission
Details of sympathetic neurotransmission has been reviewed extensively [Philippu
and Matthaei 1988, Knight et al 1989], and will be summarised here briefly.
Synthesis and storage ofNA
In adrenergic neurons, enzymes catalysing the formation of NA are synthesized in
the perinuclear region of the cell body and conveyed along the axons to the nerve
terminals, where NA synthesis takes place. The starting point, and also the rate-
limiting step, is hydroxylation of tyrosine by tyrosine hydroxylase. The formed dopa
is rapidly transformed into dopamine by dopa decarboxylase. Dopamine is then
transported into storage vesicles by a carrier. In the vesicle dopamine-|3-hydroxylase
(DBH) catalyses the conversion of dopamine to NA [Philippu and Matthaei 1988].
The storage vesicles contain a very high concentration of NA (>0.6 M) and ATP,
together with proteins (e.g. DBH, chromogranin A, calmodulin, synapsin I) and
various peptides. It is believed that NA may be bound to ATP resulting in a complex
without electrical charge. Chromogranins act as a matrix for the aggregation of NA
and ATP to form a gel. Thus, osmolality of the soluble components and the
concentration of "free NA" in the vesicles are low. There is a vesicular NA uptake
process, which plays a major role in accumulation and retention of NA from
axoplasm. Through the activity of Mg2+-dependent H+-ATPase located in the
vesicular membrane, protons are actively accumulated within the storage vesicle at a
concentration of as high as 10 mM, thereby creating a transmembrane H+
electrochemical potential of about 200 mV. The proton potential is the driving force
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of vesicular NA uptake. NA inward transport is coupled with proton extrusion
through a special carrier which is sensitive to reserpine-like agents. As a result, most
NA reuptaken from the synaptic cleft (vide infra) is stored in vesicles for further
release (Figure 1.5). This "pH-dependent trapping mechanism" keeps a very low
axoplasmic concentration of NA [Philippu and Matthaei 1988].
Exocytotic release
When an action potential is conducted to the nerve terminal by voltage sensitive
Na+ channels, depolarization of the neuronal membrane opens voltage-sensitive Ca2+
channels and hence leads to an increase in intracellular Ca2+ concentration of
approximately 1 fiM. Through the activation of Ca2+ sensitive proteins, this increased
Ca2+ facilitates vesicles approaching to and fusing with the presynaptic membrane and
spilling their contents into the synaptic cleft. ATP is required perhaps for vesicular
movement and to reestablish the ionic distribution afterwards. Together with the
release of NA, some co-transmitters like neuropeptide Y, ATP and proteins are also
expelled into the synaptic cleft (Figure 1.5) [Knight et al 1989].
Exocytotic NA release is 1) calcium and energy dependent, 2) accompanied with
co-transmitter release, and 3) modulated by presynaptic mechanisms (vide infra)
[Knight et al 1989].
Figure 1.5 Schematic illustration ofNA synthesis, storage, exocytotic release and clearance.
I = Tyrosine hydroxylase, II = Dopa decarboxylase, III = Dopamines-hydroxylase,
MAO-Monoamineoxydase, COMT=Catechol-0- methyltranferase
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Clearance ofNA released
Neuronal uptake (uptake^ plays a central role in the clearance of NA from the
synaptic cleft [Goldstein et al 1988, Iverson 1973]. This active NA transport is
energetically dependent on the electrochemical Na+ gradient (outside » inside)
created by Na+-ATPase which keeps axoplasmatic concentration of Na+ low. In the
heart, most NA released is uptaken through uptakej carrier and then returned to the
vesicles [Goldstein et al 1988, Dart et al 1984a]. Only a small fraction of NA, when it
is free in the axoplasm, is metabolized by monoamine oxidase (MAO) into inactive
3,4-dihydroxyphenylethylglycol (DOPEG). Uptakej carrier has a high affinity for NA
(Km=0.27 |iM) and for some other sympathomimetic amines [Iversen 1973]. As a
result, adrenaline (1-2% of total catecholamines) is also stored in the vesicle and
released during nerve stimulation. Inhibition of uptakej process with antidepressants
such as desipramine leads to an enhanced NA overflow and increased chronotropic
response during sympathetic nerve stimulation [Dart et al 1983, Docherty and
McGrath 1980]. In the rat heart, desipramine at the concentration of 0.01 (iM leads to
50% inhibition of the uptakej [Iversen 1973].
Released NA may also be uptaken by myocytes through a second uptake
mechanism, which is sensitive to corticosteroids but not to desipramine [Iversen
1973]. NA transported into cells is exposed to the action of MAO and catechol-O-
methyltransferase (COMT) and transformed into inactive metabolities, such as
DOPEG and normetanephrine. However, compared with neuronal uptakel5
extraneuronal uptake has a low affinity for NA (Km=252 (iM) and is of minor
importance [Iverson 1973, Dart et al 1984b, Goldstein et al 1988]. In addition, part of
the released NA is removed from the synaptic cleft by washout [Dart et al 1983].
Postsynaptic effects ofNA
The mechanisms of |3- and a-adrenergic signal transmission have been studied in
great detail and reviewed recently [Berridge 1988, Casey and Gilman 1988, Stiles
1989, Katz 1990, Brown and Birnbaumer 1988].
All 4 subtypes of adrenoceptors coexist in the heart. Three of them, pr, (32- and
a2-receptors, are coupled to the adenylate cyclase complex, which generates the
second messenger 3',5'-cyclic adenosine monophosphate (cAMP). Adenylate cyclase
complex is composed of at least three distinct protein components: receptors, which
recognize and bind ligands and interact with the second component of the complex - a
guanine nucleotide binding protein (G protein), that either stimulate (Gs) or inhibit
(G;) the next component - adenylate cyclase. G-proteins are heterotrimers comprising
three separate gene products termed a, P, and y subunits. The p and y subunits are
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identical for both Gs and Git while the a subunits differ, a subunits contain guanine
nucleotide-binding site and GTPase activity. Binding of NA with (3r and P2-receptors
leads to activation of Gs with a replacement of GDP by GTP . The a subunit then
dissociates from the P and y subunits. The free Gsa-GTP activates the catalytic subunit
of adenylate cyclase, thereby enhancing the production of cAMP. cAMP in turn,
binds to protein kinase (PK) resulting in dissociation of the regulatory subunits from
the catalytic subunits, thereby activating the kinase. cAMP-dependent PK catalyses
the transfer of phosphate groups from ATP to specific sites on intracellular proteins
whose functions are being regulated. A number of proteins are targets of cAMP-
dependent PK, including Ca2+ and K+ channels, sarcolemmal proteins like
phospholamban, contractile proteins, and metabolic enzymes responsible for
glycogenolysis and lipolysis. These changes enhance Ca2+ influx, uptake and release
leading to increased myocardial contractility and relaxation. Meanwhile, ATP
production is stimulated to meet the needs of the increased energy demand. Recent
studies have demonstrated that activation of Gs is able to regulate Ca2+, K+ and Na+
ionic channels independent of cAMP pathways [Brown and Birnbaumer 1988]. The
whole process is terminated by converting of Gsot-GTP into Gsa-GDP via the intrinsic
GTPase activity and inactivation of cAMP by a phosphodiesterase to 5'-AMP. In
addition, a tonic inhibition of adenylate cyclase comes from G;. Stimulation of several
receptors, such as a2-adrenoceptors, muscarinic cholinoceptors, or adenosine
purinoceptors, results in the dissociation of Gia from its J3y subunits, allowing the (3y
subunits to combine with the free Gsa, thereby inactivating Gsa.
Stimulation of the a-receptor leads to, via an unidentified G protein, enhanced
phosphatidylinositol-4,5-bisphosphate (PIP2) metabolism and turnover with the
consequent release of two second messengers, diacylglycerol (DAG) and
myoinositol-1,4,5-trisphosphate (IP3) into the intracellular milieu. IP3 mobilizes
endogenous Ca2+ stores, leading to the enhanced contraction of myocardium and
vascular smooth muscle. DAG activates protein kinase C, which increases both
extracellular Ca2+ influx and endogenous Ca2+ release from sarcoplasmic reticulum
[Berridge 1988].
1.3.3 Cholinergic Neurotransmission
ACh synthesis and storage
ACh is synthesized from choline and acetylcoenzyme A (AcCoA) in the axoplasm
of cholinergic nerve terminals. This reaction is catalysed by the choline-
acetyltransferase (ChAT). AcCoA is originally synthesized in the mitochondria and
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translocated to axoplasm. The other substrate, choline, is taken up from the
extracellular space (Figure 1.6). Choline is a charged polar molecule and can not
freely cross the cellular membrane. Cholinergic nerve terminals possess a high-
affinity choline uptake (HACU) carrier with a of 1-5 (iM [Ducis 1988] and
choline required for ACh synthesis is almost entirely transported by this carrier. This
is the rate limiting step for ACh synthesis. Inhibition of HACU carrier by 3-
hemicholinium leads to a parallel decrease in the rate of ACh synthesis and release.
Conversely, stimulation of vagal nerves results in an immediate increase in choline
transport. HACU carrier does not require energy directly but is highly dependent on
Na+-transport. It also exhibits some sensitivity to K+ and CI" ions. ACh synthesis per
se is a rather simple process and is capable of supporting a very high rate of synaptic
release. This is important as unlike NA, ACh itself is not recycled [Ducis 1988].
Each nerve varicosity contains thousands of vesicles and about 80% of all ACh is
stored within them. Concentration of ACh inside the vesicle (500-800 mM) is much
higher than that in the axoplasm (0.3 mM). The vesicular membrane contains a
bicarbonate stimulated Ca2+- or Mg2+-ATPase that drives the active transport of ACh.
Similar to NA storage, ACh transport into vesicles is dependent on a proton gradient






Figure 1.6 ACh synthesis,
storage, exocytotic release and
clearance in cholinergic nerve
terminals
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ACh release and inactivation
Exocytotic release of ACh occurs when an action potential reaches the terminals
and triggeres sufficient influx of Ca2+ to "destabilize" the storage vesicle. After
vesicles fusing with the presynaptic membrane, ACh and co-transmitters (ATP,
peptides and proteoglycan) are extruded into the synaptic cleft [Kilbinger 1988].
ACh diffuses to receptors and also comes in contact with acetylcholinesterase
(AChE) located at the cellular surface, where ACh is hydrolysed. Inhibition of AChE
by agents like physostigmine raises the overflow of ACh by a factor of 2-3 [Dieterich
et al 1978, Richardson and Szerb 1974]. The rate of ACh hydrolysis in the heart,
however, is much slower than that at neuromotor endplates. Therefore, washout from
the synaptic cleft is another important mechanism to terminate the action of ACh.
Indeed, in the perfused heart a large fraction of ACh appears in the coronary effluent
during nerve stimulation [Loffelholz and Pappano 1985]. About 50% of choline from
hydrolyzed ACh is reuptaken for ACh resythesis. Blocking the HACU carrier during
nerve stimulation causes enhanced overflow of free choline [Loffelhoz et al 1984].
Postsynaptic effects ofACh
Myocardial cholinergic receptors belong to muscarinic2 (M2) subtype. There are
several molecular mechanisms by which cholinergic signal transmission is achieved.
Binding of ACh to M2-receptors may directly activate an inward potassium current
(Iki) in sinus and AV node cells. Actually, the M2-receptor may be an integral part of
a K+-specific membrane channel (ACh-dependent K+-channel). Therefore, this
process is independent of a second messenger. Meanwhile, stimulation of M2-
receptors activates an inhibitory guanine-nucleotide-binding inhibitory protein (G;),
thereby decreasing AC activity and cAMP production. Furthermore, the guanylate
cyclase may be activated by binding of ACh to M2-receptors and thus intracellular
cGMP level is increased. The overall effect is that cellular K+ conductance is
increased and Ca2+ influx is inhibited [Kilbinger 1988, Watanabe 1984]. Studies have
shown a positive correlation between the accumulation of cGMP and the negative
inotropic effect of either ACh or vagal nerve stimulation. Furthermore, it is proposed
that stimulation of M2-receptors may activate breakdown of phosphatidylinositol and
thus produce IP3 and diacylglycerol. This is probably responsible for a "rebound"
positive inotropic effect after vagal nerve stimulation [Loffelholz and Pappano,
1985]. Vasoactive intestinal polypeptide (VIP) is present in parasympathtic neurones
as a co-transmitter with ACh. At high frequency of vagal nerve stimulation, the
released VIP mediates atropine-resistant vasodilatation, tachycardia and presynaptic
inhibition of ACh release [Hill et al 1990, Rand et al 1987, Fahrenkrug 1989].
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1.3.4 Presynaptic Modulation of Neurotransmitter Release
Concept ofpresynaptic modulation
Since the first description of enhanced NA overflow by a-adrenergic blockade in
1957 by Brown and Gillespie, the concept of presynaptic receptors which modulate
neurotransmitter release is generally accepted. Although efforts have been made to
identify and characterize the presynaptic receptors, especially those that regulate NA
release in the heart [Rand et al 1987, Sharma and Baneijee 1978], much of our
knowledge about this aspect comes from pharmacological studies.
Neurotransmitter release may be affected by a series of substances via different
pathways. Presynaptic modulation can be classified into four types according to the
site of origin of these modulators (Figure 1.7). 1) Automodulation: transmitter
released may interact with presynaptic receptors thereby enhance or inhibit further
release of the same transmitter; 2) Axo-axonal modulation: a transmitter release may
be modulated by a variety of substances released from adjacent neurons of a different
type; 3) Trans-synaptic modulation: after being stimulated by a neurotransmitter
postsynaptic tissues release a substance which crosses the synaptic cleft and acts on
relevant presynaptic receptors; and 4) Substances brought to nerve terminals via the
circulation and then acting on relevant presynaptic receptors.


















Figure 1.7 Schematic diagram ofpresynaptic modulation ofNA release. The numbers correspond to
the types described in the text. + facilitatory - inhibitory
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Presynaptic receptors modulating neuronal NA and ACh release from peripheral
nerve terminals in the heart are listed in Table 1.1 [Fuder 1985, Langer 1981,
Kilbinger 1988].
Table 1.1 Presynaptic receptors activating (+) or inhibiting (-) sympathetic and parasympathetic















Feedback inhibition of NA release mediated by presynaptic (^-adrenoceptors has
been well defined. Activation of presynaptic c^-receptors by NA released suppresses
further release of NA in the in vivo and in vitro heart or atria. a2-Antagonists could
block this inhibition, hence leading to an enhanced release of NA and of large
molecular substances like dopamine-P-hydroxylase, chromogranin and neuropeptide
Y [Starke 1987, Haass and Schomig 1989]. The operation of this negative feedback
mechanism requires a threshold concentration of NA in the synaptic cleft. When the
neuronal uptakej is inhibited, this negative feedback mechanism is enhanced
apparently due to an increased NA level in the synaptic cleft [Langer 1981]. The
magnitude in reduction of NA by way of a2-agonist stimulation is more pronounced
at low frequency nerve stimulation and disappears at high frequencies [Medgett et al
1978, Starke 1987]. On the other hand, the efficacy of a2-antagonist in increasing NA
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all presynaptic a2-receptors [Fuder et al 1984, Langer 1981, Starke 1987]. The
mechanism of this autoinhibition is due to Grmediated inhibition of Ca2+-dependent
intra-axonal mechanisms leading to NA release [Rand 1987]. There have been some
studies which suggest the presence of inhibitory oq-receptors on the adrenergic nerve
endings [Strarke 1987, Story et al 1985]. Recently, 3 subtypes of a2-adrenoceptors
(a2A, a2B and a2C) have been described based on pharmacological and molecular
biological evidence [Bylund 1988]. The implication of these subtype a2-receptors is
to be studied.
The co-transmitter neuropeptide Y (NPY) can stimulate presynaptic NPY-
receptors thereby inhibiting the release of NA as well as NPY itself [Potter 1987,
Haass and Schomig 1989].
At a low frequency of nerve stimulation, evoked NA release may be facilitated
through activation of presynaptic p-adrenoceptors [Yamaguchi et al 1977].
enhances
Isoprenaline NA release from the heart in vitro and in vivo. In the presence of
propranolol neuronal NA release is slightly reduced [Langer 1981]. It is believed that
facilitatory [3-receptors are mainly activated by circulating adrenaline [Adler-
Graschinsky and Langer 1975, Langer 1981]. The magnitude of this facilitation varies
and some studies find that it is rather small or undetectable [Fuder 1985, Cousineau et
al 1984, Dart et al 1984b].
A similar inhibitory feedback mediated by presynaptic muscarinic receptors also
exists for cholinergic neurotransmission in the heart. Atropine enhances and ACh or
methacholine, an ACh analogue, inhibits vagal stimulation-induced ACh release in
the in vitro heart [Loffelholz et al 1984]. Meanwhile, the co-transmitter VIP may
inhibit ACh release presynaptically [Fahrenkrug 1989].
Axo-axonal modulation
Reciprocal modulation between sympathetic and parasympathetic nerves is the
most important axo-axonal modulation in the heart. In the in vivo and in vitro heart,
exocytotic NA release can be inhibited by vagal nerve stimulation or ACh infusion
[Fuder et al 1985, Wetzel and Brown 1985, Levy 1984, Lavallee et al 1978].
Preservation of ACh in the biophase by cholinesterase inhibitors leads to enhanced
inhibition of NA release [Fuder et al 1985]. Similar inhibitory effects can be achieved
by using muscarinic agonists like methacholine. Pharmacological and ligand binding
studies suggest that pre- and post-synaptic M-receptors are similar.
A number of studies have shown that a2-adrenergic agonists may also inhibit
exocytotic ACh release in the heart [Rand et al 1987]. The presynaptic a-receptors
mediating this inhibition are a2-subtype, although presynaptic arreceptors may also
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be involved [Wetzel et al 1985, McGrattan et al 1987]. However, there has apparently
been no study to demonstrate that endogenous NA released by sympathetic nerve
stimulation modulates ACh release from adjacent vagal terminals. In the in vivo dog,
the influence of the vagus on R-R intervals is attenuated by sympathetic nerve
stimulation. This inhibition is mainly mediated by a co-transmitter NPY, not by
presynaptic a-adrenoceptors, because the effect remains in the presence of oc-
antagonists and is mimicked by exogenous NPY [Hall and Potter 1990, Warner and
Levy 1989, Potter 1987]. Therefore, these results question the role of a-receptor-
mediated inhibition of ACh release during sympathetic nerve stimulation. However,
the release of transmitters involved was not directly measured in these studies.
Inhibition of ACh exocytosis by NPY in the heart has not been demonstrated.
Trans-synaptic and other modulations
Sympathetic stimulation of the heart is accompanied by increased production of
adenosine secondary to an enhanced degradation of adenosine phosphates [Headrick
et al 1989]. Adenosine can inhibit NA release through activation of A;-presynaptic
receptors, an effect blocked by Aj-receptor antagonist such as 8-phenyltheophylline
[Fuder 1985, Richardt et al 1989, Rand et al 1987]. Under basal conditions, the
biophase level of adenosine in the heart is far below the threshold necessary to inhibit
NA release (about |iM level). However, under conditions of enhanced adrenergic
stimulation, myocardial hypoxia or ischaemia, extracellular concentrations of
adenosine are high enough to exert this inhibition [Edlund et al 1983, Richardt et al
1987 and 1989, Headrick et al 1989]. This trans-synaptic modulation provides an
important feedback control, thereby attenuating the intensity of adrenergic stimulation
when myocardial energy supply/demand relation is compromised. ACh release is
similarly inhibited by adenosine in other organs [Dun6r-Engstrom and Fredholm
1988, Gustafsson et al 1978]. Therefore, it may be an alternative and indirect way by
which sympathetic nerve activation affects ACh release in the heart.
Membrane phospholipase-A2 is also activated by the adrenergic stimulation. This
is accompanied by an increased lipolysis of membrane phospholipids and subsequent
prostaglandin (PG) production. In the perfused heart, prostacyclin (PGI2) is the major
product from arachidonic acid (20:4n-6) [Wennmalm et al 1987, Lamers et al 1987].
Infusion of PGI2 and PGE series into the heart reduces NA release [Langer 1981,
Khan and Malik 1982, Fuder 1985]. Locally produced PGs may also have a similar
effect [Edlund et al 1983]. Blocking the synthesis of PGs by cyclooxygenase
inhibitors, like indomethacin, increases NA release in some studies, but not in others
[Langer 1981, Fuder 1985].
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Serotonin and 5-hydroxytryptamine can also be locally synthesized and released
by myocardium, platelets and endothelium, especially during pathological conditions
like ischaemia, and facilitate NA release [Thandroyen et al 1985, Rand et al 1987].
In the heart, the existence of gene expression of renin and angiotensinogen, and local
conversion of angiotensin I to angiotensin II have been demonstrated [Lindpaintner et
al 1988, Dzau 1988]. Therefore, locally generated angiotensin II may facilitate NA
release, especially when angiotensin II production is increased by adrenergic
stimulation [Nakamuru et al 1986].
A series of substances carried by the blood stream may reach relevant receptors
on sympathetic nerve terminals in the heart, thereby modulating exocytotic NA
release. Some of these non-synaptic modulations may be of physiological and
pathological importance, such as the facilitatory effect by angiotensin II, adrenaline,
serotonin and 5-hydroxytryptamine [Rand et al 1987, Langer 1981, Corr et al 1986].
Atrial natriuretic factor, a peptide synthesized in the heart, may inhibit exocytotic NA
release in non-cardiac tissues [Nakamuru and Inagamin 1986, Kuchel et al 1987].
A milieu of high K+ and low pH interferes with action potential propagation in
neurons, thereby presynaptically inhibiting transmitter release [Puig and Kirpekar
1971, Forfar and Riemersma 1987, Sanchez-Prieto et al 1987]. This mechanism may
not be of importance during normoxic conditions but is of potential significance
during myocardial ischaemia when tissue pH falls.
Thus, presynaptic modulation of transmitter exocytosis and subsequent
postsynaptic effects are extraordinary complex. Most of our knowledge has been
obtained under well perfused, well oxygenated conditions. Endogenous
neuromodulators, although present in small amounts under normal conditions, can be
synthesized and released in greater quantities during a variety of pathological
conditions, thereby playing a more important role in modulation of transmitter release
and subsequently of cardiac function and electrophysiology.
1.4 Catecholamine Release in Early Myocardial Ischaemia
In acute myocardial ischaemia, enhanced sympathetic activity may have
beneficial as well as deleterious consequences. On the one hand, adrenergic
stimulation of the cardiovascular system is necessary to compensate for acute loss of
pump function. On the other hand, catecholamines accelerate the progression of
ischaemic cell damage [Elson et al 1981, Rona 1985] and initiate malignant
ventricular arrhythmias [Corr et al 1986, Verrier 1988]. Concomitant increase in
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adrenoceptor number and perhaps the maintained intracellular signal transduction in
ischaemic myocardium (vide infra) exaggerate these detrimental influences.
Thus deleterious effects of sympathetic activation on myocardium depend on local
catecholamine concentrations and receptor mediated signal transduction.
Theoretically, enhanced catecholamine stimulation to the heart could be due to both
increased plasma concentration of catecholamines and local release from the
sympathetic nerve terminals in the myocardium.
1.4.1 Elevation of Circulating Catecholamines
Plasma catecholamine concentrations are raised in patients with acute MI
[Karlsberg et al 1981, Bertel et al 1982, Goldstein 1981, Nadeau and de Champlain
1979] and remain elevated for at least 48 hours [Benedict and Graham-Smith 1979,
Nadeau and de Champlain 1979]. In dogs with experimental MI, progressive
elevation in plasma catecholamines occurs within the first 60 min [Corr and Gillis
1978, Forfar et al 1984, Godin et al 1985, Daugherty et al 1986], especially in
conscious animals [Karlsberg et al 1979]. The magnitude of this increment varies
from just above normal range to over ten-fold, largely depending on the extent ofMI
and impairment of ventricular function [Schomig et al 1984b, Karlsberg et al 1979
and 1981, Benedict and Graham-Smith 1979].
Some clinical studies revealed an association between plasma levels of
catecholamines and severity of ventricular arrhythmias [Nadeau and de Champlain
1979, Bertel et al 1982, Goldstein 1981]. However, this association may also be
explained by a bigger infarct size and more severe ventricular dysfunction (Section
1.1.3). It is assumed that the initial increase in catecholamine levels at the onset of
acute MI may be more meaningful [Goldstein 1981]. But there is no temporal relation
between onset of arrhythmias and plasma catecholamine levels, arguing against a
direct effect of circulating catecholamines [Riemersma and Forfar 1982]. In
experimental studies, adrenalectomy or ligation of the adrenal vein attenuates the
elevation of plasma catecholamine but does not reduce the onset of VT or VF [Corr
and Gillis 1978, Daugherty et al 1986]. Very high levels of plasma catecholamines,
which can be toxic to myocardium, are observed only in patients with severe pump
failure [Goldstein 1981, Benedict and Graham-Smith 1979]. Moreover, reduced blood
supply to the ischaemic region limits the effects of circulating catecholamines there.
Thus, enhanced circulating catecholamines provide evidence for an overall
sympathetic activation. However, as discussed above, it may be unimportant for the
development of ventricular arrhythmias. Furthermore, as the contribution of cardiac
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catecholamines to the circulating pool is small (3%) [Goldstein et al 1988] and is
limited by a reduced washout from the ischaemic myocardium. Thus circulating
catecholamines do not provide a sufficiently sensitive index to reflect local
catecholamine spillover in ischaemic myocardium.
1.4.2 Neuronal NA Release in Ischaemic Myocardium
In vivo NA release from ischaemic region
As enhanced circulating catecholamine level and cardiac efferent tone occur soon
after myocardial ischaemia, it is generally assumed that there is enhanced neuronal
NA release from the heart. However, most clinical and experimental studies do not
support this view. In man, a short period of coronary occlusion (0.5-2 min) did not
evoke NA overflow from the heart [Schwartz et al 1979, Schomig 1988, Richardt et
al 1990], although an increase in arterial NA level was noticed in one study [Richardt
et al 1990]. Similarly, experimental studies cannot find increased NA overflow into
ischaemic effluent [Forfar et al 1984, Godin et al 1985, Yamaguchi et al 1990], or a
small amount if it did occur [Hirche et al 1980].
This technique, however, disregards the influence of NA clearance. Actually
neuronal uptake increases during early ischaemia in man and in animals [Richardt et
al 1990, Riemersma and Forfar 1982, Dart 1989], presumably because reduced
washout increases the retention of NA in the synaptic cleft. Recently, using 3H-NA
kinetic analysis, allowing assessment of NA spillover and clearance separately,
McCance and Forfar have found that cardiac NA spillover is higher in patients with
recent ischaemic symptoms than those with stable angina. During exercise, cardiac
NA spillover is 67% higher in those who developed ischaemia than those who did not
[McCance and Forfar 1989a and 1989b].
Experimental and clinical studies in vivo all show enhanced NA overflow during
the first few minutes of reperfusion following a period of ischaemia [Forfar et al 1984
and 1985, Godin et al 1985, France-Cereceda et al 1990, Yamaguchi et al 1990].
The pattern of this reperfusion NA overflow fits the one compartmental model, thus
suggesting that this is washout of NA accumulated in the extracellular space, rather
than released by reperfusion per se. Although the mechanism of this NA release is
still unclear, several observations indicate the possibility of exocytosis: 1) Increased
NA overflow during reperfusion is accompanied by an enhanced overflow of
neuropeptide Y [France-Cereceda et al 1990], a co-transmitter released only by
exocytosis [Haass and Schomig 1989]; 2) Blockade of a2-adrenoceptors or neuronal
uptakej enhanced this reperfusion NA overflow [Forfar et al 1985]; 3) In the
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ischaemic area, a typical ultrastructural change of sympathetic nerve terminals
observed is a profound reduction in the number of dense-cored synaptic vesicles
[Muntz et al 1984] without simultaneous increase in empty vesicles, as in the case of
inhibited vesicular storage of NA by reserpine treatment [Tranzer and Richards
1976]. This morphological change suggests enhanced exocytosis.
Although most studies failed to find an increase in local NA level in ischaemic
venous effluent during acute myocardial ischaemia, a reduction in myocardial NA
content is a consistent observation in various species in vivo [Muntz et al 1984,
Kaufman and Jugdutt 1987, Hirche et al 1985, Schwaiger et al 1987, Abrahamsson
1982, Mukherjee et al 1979]. This change becomes evident within the first 30-60
mins. In some studies, ischaemia of 5-20 min with or without reperfusion reduces
myocardial NA content by 30-40% [Schwaiger et al 1987, McDonald et al 1986]. In
dogs reduction of intraneuronal NA precedes that of myocardial NA content,
indicating a redistribution of NA within ischaemic area [Muntz et al 1984].
Meanwhile, the rate and extent of reduction of NA content vary according to the
severity of ischaemia [Muntz et al 1984, Schmid et al 1982]. Temporary reduction in
NA content in non-ischaemic myocardium also occurs in the first few days after acute
ischaemia [Mathes et al 1971, Seth etal 1974].
Nerve stimulation-induced NA release from ischaemic myocardium
In the anaesthaetized dog, when nerve stimulation is given early during a period
of coronary artery occlusion, there is significant rise in NA concentrations in the
venous blood from both ischaemic and non-ischaemic myocardium. After 30 min
ischaemia, however, such stimulation is ineffective in eliciting a rise in NA in
ischaemic venous effluent [Forfar et al 1984]. These observations are supported by
other studies using functional responses (effective refractory period or segmental
contraction) as endpoints to nerve stimulation [Martins et al 1980, Inoue and Zipes
1988].
Dart et al described an in situ perfused and innervated rat heart model in which
left sympathetic ganglion stimulation evokes a frequency-dependent NA overflow
into coronary effluent [Dart et al 1983 and 1984b]. This model has advantages of
precise control of coronary flow and other relevant experimental conditions and
therefore more suitable for quantitative studies than the in vivo dog model. By
stimulating sympathetic nerves during a period of stop-flow ischaemia followed by
reperfusion, the amount of NA overflow can be quantified and compared with that
induced by nerve stimulation during normoxic perfusion [Dart et al 1984b]. After
stopping coronary flow or reducing the flow rate by 95% for 1 to 10 min, a reduction
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in NA overflow to about 20-30% of control values was observed (Figure 1.8) [Dart et
al 1984b, Dart and Riemersma 1985, Schdmig 1988]. In the presence of the neuronal
reuptake inhibitor desipramine, the suppression of NA overflow during the first few
minutes of stop-flow or low-flow ischaemia is restored to some extent, thereby
indicating the importance of neuronal reuptake (Figure 1.8) [Dart et al 1984b, Dart
and Riemersma 1985]. The efficacy of the neuronal reuptake of NA shows
progressive decline during energy depletion mimicked by glucose-free perfusion and
anoxia or cyanide intoxication [Schomig 1989]. Despite this, neuronal NA overflow
during the later period of a 15 min stop-flow ischaemia is again depressed in the
presence of desipramine [Dart et al 1984b, Dart 1989]. This suggests a failure of
neurotransmitter release at this time. When stop-flow ischaemia lasts for more than 15
min there is a progressively enhanced spontaneous NA overflow during reperfusion
[Schomig et al 1984a]. The magnitude of this NA overflow is too big to allow any
detection of additional nerve stimulation evoked NA release at this period of
ischaemia [Dart et al 1984b]. In contrast to the role of neuronal reuptake,
extracellular uptake is of minor importance in the heart both in normoxia and
ischaemia [Goldstein et al 1988, Dart et al 1984b].
Duration of myocardial ischaemia (min)
Figure 1.8 NA overflow induced by electrical stimulation of left stellate ganglion in the perfused rat
heart subjected to 1-10 min period of stop-flow ischaemia followed by reperfusion. Data are given as
the ratio of the amount ofNA overflow evoked by the first (SI in normoxia) and the second (S2 in
ischaemia) stimulations [Schomig 1988, Dart 1989],
Mechanism of reduced exocytotic NA release
Several possible mechanisms may account for reduced neuronal NA release
during early ischaemia.
1) Presynaptic inhibition Of the substances that may inhibit the exocytotic NA
release via presynaptic receptors (Section 1.3.4), two possibilities have been explored
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in the setting of myocardial ischaemia so far. In the in vivo dog heart subjected to a
period of coronary ligation (<12 min), the rise in the ischaemic venous effluent NA
level during sympathetic ganglion stimulation was increased by the a2-adrenergic
antagonist yohimbine [Forfar et al 1987]. In the perfused rat heart addition of
yohimbine did not lead to a further increase in neuronal NA release within 10 min
stop-flow ischaemia [Dart et al 1984b]. This discrepancy may be due to a mild
ischaemia in the dog study with a residual blood flow of 0.3-0.4 ml/g/min in
comparison to normal flow of 0.8-0.9 ml/g/min [Forfar et al 1987].
Inhibition of NA release by adenosine in early ischaemia has been examined.
Within a few min of stop-flow ischaemia, extracellular adenosine reaches micromolar
concentrations capable of inhibiting neuronal NA release [Headqvist and Fredholm
1989, Richardt et al 1987]. Adenosine receptor antagonists restored the suppressed
NA overflow to control levels within 3 min of ischaemia, but not when ischaemia was
extended to 10 min [Richardt et al 1987]. Inhibition of sympathetic neurotransmission
by exogenous adenosine has also been demonstrated in the in vivo dog heart with and
without ischaemia [Miyazaki and Zipes 1990, Forfar and Riemersma 1987].
2) High extracellular potassium and acidosis In the first minutes of ischaemia,
there is a progressive increase in extracellular concentrations of K+ and H+ [Hill and
Gettes 1980, Kleber 1984, Lavanchy et al 1986]. These may modify the resting and
act on potentials of neuronal membranes and Ca2+ influx, thereby interfering with NA
release.
In the in vivo dog heart, NA overflow is inhibited by intracoronary infusion of 10
mM K+, and facilitated by infusion of high K+ (75 mM) which leads to a 3-fold
increase in K+ concentration (9 mM) in venous blood [Forfar and Riemersma 1987].
In another study in dogs, sympathetic neurotransmission in the heart is prevented by
increasing the extracellular K+ to 12 mM [Miyazaki and Zipes 1990]. In isolated
canine veins, 3H-NA release elicited by electrical stimulation is suppressed by K+
with a dose-dependent manner in the range of 6-20 mM [Lorenz and Vanhoutte
1975]. In another careful study, however, 3H-NA release from canine coronary
arteries is enhanced by K+ of 10-15 mM and inhibited when exposed to 40 mM K+
[Borda et al 1977].
In the dog heart and cat spleen, a low pH of 6.3-6.4 significantly suppressed
sympathetic neurotransmission and NA release [Miyazaki and Zipes 1990, Puig and
Kirpekar 1971]. Using the perfused guinea-pig heart, Haass et al [1990] show that
exocytotic NA release was also suppressed by acidosis (pH=6.0). In the innervated rat
heart, however, perfusion with low pH of 6.5, evoked NA overflow was not affected,
although its postsynaptic effect is markedly suppressed [Dart and Riemersma 1989].
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3) Energy depletion in the nerve terminal Myocardial ischaemia is
associated with reduced high energy phosphates. The effect of energy depletion was
examined in the innervated rat heart perfused at constant flow rate, thereby avoiding
the interference of accumulated H+, K+ and metabolites. During anoxia and glucose-
free perfusion (replaced by lactate), there is a rapid fall in the amount of neuronal NA
overflow [Dart et al 1987]. Omission of glucose, but maintaining the oxygen supply,
also leads to a progressive decline in NA overflow but less rapid. In contrast, anoxia
per se has no discernable effect on evoked NA release provided exogenous glucose
supply is maintained [Dart et al 1987, Dart and Riemersma 1989]. Thus, it seems that
exogenous glucose supply plays a vital role in the maintenance of an effective
exocytotic release of NA. Similarly, glycolytic energy production is of pivotal
importance in preventing the non-exocytotic NA release (vide infra) [Dart et al 1987,
Carlsson 1988, Schomig et al 1987]. Indeed, the major route of ATP production in
cultured sympathetic neurons is via anaerobic glycolysis and only a small amount
ATP supply is necessary to maintain normal nerve function [Wakade and Wakade
1985].
In summary, during early ischaemia and enhanced sympathetic activity, an
increase in local NA concentration is counteracted by an effective presynaptic
inhibition and neuronal reuptake. The ability of neurons to release NA is maintained.
Later, there is a failure of the exocytotic release of NA, presumably due to reduced
ATP supply, in which impaired glycolytic energy production is of particular
importance.
1.4.3 Non-Exocytotic NA Release in Myocardial Ischaemia
In the isolated perfused rat heart subjected to stop-flow ischaemia, there is a
progressive "spontaneous" NA overflow during subsequent reperfusion, when
ischaemia exceeds 15 min [Schomig et al 1984a]. The data indicate that 90% of total
*
NA overflow is washout from the extracellular space [Schomig et al 1984a, 1985].
Dart and Riemersma showed a fair correlation between the overflow of NA and
washout of an extracellular space marker [1988]. The quantity of NA overflow during
late ischaemia greatly surpasses that achieved by tonic nerve stimulation [Dart et al
1984b, Schomig et al 1984a]. Thus, assuming an uniform NA distribution in the
extracellular space, it is estimated that after 20-40 min total ischaemia extracellular
NA concentration may reach 1-6 (iM range [Schomig et al 1984a], a level which is
toxic even to non-ischaemic myocardium [Rona 1985, Waldenstrom et al 1978].
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Blocking substrate metabolism (oxidative phosphorylation and anaerobic
glycolysis) can mimic ischaemia-induced NA release. Anoxia itself or blockade of
aerobic metabolism could not trigger such release [Dart el al 1987, Schomig et al
1987, Carlsson 1988]. Furthermore, non-exocytotic release of NA never occurs
within the first 10-15 minutes of stop-flow ischaemia. This delay is believed to be due
to an ongoing glycolytic ATP production from endogenous glycogen [Dart et al 1987,
Schomig et al 1987, Carlsson 1988]. However, in the isolated perfused rabbit heart,
anoxia in the presence of exogenous glucose supply evokes an immediate overflow of
NA which peaks within 10 min of anoxia [Wollenberger and Shahab 1965,
Karwatowska-Krynska and Beresewcz 1983]. The reason for this discrepancy is
unclear.
The ischaemia-induced NA release differs from the exocytotic release in several
aspects. It is independent of extracellular Ca2+ and not modulated by presynaptic
mechanisms [Schomig 1988]. The relation of non-exocytotic NA release and co-
transmitter release has not been studied during ischaemia, although a co-release of
NPY has been found in guinea pig heart during anoxia and glucose-free perfusion
[Haass and Schomig 1989]. In contrast to exocytotic release which is increased by
blocking neuronal reuptake, inhibition of uptake carrier by desipramine suppresses
this release up to 60 min of stop-flow ischaemia [Schomig et al 1987]. This indicates
the involvement of the uptake carrier in ischaemia-induced NA release. Schomig and
his colleagues [1984a, 1987 and 1988] hypothesize that this ischaemic release of NA
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During myocardial ischaemia energy exhaustion interferes with both NA vesicular
storage and reuptake mechanisms. As discussed in Section 1.3.2, a transmembrane
proton electrochemical potential, created through the activity of membrane H+-
ATPase, is the driving force of vesicular NA uptake. ATP depletion could lead to
reduction of the H+-induced potential, followed by loss of NA from vesicles into
axoplasm. As a result of anoxia, axoplasmic NA is largely protected from the
degradation by monoamine oxidase (MAO, Km oxygen = 50 mm Hg) [Carlsson et al
1986, Schomig et al 1987]. Meanwhile, energy deficiency inhibits the activity of
Na+/K+ ATPase on neuronal membranes. Developed intracellular acidosis during
ischaemia may result in an enhanced Na+/H+ exchange. Both changes could lead to
enhanced concentration of Na+ in the axoplasm. As the sodium gradient is the
determinant for the carrier transport direction, accumulation of Na+ in axoplasm
initiates a carrier-mediated efflux of NA from axoplasm into the extracellular space
[Schomig et al 1984a, 1987, 1989]. When the duration of ischaemia exceeds 40 min,
inhibition of neuronal uptake no longer suppresses NA release [Schomig et al 1984a],
perhaps because NA efflux at this stage is largely due to ischaemia-induced
membrane disintegration. The difficulty in proving this hypothesis is that it is not
possible to measure axoplasmic NA and Na+ concentrations. However, experimental
simulation of the above mentioned prerequisites, i.e., increase in the axoplasmic NA
concentration, inhibition of MAO activity, and intracellular accumulation of sodium,
could induce a similar carrier-mediated NA efflux [Schomig et al 1988].
Using isolated perfused rat heart model, arrhythmogenic effect of NA release via
this mechanism has been demonstrated [Riemersma et al 1986b, Dietz et al 1989].
However, further work is required to examine whether this carrier-mediated NA
efflux occurs in the in vivo ischaemic heart.
1.4.4 Effects of Ischaemia on Postsynaptic Adrenergic Signal Transduction
Postsynaptic adrenergic signal transduction in ischaemic myocardium has been
intensively studied and reviewed [Thandroyen et al 1990, Strasser et al 1988,
Yamada et al 1988, McGrath 1989], and will be briefly summarized here.
Increased P- [Thandroyen et al 1990, Mukherjee et al 1979 and 1982, Strasser et
al 1990, Reddy 1989, Yatner et al 1988] and a-adrenoceptor density [Corr et al 1981,
Dillon et al 1988, Yamada et al 1988] in ischaemic myocardium has been reported in
various species and models, although not always [Corr et al 1981, Dillon et al 1988].
In the dog, rat and guinea pig heart, P-receptor number show progressive increase
over the first 1-2 hour period of ischaemia starting within 15 min [Maisel et al 1985,
Reddy 1989, Strasser et al 1990, Mukherjee et al 1979]. This increase lasts at least 5
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hours in the in vivo ischaemic dog heart [Devos et al 1985]. The magnitude of
increased receptor number varies between 20% to over 100%. In cats, the density of
a-receptors increased over 3-fold within 30 mins of ischaemia [Corr et al 1981]. One
study shows a 49% increase in (3j-receptor number in the perianeurysmic myocardial
tissues from patients with recurrent sustained VT [Bevilacqua et al 1986].
Mechanisms for this increase in receptor density are still undefined but at least two
possible mechanisms have been proposed. One possibility is an increased receptor
externalization during ischaemia owing to depletion of energy and an impaired
desensitizing process, normally seen during high adrenergic stimulaton [Maisel et al
1985, Strasser et al 1988, Thandroyen et al 1990]. Corr and his co-workers have
demonstrated an association of the increase in long-chain acylcarnitine levels and oc-
receptor numbers in hypoxic myocytes. Both events are completely prevented by the
inhibition of carnitine acyltransferase [Yamada et al 1988]. Thus, in ischaemic
myocardium increased long-chain acylcarnitine may be inserted into membranes,
thereby exposing those internal and functionally uncoupled adrenergic receptors. As
the receptor affinity and the fraction of receptors coupled with adenylate cyclase is
unchanged in ischaemia, the total number of functional (3-receptors is increased
[Maisel et al 1985, Strasser et al 1988].
Substantial data show that arreceptors mediate arrhythmic effects of
catecholamine stimulation during ischaemia and reperfusion, probably via an
enhanced calcium influx [Yamada et al 1989, McGrath 1989, Sheriden et al 1980].
This effect is found only during early ischaemia and reperfusion but not during non-
ischaemic conditions [Sheridan et al 1980], suggesting an enhanced a-adrenergic
signal transduction. However, the relevant intracellular events, like increased
phosphatidylinositol turnover, release of IP3 and diacylglycerol, and (Xj-stimulation
mediated Ca2+ influx remain to be defined.
There is some disagreement on the coupling of increased (3-receptors and Gs-
adenylate cyclase activity during ischaemia. A maintained adenylate cyclase activity
is supported by increased cAMP levels in ischaemic myocardium [Thandroyen et al
1986, Ohyanagi et al 1988]. Isoprenaline-induced stimulation of adenylate cyclase is
found to be enhanced in some studies [Maisel et al 1985, Mukherjee et al 1979], but
reduced in others [Strause and England 1982, Devos et al 1985, Vatner et al 1988,
Will-Shahab et al 1985, Reddy 1989]. Strasser et al [1990] demonstrate an transcient
increase in adenylate cyclase activity at 15 mins of ischaemia followed by a
progressive decline. This can be is partly explained by an effect of adenosine and
acidosis [Reddy 1989]. Thus, the functional significance of increased [3-receptors is
questionable. However, recent studies suggest that the signal transduction of (3-
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stimulation may be achieved at least by two pathways (Section 1.3.2). Gs-mediated
activation of adenylate cyclase probably remains effective during early ischaemia
[Strasser et al 1990, Strause and England 1982]. Increased p-receptor density may
also couple with Ca2+, K+ and Na+ channels via cAMP-independent pathways [Brown
and Birnbaumer 1988]. The importance of this receptor-Gs-ion channel pathway in
arrhythmogenesis remains to be elucidated. The effectiveness of P- and a-
adrenoceptor blockers in the protection against ischaemic damage and ventricular
arrhythmias during prolonged ischaemia and infarction also indicate an effective
postsynaptic signal transduction [Corr et al 1986, Norris et al 1984, Peter et al 1978].
1.5 Questions and Working Hypothesis
In the rat heart subjected to stop-flow ischaemia, three phases of NA release via
different mechanisms has been proposed: exocytosis (<10 min), carrier-mediated
efflux (10-40 min) and leaky diffusion (>40 min) [Schomig et al 1984a, 1988]. When
extrapolating these findings to the in vivo condition, however, one of the major
limitations is the severity of ischaemia. Complete cessation of blood flow in vivo may
be rare both in man and various animal species [Rentrope et al 1985, Piek and Becker
1988, Reimer et al 1987, Maxwell et al 1987]. Considering the importance of energy
supply for the maintenance of exocytosis and prevention of non-exocytotic efflux,
severity of flow reduction may be critical in determining the time-course of
deterioration of sympathetic nerve function.
A variety of substances can modulate the exocytotic release of NA (Section
1.3.4). Although presynaptic a-adrenergic and purinergic inhibition on NA release
has been examined in the ischaemic heart to some extent [Forfar et al 1983, Dart et al
1984b, Richardt et al 1987], the importance of presynaptic control of NA release
during ischaemia cannot be fully derived from these rather limited data. Of the many
other presynaptic modulatory mechanisms not examined, vagal nerve activation
mediated inhibition of NA release is of great interest. It is believed that this
presynaptic inhibition of exocytotic NA release contributes to vagal protection against
ischaemic arrhythmias (Section 1.2.2). But vagal-sympathetic interactions during
ischaemia have rarely been studied.
As summarized in Section 1.1.3, several factors may modify the susceptibility of
the ischaemic heart to VF. The relevant mechanisms, however, are largely unknown.
As neuronal activity have profound impact on the electrical stability of the ischaemic
heart, it would be reasonable to speculate that some of these factors may exert their
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influence on the arrhythmogenesis through a modulation of autonomic
neurotransmission in the heart.
Finally, the role of the exocytotic NA release in the genesis of ischaemic
arrhythmias is still unclear. Clinical and experimental studies suggesting such a role
have done so largely on the basis of indirect evidence.
WORKING HYPOTHESIS
of ischaemia
• Neuronal NA overflow varies depending on the the severity and duration,7 as will
its modulation by presynaptic muscarinic, a-adrenergic and purinergic receptors
• Factors (gender and dietary fats) influencing ischaemic arrhythmias affect
neuronal NA release directly or presynaptically.
• Development of ischaemic-reperfusion arrhythmias relate to neuronal NA release
and can be modulated by presynaptic mechanisms.
0 I
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By providing new experimental data, it is hoped that this thesis will make a
contribution to the understanding of neuronal mechanism(s) leading to severe





MaleWistar, and subsequently male and female Sprague-Dawley rats (9-12 weeks
old, 200-300 grams) were used for the experiments described in Chapter 3-7. They
were purchased from Banting & Kingman Co. (Hull, UK) and housed in an
environment with an ambient temperature of 20°C and 12/12 hour light/dark cycle.
Four animals were kept per cage. Water and food were taken ad libitum. For the
gonadectomy study in Chapter 5 and 6, the operation was carried out in rats 4-6 weeks
old, an age prior to puberty (7-8 weeks). No attempt was made to ascertain the phase
of the estrous cycle of female rats at the time of heart perfusion study.
Male Lew rats (from Banting & Kingman Co.) were used to study the effects of
dietary lipids on sympathetic neurotransmission (Chapter 8). The rationale of using
Lew rats in this study was that a substantial amount of data from this strain has been
collected in this Unit on the effects of dietary lipids on the fatty acid composition of
myocardium, ischaemic arrhythmias and postsynaptic a-adrenoceptors [Riemersma et
a/1988, MacLeod and Riemersma 1990, Sargent 1990].
2.2 Innervated and Perfused Heart Model
2.2.1 Preparation
An in situ perfused, innervated heart model, described by Dart et al[ 1984b] was
used for most of the experiments. Rats were anaesthetized with pentobarbitone sodium
(60 mg/kg, ip). Heparin (200 u/rat) was injected intravenously using a femoral vein.
The thorax was then opened and a metal cannula (I.D. 0.8 mm) was inserted and tied
into the ascending aorta for Langendorff perfusion. The interval from opening the
chest to starting heart perfusion was 50-70 seconds. The pulmonary vessels (both
sides) were tied off. A polyethylene cannula (I.D. 0.86 mm) was introduced into the
right atrium via the inferior vena cava for collection of coronary effluent. Each heart
was perfused at a constant flow rate, adjusted to given flow value of about 5 ml/g/min
by the estimated heart weight, with a multichannel Watson-Marlow peristaltic pump
(Waston-Marlow Ltd, Cornwall, UK). This flow rate was chosen as it was close to in
vivo values of coronary blood flow [Malic et al 1976]. The perfusate was a modified
Krebs-Henseleit solution (composition listed in Table 2.1).
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Table 2.1 Composition ofKrebs-Hensenleit solution




Ca2+ 1.85 mM EDTA 0.027 mM
Mg2+ 1.05 mM Po2 550-650 mm Hg
Cl" 140 mM Pco2 36-41 mm Hg
HCO"3 25 mM pH 7.36-7.43
PO3-4 0.5 mM
*Present in the experiments examining vagal nerve function. Pyruvate provides acetate for
acetylcholine resynthesis [Ldjfelholz 1981].
Perfusate was continuously gassed with 02:C02 (95%:5%). The temperature of the
perfusate at the point of entry into the aorta was 37°C. pH, Po2 and Pco2 in the
perfusate were regularly (approximately every hour) checked with an IL 1302
pH/Blood Gas Analyser (Instrumentation Lab, Milan, Italy).
The coronary flow recovery was determined during the stabilizing period. The
superior vena cava was also tied if the recovery of coronary effluent was low.
Recovery of flow was rechecked during the experiment. In most preparations it was
found that the recovery rate was nearly complete even without tied superior vena
cava. In the low-flow ischaemia experiments the superior vena cava was tied in all
preparations to prevent any possible leakage and to ensure a good recovery.
2.2.2 Measurement of Functional Parameters
The perfusion pressure was monitored by a transducer (Model EM 751,
Elcomatic, Glasgow, UK) and was between 40-50 mm Hg at the flow rate of 5
ml/g/min. A 4FG cannula (I.D. 0.8 mm) connected to another pressure transducer
(Model EM 751, Elcomatic) was introduced into the left ventricular cavity through
the apex. This procedure did not affect cardiac function and the stability of the
perfused heart. Left ventricular pressure and the first derivative of the ventricular
pressure (dP/dt) were measured with a polygraph (Department of Medical Physics,
Royal Infirmary of Edinburgh, University of Edinburgh). Heart rate was derived from
the epicardial ECG signal with a built-in chronometer and continuously displayed on
the polygraph. Epicardial ECG, ventricular pressure, dP/dt and perfusion pressure
were recorded with a U.V. recorder (Model 2106, Visicorder Honeywell, Hemel-
Hempstead, UK) or an ink-jet Mingograph 34 (Schonema-Elander, Sweden), and later
with a Gould TA 2000 recorder (Gould Electronics Inc, Ohio, USA) with a paper
speed of 5-10 mm/min during control periods and 10 mm/sec during nerve
stimulations.
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2.2.3 Electrical Nerve Stimulation
The left cervico-thoracic stellate ganglion was carefullly exposed with the help of
a surgical microscopy (Wild, Chatham. UK), at the level of the first rib [Dart et al
1983]. Pre-ganglionic fibres were cut. After a few cardiac sympathetic nerves (usually
two branches) were identified, a bipolar platinum electrode was placed underneath the
ganglion structure, above the cardiac nerves, with the aid of a micromanipulator
(Prior, UK). In the experiments in which vagal nerve stimulation was required,
bilateral vagi were dissected free at the cervicothoracic level, and also mounted on a
pair of bipolar platinum electrodes held by another micromanipulator. The electrode
close to the heart was always the cathode. The nerves were continuously superfused














Figure 2.1 A schematic illustration of the basic model. ECG: electrocardiogram; CPP: coronary
perfusion pressure; LVSP: left ventricular systolic pressure.
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Nerve stimulation was performed using a 2-channel Grass S88 stimulator (Grass
Instruments, Quincy, Mass, USA) with two stimulus isolation units (Grass SIU 7) to
minimize effects of capacitance and ensure a good isolation. The electrical stimulus
was a monophasic square wave pulse with a width of 2 msec and a current of 0.8 mA.
The frequency was 15 Hz for vagal nerves and 5 Hz for sympathetic nerve
stimulation. These had been determined from frequency response studies of cardiac
inotropic and chronotropic responses without significant fading of either functional
responses and/or NA overflow to several repeated nerve stimulations (vide infra).
2.3 Models for Arrhythmia Study
The two models described here were used for arrhythmia studies in Chapter 7.
2.3.1 Isolated Langendorff Perfused Rat Heart Model
After anaesthesia and heparinisation hearts were quickly excised and immersed in
ice-cold perfusion buffer to achieve rapid arrest. The aorta was cannulated for
retrogradely perfusion with Krebs-Henseleit solution containing 3 mM K+ and 5.55
mM glucose and continuously gassed with 02:C02 (95%:5%). The perfusion pressure
was 60 cm H20. Four hearts (two from males and two from females) were mounted
within a period of 10 min in each experiment (Figure 2.2). A pair of silver electrodes
were attached to the free wall of the left ventricle and the right atrium respectively for
the recording of the electrocardiogram (ECG). This electrode arrangement gave a
clear P-wave and QRS complex. The ECG was continuously displayed on a
oscilloscope (Type 41A, Lan-Electronics Ltd, UK) at 100 mm/s sweep speed and
recorded on a four channel Mingograph ink jet recorder at a paper speed of 25 mm/s.
A traction-type coronary occluder consisting of a 4/0 silk suture threaded through
a polyethelene guided cannula was used for coronary occlusion [Curtis et al 1987].
The suture was positioned loosely around the left main descending coronary artery
approx 3 mm from the origin [Spadaro et al 1980]. A 10 min period was allowed to
stabilize the preparation before the coronary ligation. During this period, the pre-
ischaemic coronary flow rate was measured and coronary effluent was collected for
the analysis of lactate and a normal ECG was recorded for comparison.
After stabilization the coronary artery was occluded by pulling the thread through
the tube and securing them by clamping the tube with a staple. The period of
ischaemia was 20 min followed by 5 min reperfusion. The ECG was recorded
throughout the ischaemic/reperfusion period. Coronary effluent was collected over 30
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Figure 2.2 Experimental set-up of the Langendorffperfusion system for the study ofarrhythmias in
vitro.
2.3.2 The In vivo Anaesthetized, Open-chest Rat Model
The technique used was as described by Johnston et al [1983]. After anaesthesia
the trachea was cannulated to ventilate with room air (50 strokes/min and 2 ml/100 g
body weight) using a Harvard ventilator (Model 683, Harvard Apparatus, South
Natick, USA). The chest was opened at the fourth intercostal space and the heart was
exposed with a rib expander. Using a non-traumatic needle, a loose 4/0 silk loop was
placed around the left coronary artery. The needle was superficially driven into and
passed through the tissue between the imaginary midpoint of the left auricular
appendage and the left margin of the pulmonary cone (about 3 mm from the origin of
the left descending coronary artery). After slight compression of the chest to restore
negative intrathoracic pressure, the thorax was then closed by suturing chest muscles
and skin . The ends of the loose coronary ligature were left on either side of the chest.
After heparinisation (200 u, iv) the right carotid artery was dissected and
cannulated with a 4 FG polyethylene catheter (I.D. 0.8 mm). Arterial blood pressure
was measured with an EM751 pressure transducer. A lead II ECG was recorded from
subcutaneous steel needles. ECG and blood pressure were displayed on an
Materials andMethodology 45
oscilloscope (lOOmm/s sweep speed) and recorded on a Gould TA 2000 recorder with
a paper speed of 25 mm/s. Two rats were instrumented and studied in one experiment.
After completion of the surgical procedure, animals were allowed to stabilize for
at least 10 mins. Coronary ligation was induced by pulling the ends of the ligature.
The period of ischaemia was 20 mins. ECG and blood pressure were continuously
monitored during this period. During the experiment, body temperature was kept
stable with an electric heating blanket. In rats without sustained ventricular
fibrillation, a bolus injection of Evans blue (Sigma, 10% in isotonic saline, lml/rat
iv), was given at the end of 20 mins ischaemia to measure the amount of ischaemic
myocardium. One minute after the injection, hearts were excised. The ischaemic
myocardiaum (unstained) was separated from non-ischaemic myocardium (stained)
along the epicardially visible border line and both were weighed on a micro-balance.
Different types of ventricular arrhythmias, i.e. ventricular premature beats (VPB),
ventricular tachycardia (VT), and ventricular fibrillation (VF) were defined according
to the Lambeth Conventions [Walker et al 1988]. Typical recordings of VPB, VT and
VF are shown in Figure 2.3.
Figure 2.3 Typical ECG and arterial blood pressure recordings after left coronary artery ligation
from a rat in vivo. Paper speed of25 mm/sec. a) ventricular premature beats in the form ofbigeminy;
b) unsustained ventricular tachycardia; and c) ventricular flutter and fibrillation.
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2.4 Gonadectomy
Male and female Sprague-Dawley rats were gonadectomised or sham-operated at
4-6 weeks of age according to the techniques described by Waynforth [1980]. Briefly,
under light ether anaesthesia and local sterilization, two small skin cuts were made on
scrotum (males) or on the back (females). Testis or ovaries were removed and cuts
were sutured. Animals were then returned to their cage to recover. Body weights were
measured in all animals on a weekly basis. The effects of gonadectomy on the body-
weight growth curves of rats have been well-documented [Schaible et al 1984]. Heart
perfusion experiments were performed 7-8 weeks after the operation. At the time of
sacrifice, adequacy of the gonadectomy was determined by inspecting if any residual
gonadal tissues were present and whether uterine atrophy in female rats had occurred.
2.5 Experimental Diets
Experimental diets were semi-synthetic and were prepared by mixing dry
ingredients and fat. One kg of diet was made up of cornflour 456 g, casein 267 g,
cellulose 65 g, salt mix 23 g, vitamin mix 4 g, and fat mix 185 g [Sargent 1990]. The
basic control diet had 40% calorie supply from fat, 23% from protein and 37% from
carbohydrate, representing the diet consumed by the average Scottish man [Thomson
et al 1985]. The ingredients for fat mixtures varied in different diets (see Table 2.2).
Maxepa was obtained from Seven Seas Health Care Ltd (Hull, UK) and contained
18% of 20:5n-3 and 12% of 22:6n-3 out of total fatty acids. Other oils were pure
products obtained from the local market. To minimise peroxidation of the dietary fat,
diets were freshly prepared every week and stored at 4°C. Fresh diet was fed and
animal cages changed every second day. In order to prevent oxidation of n-3
polyunsaturated fatty acids (PUFA), Maxepa mixed with olive oil was given daily by
oral dosing for 10 weeks. The dose was calculated from the amount of diet consumed
daily by each animal. Olive oil in the basic diet for the control and n-3 dietary groups
was reduced accordingly.
Table 2.2 Ingredientsfor the fat mix ofdifferent experimental diets (% of total fat by weight).
Ingredients Control n-6 Control n-3
Beef dripping 74.3% 13.1% 74.1% 74.1%
Olive Oil 13.5% 23.6% 13.1% * 11.4% *
Safflower Oil 12.2% - 12.8% 12.8%
Com Oil - 63,4% - -
Maxepa - - - 1.7% *
* given daily by oral dosing
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2.6 Drugs Used
The drugs used in all the experiments are listed in Table 2.3
Table 2.3 Drugs used in the experiments
Drugs Type Conc(M) Source
Atropine muscarinic receptor agonist io-5 Sigma
Choline chloride precursor for acetylcholine synthesis 10"5 Sigma
Clonidine a2-adrenoceptor agonist 3xl0"6 Sigma
Desipramine neuronal NA reuptake inhibitor 10-7 Sigma
Isoprenaline [^-adrenoceptor agonist 10"9-10-6 Sigma
Flurbiprofen prostanoid inhibitor 10"5 Boots
Methacholine muscarinic receptor agonist 10"9-10"4 Sigma
Phentolamine a-adrenoceptor antagonist 10"6 CIBA
8-Phenyltheophylline adenosine j-receptor antagonist 10-5 Sigma
Physostigmine acetylcholinesterase inhibitor 10"6 Sigma
Rauwolscine a-adrenoceptor antagonist 10-7-10"5 Carl Roth
Timolol [3-adrenoceptor antagonist 3xl0"6 Sigma
Sigma: Sigma Chemicals, St. Louis, USA; CIBA: CIBA Laboratories, Horsham, UK;
Boots: Boots Co Ltd., Nottingham, UK; Carl Roth: Carl Roth, Karlsruhe, West Germany
Water insoluble drugs were firstly dissolved in ethanol and the final concentration
of ethanol in the perfusate was <0.02%. Desipramine and choline chloride were added
directly to the perfusate. Other drugs were infused using a Harvard pump (Model
600/900 and Model 22, Harvard Apparatus Inc., Mass, USA) via a side port close to
the heart. The ratio of the perfusion flow/infusate was always >40 (40-100) to ensure
that the composition and temperature of the perfusate would not be significantly
affected. Drug infusion started at least 12 min before nerve stimulation or before the
induction of global ischaemia. In those experiments in which hearts were subjected to
a period of low-flow ischaemia, drugs were added to perfusate in a separate gassing
resevoir. Through a three-way stopcock, it was easy to switch to the perfusate
containing drugs and to ensure an accurate concentration.
The drugs used did not affect the spontaneous NA overflow, nor did they interfere
with our biochemical measurements.
There was a less than 10-second lag between starting the drug pump and the
appearance of drug effect on the heart.
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2.7 Radioenzymatic Assay of Catecholamines
2.7.1 Principle
NA, adrenaline (A) and dopamine (DA) concentrations in the heart and NA and A
levels in the coronary effluent were analysed by a radioenzymatic assay described by
Da Prada and Zurcher [1976]. This method has the advantage of simultaneous
measurement of NA, A, and DA, high sensitivity and specificity, and small sample
volume required.
Catecholamines are converted to 3-O-methylated derivatives catalized by
catechol-O-methyltransferase (COMT, EC 2.1.1.6) using tritium labelled methyl-
group donor, 3H-methyl-S-adenosyl methionine (3H-SAM). After purification and
separation by thin layer chromatography, the products are visualised under ultraviolet





The radioactivity of normetanephrine (from NA), and metanephrine (from A) and
methoxytyramine (from DA) was determined by liquid scintillation counting
2.7.2 Main Reagents, Materials and Working Solutions
• COMT, purified from rat liver according to the method of Axelrod and Tomchick
[1958]. The enzyme is stable for at least three months at -40° C.
• 3H-SAM, purchased from Amersham (Amersham, UK) with the specific activity
10 Ci/mmol and stored at -20° C.
• TLC plate LK5 (Whatman, International Ltd., Maidstone, USA)
• Catecholamine standards
Stock: 0.6 mM stirred at 4°C, fresh every 2 months
Working standard: 60 and 600 fmol/50 |il, fresh daily
• Carrier solution (50 1)
3-Methoxy-4-hydroxphenylethylamine HC1 61 mg (MW=203.7)
D,L-Methanephrine HC159.2 mg (MW=233.7)
D,L-Normetanephrine HC1 60.0 mg (MW=219.7)
HC1 0.01N up to 50 ml
CH3
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• Solventfor thin-layer chromatography (TLC)
Chloroform/Ethanol/Ethylamine (70%) = 80/150/10 v/v/v
• Scintillation solution
Butyl-(PBD) 12.5 g in 2.5L toluene (Merck)
• Perchloric acid solution (HC104) BDH Analar 0.3 or 0.6N
2.7.3 Procedure
Sample preparation
Coronary effluent: Sample (500 pi) was immediately deproteinized by addition
of 500 pi of 0.6 N HC104 and stored at -40°C until assay. Samples were usually
analysed within a month.
Heart tissue: hearts were weighed, homogenized in 10 volumes 0.3 N HC104
(containing 68 mM EGTA). The homogenate was centrifuged at 15,000 rpm for 10
mins and the supernatant decanted. The pellet was resuspended in 0.3 N HC104 and
centrifuged at 15,000 rpm for 10 min. The combined extracts were used for analysis.
Catecholamine methylation and extraction ofmethylated products
The methylation reaction was carried out at (35°C), in a shaking waterbath,
according to the following scheme:
Nature of sample Sample Blank Standard
Deprotenised effluent or tissue extract 100 pi - -
0.3 N HCH04 - 100 pi 100 pi
Reference standards (60,600 fmol/50 pi) - - 50 pi
0.01 NHC1 50 pi 50 pi -
Enzyme mix 100 pi 100 pi 100 pi
Reaction was stopped after one hour by placing tubes in an ice-cold bath and
adding 200 pi of a mixture of three pans borate buffer (1 M, Anaiar BDH, pH=8.0)
and 1 part carrier solution (see 2.7.2). Freshly prepared 100 pi TPB solution
(tetraphenylborate 1.5%) was added and the mixture extracted into 10 ml dietylether
by shaking for 5 mins and recentrifuged before freezing the water on dry ice. The
methylated catecholamines in the ether phase were back-extracted into hydrochloric
acid and the acid phase washed with 5 ml butylacetate. After shaking and
recentrifugation, the water phase was frozen and the buytylacetate phase was
discarded. The acid phase was evaporated to dryness under vacuum and the residue
was dissolved in 100 pi of 0.1 N HC1.
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Amine separation and radioactive measurement
50 pi of purified extract was carefully spotted onto precut 3x20 cm TLC plates
with a preabsorption zone. The plates were developed in a chromatography tank for at
least one hour. The plates were then dried under a stream of cold air and the
individual catecholamines identified under ultraviolet light. Metanephrine (Rf=0.5),
normetanephrine (Rf=0.3), and methoxytyramine (Rf=0.7) were scraped off
individually and transferred to liquid scintillation vials with the aid of greaseproof
paper. The methylated products were diluted with 1 ml 2 N ammonia (Merck),
oxidized by the addition of 50 piperiodate. The oxidation was stopped after 5 mins by
the addition of 50 pi 10% glycerol solution. The solution was acidified by the
addition of 0.5 ml 10 N acetic acid (BHD Analar) and 10 ml scintillation solution was
added, shaken vigorously for 10 mins to extract the oxidized products. Samples were
counted using Packard Liquid Scintillation Spectrometer or LKB 1217 Rackbeta
Liquid Scintillation Counter (LKB Wallac OY, Finland).
Typically the blank and the 60 and 600 fmol standards (routinely assayed in
triplicate) yield the following counts per minute:
Blank 60 fmol 600 fmol
NA 20-60 150-300 1200-2000
A 20-50 200-350 1700-2500
In general, each experiment was analysed in the same assay to avoid inter-assay
variability and allow a better comparison of NA concentrations before and after an
intervention. The intra-assay coefficient of variation by repeated analysis of a sample
with 2 pmol/ml was 7% for NA and 9% for A. The inter-assay coefficient of variation
by the measurement of the standards at concentrations of 60 fmol and 600 fmol/tube
were 29% and 28%, respectively. All samples were analysed in duplicate or triplicate
and the mean of the measurements was used. The concentration of adrenaline in the
effluent collected during sympathetic stimulation was found to be very low (less than
1 pmol/ml) and therefore not included in the data analysis.
2.8 Other Biochemical Measurements
2.8.1 Lactate
Lactate in coronary effluent was measured using a fully enzymatic kit purchased
from Boeringer Mannheim (Kit Cat No. 256773).
The following reactions show the principle of the analysis. Lactate was measured
spectrophotometrically (340 nm) at 37° C. The equilibrium of the coupled reaction lies
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far to the right and therefore ensuring the complete conversion of the first reaction.
The standard used was 1 or 10 mM L-lactate.
LDH
L-Lactate + NAD+ — **
GPT
Pyruvate + L-glutamate
LDH = Lactate dehydrogenase
GPT = Glutamate-pyruvate transaminase
A Cobas Bio centrifugal analyser (Roche Diagnostics, Welwyn Garden City, UK)
was used for all the measurements. Precinorm S (880 |iM lactate, Boeringer) was used
as a quality control in every assay. The inter-assay coefficient of variation determined
by repeated analysis ofPrecinorm S over the entire period of the studies was 3.1%.
2.8.2 Lactate Dehydrogenase (LDH)
LDH activity in the coronary effluent was measured using the optimised standard
method produced by Boehringer Mannheim (Kit Cat No 543039). The principle of the
measurement is the following forward reaction:
LDH
Pyruvate + NADH + H+ * L-lactate + NAD+
Thus, LDH was measured spectrophotometrically at 340 nm and 37°C by the
disappearance of NADH. All solutions were as described in the commercial kit. The
activity was measured on a Cobas Bio centrifugal analyser and the results were
calculated from the rate of change in optical density. Samples were stored at 4° C and
measured within three hours after collection.
Quality control was monitored using Precipath UBS (445 u/L, Boerhinger, West
Germany) throughout all studies. The inter-assay coefficient of variation was 7.5%.
2.8.3 Fatty Acid Composition ofMyocardial Phospholipids
Hearts were freeze dried for 48 hrs on a Edwards Modulyo freeze drier. A mortar
and pestle was used to crush hearts into a fine powder. The powder was weighed (145
mg) and transferred into Quickfit tubes. The phospholipids were extracted in 21 ml
choloroform/methanol (2:1 v/v). The lipid extract was then dried down under vacuum
using a Buchi-R rotary evaporator and a water bath at 30°C, redissolved in 6 ml
Pyruvate + NADH + H+
L-alanine + a-oxoglutarate
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choloroform/methanol (2:1 v/v), dried down again under vacuum, and finally
redissolved in 1.0 ml of chloroform/methanol dispensed with a Hamilton syringe.
Phospholipids were separated by TLC using LK5 plates (Whatman). The plates
were saturated with 1.2% boric acid and reactivated at 100° C (60 min). 100 |il of the
lipid extract was spotted. The plates were developed in CHCl3:MeOH:H20:NH3
(120:75:6:2 by volume) in a paper-lined tank at room temperature. The plates were
left to run for one hour, air dried, sprayed with 0.1% dichlorofluorescein, and
visualised under ultraviolet light (365 nm). All bands of the five fractions of
phospholipids (phosphatidylinositol, phosphatidylserine, phosphatidylcholine,
phosphatidylethanolamine and cardiolipin) were scraped off and placed into a
Quickfit tube. The methylesters were obtained by base-catalysed transmethylation
using toluene and sodium methoxide (0.5 M) and then redissolved in 25 jil
chloroform and stored at -20°C for later gas chromatography. Before
transmethylation, 70 p.g dimargerinyl (C17:0) phosphatidylcholine was added to each
tube as internal standard. The methylesters were separated and quantified using a
GLC system (Pye Unicam Series 204, Cambridge, UK) fitted with PU 4700
autoinjector and linked to a Trilab Model II Integrator. A glass column (1.5 m, I.D. 2
mm packed with a stationary phase of GP 10% SP2330 on 100/120 mesh Chromosorb
WAW, Supelco, Essex, USA) was used for all separations. The relative retention
times with respect to C17:0 methylesters were used to identify individual fatty acid
methylesters [Wood et a/1987].
2.9 Statistical Analysis
Statistical analysis was carried out using MINITAB (CLE.COM Ltd,
Birmingham, England) Biochemical measurements are normally distributed and the
statistical protocol was one- or two-way analysis of variance (ANOVA), followed by
paired or unpaired Student's t-test. For the analysis of NA overflow data each animal
served as its own control, whenever possible, to eliminate between animal variation
and to improve the statistical power. Therefore, NA data are expressed in absolute
terms and also as a ratio of the value measured before and after an intervention.
The incidence of arrhythmias is presented as a frequency (%) and were analysed
using a Chi-square test. Other parameters which are not normally distributed were
analysed using a non-parametric test (MannWhitney).
All results are presented as Mean±SEM. Statistical significance was assumed if
p<0.05 was achieved.
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2.10 Nerve Stimulation Experiment: General Protocols and Model
Characteristics
2.10.1 Stability of the Model
After preparation, all hearts underwent a stabilization period of at least 20 mins.
During this period hearts were perfused at a constant flow rate (about 5 ml/g/min).
Heart rate and ventricular contractility were continuously monitored (Figure 2.4). It
was found that cardiac function became stable after 10 mins. Ischaemia was made
either by reducing the flow rate (low-flow ischaemia) or stopping of the perfusion
pump (stop-flow ischaemia). During ischaemia, hearts were covered with a
thermostatic chamber thereby keeping the intracardiac temperature between 35.3-
37°C monitored with a probe thermometer (Technoterm 9300, Testotem Ltd, West
Germany).
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Figure 2.4 Typical recordings of the epicardial ECG, coronary perfusion pressure, left ventricular
pressure, and dPldt in a normoxically perfused rat heart.
In some experiments, two hours were necessary to complete the entire protocol. In
order to test the stability of the model during this period, seven hearts were perfused
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at a flow rate of 5 ml/g/min for 2 hours. Functional and biochemical parameters in
coronary venous effluent were monitored throughout (Figure 2.5). All indices
remained stable for at least two hours. There was no significant increase in the
perfusion pressure. This suggests that critical interstitial oedema did not occur under
the experimental conditions. Spontaneous NA overflow in the presence of neuronal
reuptake inhibitor desipramine (0.1 (iM) was also low and stable. Both vagal and
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Figure 2.5 Haemodynamic and metabolic stability of the rat heart perfused at 5 ml/g/min (n-7). No
significant changes were observed over a two-hour period in functional indices and biochemical
parameters measured in coronary venous effluent (by ANOVA).
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2.10.2 Functional Responses to Nerve or Drug Stimulation
Both sympathetic and vagal nerve stimulation resulted in marked changes in
cardiac function depending on the intensity of the stimulation. Peak response of dP/dt,
left ventricular systolic pressure (LVSP) and heart rate by sympathetic ganglion
stimulation was usually achieved after 20 to 30 sees of nerve stimulation. In contrast,
bilateral vagal stimulation resulted in an immediate maximum response (mainly
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Figure 2.6 The effects of
sympathetic nerve stimulation
on dP/dt (A, n=8) and of vagal
nerve stimulation on heart rate
(B, n=9) in perfused, inner¬
vated rat hearts.
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The reliability of the functional measurement in this model was also examined.
Normoxic hearts were exposed to concentrations of methacholine (3 groups, n=7-
12/group) or isoprenaline (1 group, n=8). Dose dependent changes in ±dP/dt or heart
rate were observed (Figure 2.7).
At the end of each experiment, the functional response to a test nerve stimulation
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Preparations were discarded if the following conditions were fulfilled:
• Low recovery of coronary effluent <85% of perfusion flow;
• Poor response to nerve stimulation: <25% increase in peak ±dP/dt (sympathetic
ganglion stimulation at 5 Hz), or <30% decrease in heart rate (vagal nerve
stimulation at 15 Hz);
• Sustained arrhythmias, including ventricular tachycardia and fibrillation, and
atrio-ventricular block during the initial perfusion period prior to nerve stimulations.
In all experiments about 10% of preparations were rejected because of above
mentioned reasons, mostly due to a poor response to nerve stimulation.
2.10.3 Nerve Stimulation-Induced NA Overflow
In all experiments, several sympathetic ganglion stimulations (GS), always
followed by a 15 min normoxic recovery interval, were delivered during the
experimental period, except when specified in Chapter 3, 7 and 8. In four groups of
hearts, four consecutive GS (60 sec duration) or 5-6 consecutive GS (30 sec duration)
produced a reproducible amount of NA overflow accompanied by a constant increase
in heart rate, dP/dt and LVSP (Figure 2.8). In 4 multiple 60 sees nerve stimulation
groups, the coefficient of variation (CV%) of NA overflow was smaller if the results
were expressed relative to that of the first stimulation (Sn/Sl ratio, Table 2.4). Sn/Sl
ratio is generally used for the inter-group comparisons [Dart and Riemersma 1989,
Richardt et al 1987, Schomig 1988]. Therefore, the inter-group comparisons were
made for both NA values and Sn/Sl ratio of NA overflow.
Table 2.4 Coefficient of variation (CV%) of NA overflow data expressed in absolute terms (pmollg)
or as a ratio ofcontrol (Sn/Sl)
SI S2 S3 S4
Wistar (n=8)
NA (pmollg) 55.5% 45.4% 32.5% 59.3%
SnlSl Ratio - 31.7% 28.1% 18.8%
Sprague-Dawley (n=7)
NA (pmollg) 44.6% 71.3% 56.8% 53.0%
SnlSl Ratio - 52.9% 41.5% 36.7%
In general, collection of coronary effluent started at the beginning of a nerve
stimulation for one or two minutes. During ischaemia nerve stimulations were
delivered during the final 1 or 0.5 min of ischaemia. Coronary venous effluent was
collected during the first min or during the first two mins of reperfusion.
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Figure 2.8 The reproducibility of GS-induced NA overflow in the innervated perfused heart ofWistar
and Sprague-Dawley male rats.
a) NA overflow induced by five times GS (30 sec duration) or four times GS (60 sec duration) in
hearts from Wistar rats. Sl-induced NA overflow was 16.6±3.9 (30 sec duration) and 32.6±6.4
pmol/g (60 sec duration). Sample collection for 1 min;
b) NA overflow induced by six times GS (30 sec duration) or four times GS (60 sec duration) in
hearts from Sprague-Dawley rats. Sl-induced NA overflow was 31.0±2.5 (30 sec duration) and
79.7±13J pmollg (60 sec duration). Sample collection for 2 min.
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In mid-1989, we switched animals from Wistar to Sprague-Dawley (SD) strain. In
order to check whether there was any difference between the strains in sympathetic
innervation of the heart, we firstly analysed cardiac NA content. Myocardial NA
level in Wistar rats (6.22±0.99 nmol/g, n=5) was about 78% of that in SD rats
(7.98±1.54 nmol/g, n=7), but this difference was insignificant. Then we measured NA
overflow induced by left stellate ganglion stimulation (GS, 5 Hz for 1 min). Coronary
effluent was collected in 1-min aliquots for 2 mins starting at the onset of GS. Under
similar perfusion flow rate (SD, 4.9±0.2 ml/g/min, n=7; Wistar, 5.0±0.1 ml/g/min,
n=6), NA overflow was significantly higher in SD than in Wistar rat hearts (p<0.05,
Figure 2.9). Another finding from this experiment was that after 1 min GS, NA
overflow during the second min was about 35% of the total collected during the 2 min
period and this was not affected by animal strain (Figure 2.9). In another four SD
male rat hearts, it was observed that about 98% of total NA overflow induced by a 1
min nerve stimulation was collected within the first 2 mins (Figure 2.10). Therefore,
in the studies carried out afterwards, the sampling period of coronary effluent was
extended from 1 min to 2 mins in order to collect most of NA released.
Neuronal NA release is greatly affected by ischaemia in this model [Dart et al
1984]. In the following chapters, nerve stimulations were applied after one or more
episodes of global ischaemia (<10 min) followed by 15 min reperfusion. In order to
examine if the effect of ischaemia on neuronal NA release was reversible, eight hearts
were subjected to a 10 min period of stop-flow ischaemia plus 10 min reperfusion. GS
(5 Hz for 1 min) was given before ischaemia (SI) and after 10 min of reperfusion
(S2). NA overflow was 48.0±6.2 pmol/g by SI and 46.1±7.8 pmol/g by S2 (p=NS).
The ratio of NA overflow was 0.9810.12, indicating a good recovery of neuronal
function.
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Figure 2.10 NA overflow in hearts from Sprague-Dawley male rats during normoxia (5.1 ±0.13
ml/minig) before, during and after an 1 min sympathetic ganglion stimulation (GS, 5 Hz). Coronary




Figure 2.9 NA overflow induced by a 1 min GS in male Sprague-Dawley (n=7) and Wistar rat hearts
(n=6).
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Chapter 3
NeuronalNA Release and
the Severity ofMyocardial Ischaemia
3.1 Introduction
During early ischaemia, increased efferent sympathetic input to the heart plays an
important role in the genesis of ventricular arrhythmias [Corr et al 1986, Verrier
1988]. Stimulation of cardiac sympathetic nerves induces ventricular arrhythmias
during acute myocardial ischaemia, most probably mediated by neuronal NA release
[Corr and Gillis 1978, Schwartz and Vanoli 1981]. However, most of the in vivo and
in vitro studies have shown a reduced neuronal NA release during acute ischaemia
when compared normoxic conditions [Dart et al 1984b, Schomig 1988, Forfar et al
1984]. In the anaesthetized dog, nerve stimulation-induced NA overflow from the
ischaemic myocardium fails after 30 mins of coronary ligation [Forfar et al 1984].
But an admixture of ischaemic and non-ischaemic effluent collected for the
assessment ofNA overflow makes the quantitative studies difficult in this model. The
effect of stop-flow ischaemia on neuronal NA release has therefore been studied
quantitatively in the in situ perfused, innervated rat heart. In this model, neuronal NA
overflow is largely suppressed within 1-3 mins of stop-flow ischaemia due to
combined effects of the presynaptic inhibition, enhanced neuronal reuptake and
failure of ATP generation in the nerve terminals [Dart et al 1984b, Dart and
Riemersma 1985, Richardt et al 1987, Schomig 1988]. Other factors like acidosis and
extracellular uptake may be of minor importance [Dart and Riemersma 1989, Dart
1989]. This rapid impairment of neuronal NA release is immediately followed by an
increasing efflux of NA, mediated by the neuronal reuptake-carrier reversing its
normal transport direction [Schomig 1988]. However, extrapolation of these findings
to ischaemia in vivo may be limited since the experimental condition used was zero
flow ischaemia. Reduction ofmyocardial blood flow within the ischaemic area in vivo
is neither absolute nor homogeneous [Bolli et al 1986, Piek and Becker 1988, Reimer
et al 1987, Rentrop et al 1985, Meesmann 1982]. Until now, there has been no
quantitative data on the effect of the severity of ischaemia on neuronal NA release
and its presynaptic controlling mechanisms. The effect of low-flow ischaemia on the
neuronal reuptake process has apparently not been examined in detail. This is
surprising since the role of collateral circulation in preventing ischaemic arrhythmias
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has been clearly defined [Bolli et al 1986, von Mutius et al 1988, Meesmann 1982,
Section 1.1.3]. We considered that studying NA release at varying severity of
ischaemia in vitro may be the best approach to a better understanding of the effect of
a heterogeneous ischaemia on sympathetic nerve function in vivo. Therefore, using
the in situ perfused innervated rat heart model (Section 2.2), the effects of the severity
of ischaemia on the following aspects were studied:
• nerve stimulation-evoked NA overflow
• neuronal reuptake mechanism
• presynaptic inhibition of neuronal NA release
The flow was selected to reflect the likely flow on the basis of the normal
coronary blood flow rate (4-5 ml/g/min) [Malic et al 1976] and the reduction in flow
during in vivo ischaemia [Maxwell et al 1987].
3.2 Methods
3.2.1. Materials, Drugs, and Model
Male Sprague-Dawley rats were used for the present study. Global ischaemia of
varying severity was made by either reducing coronary flow (low-flow ischaemia ) by
90% or 95% to 0.48±0.006 or 0.24±0.003 ml/min/g, respectively, or stopping the
perfusion pump (stop-flow ischaemia, 0 ml/min/g). The neuronal NA reuptake
inhibitor desipramine, the a-adrenoceptor antagonist phentolamine (1 |iM), and the
adenosine receptor antagonist 8-phenyltheophylline (10 |iM) were used. Desipramine
was added from the beginning of all experiments (final concentration 0.1 |iM), except
when specified. Phentolamine and 8-phenyltheophylline were infused using a Harvard
infusion pump. The infusion of these drugs were commenced at least 12 mins before
nerve stimulation or the beginning of ischaemia and maintained throughout the period
of low-flow ischaemia (Section 2.6).
3.2.2. Protocols
Neuronal NA overflow during low-flow ischaemia and the effect of neuronal
reuptake inhibition
After an initial sympathetic ganglion stimulation (GS, 30 sec duration), a 90%
(n=7) or 95% (n=6) reduction in coronary flow was induced for 65 mins. GS (30 sec
duration) was repeated at 10, 20, 30 and 60 mins of ischaemia. Coronary effluent was
collected for 4 mins immediately before and starting with GS. In another 6 hearts
subjected to 95% flow reduction, desipramine was omitted from the perfusate, but the
rest of the protocol was identical.
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Neuronal NA overflow during ischaemia of various severity
Obviously it is impossible to collect effluent during stop-flow ischaemia.
Therefore, to compare the effect of stop- with low-flow ischaemia on neuronal NA
release, nerve stimulation applied during ischaemia was immediately followed by
reperfusion and coronary effluent was collected during the first minute of reperfusion.
In eight groups of hearts (n=5-9 per group), after an initial GS (SI, 1 min) during
normoxia as individual control, a second GS (S2, 1 min) was carried out during either
stop-flow (2 groups) or low-flow ischaemia of 90% (3 groups) and of 95% flow
reduction (3 groups). The duration of stop-flow ischaemia were 3 or 10 mins, and of
low-flow ischaemia was 10, 30 or 60 mins. For comparison, eight hearts were
continuously perfused in normoxic flow rate and GS (1 min) was performed twice
with a 45 minute interval between the two stimulations.
In another four groups of hearts, the possibility was tested that NA overflow in
this case was caused by the reperfusion process per se. In two groups, 90% (n=7) and
95% (n=7) flow reduction was maintained for 60 mins followed by reperfusion.
Spontaneous NA overflow was determined in the effluent samples collected during
normoxia and during the first minute of reperfusion. The effect of ischaemia on
myocardial metabolism was monitored by analysing effluent levels of lactate, pH and
Pco2 during ischaemia and LDH release during reperfusion. In the remaining two
groups, hearts were subjected to stop-flow ischaemia of 10 mins (n=9) or 40 min
(n=6) followed by reperfusion. NA overflow immediately before ischaemia and
during the first min of reperfusion was analysed.
Presynaptic control ofNA release during normoxia and ischaemia
In six groups (6-10 hearts per group), after an initial GS (SI, 1 min) as an
individual control, hearts were normoxically perfused for a further 10 mins either
with phentolamine (1 (iM, three groups) or 8-phenyltheophylline (10 pM, three
groups). In two groups receiving either of the drugs, a second GS (S2, 1 min) was
applied during normoxia. In the remaining four groups, 10 mins stop-flow ischaemia
(two groups with either of the two drugs) or 60 mins of 95% flow reduction (two
groups) were made and S2 was given during the final minute of ischaemic period
followed by reperfusion. Coronary effluent for the determination of neuronal NA
overflow was collected for 1 min during GS in normoxia or during the first minute of
reperfusion.
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3.3 Results
3.3.1. Low-flow Ischaemia and Neuronal NA Overflow
Before and during 60 mins low-flow ischaemia, both NA concentrations in the
coronary effluent and heart rate were increased by each GS in the three groups
(p<0.01, Figure 3.1 and Table 3.1). In the group with 95% flow reduction and in the
presence of desipramine, the duration of ischaemia was extended to 90 mins in three
hearts and another nerve stimulation was given at the 90 th minute of ischaemia. NA
concentration in coronary effluent was increased by stimulation from 0.84±0.29 to
9.79±3.29 pmol/ml. Spontaneous NA overflow was less than 0.5 pmol/min/g







Figure 3.1 NA concentrations in
the coronary venous effluent
before and during a 60-min
period of low-flow ischaemia
and the effect of left sympathetic
ganglion stimulation (GS) at 5
Hz for 30 seconds. Basal NA
levels remained unchanged
throughout the ischaemic period,
and each GS significantly
elvated NA concentration
(p<0.01). A: 90% flow reduction
with desipramine; B: 95% flow
reduction with desipramine; C:
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In all the three groups of hearts with 60 mins low-flow ischaemia despite the
increase in NA concentrations, GS-induced NA overflow was reduced in amount
(p<0.05-0.01 vs SI) and remained stable throughout the period studied (Figure 3.1
and Figure 3.2). In hearts perfused without the neuronal reuptake inhibitor
desipramine, NA overflow was less than in its presence (p<0.01). In the presence of
desipramine, neuronal NA overflow was lower in the group with 95% flow reduction
than in the group with less severe ischaemia (p<0.01).
Table 3.1 Heart rate (beatslmin) before and during low-flow ischaemia and the effect ofsympathetic
ganglion stimulation (GS, 5Hz for 30 sees). DMI denotes desipramine.
Duration of Low-flow Ischaemia (min)
Normoxia 10 20 30 60
90% Ischaemia (+DMI)
Control 211±20 55111 45113 50114 47114
GS 291±31 114114 89113 107113 105115
95% Ischaemia (+DMI)
Control 20018 1916 1116 613 613
GS 26319 93122 60111 5318 56111
95% Ischaemia (-DMI)
Control 207116 20113 313 919 15115
GS 266113 76111 57115 66110 73113
1) The increase in heart rate differed during ischaemia between the 90% and 95% flow reduction
groups with desipramine (two-way ANOVA; p<0.01); 2) Desipramine did not affect change in heart
rate (in comparison to the 95% ischaemia group withoutDMI, NS).
3.3.2. Severity of Ischaemia and Neuronal NA Overflow
Using a slightly different protocol in which ischaemia was followed by
reperfusion and therefore allowed the comparison of stop- with low-flow ischaemia, a
flow-dependent reduction in GS-induced NA overflow was observed (Figure 3.3).
Stop-flow ischaemia largely inhibited neuronal NA overflow within the first 10 mins
(p<0.001). NA overflow was reduced within 10 mins in the hearts subjected to 90%
flow reduction (p<0.05) and no further reduction was found in this group between 10
and 60 mins (NS). In the hearts with 95% flow reduction, a progressive reduction of
NA overflow occurred during this period (p<0.01) and S2/S1 ratio of NA overflow at
60 mins of ischaemia tended to be lower than in the hearts with 90% ischaemia
(p=0.06). In normoxic perfused hearts SI- and S2-induced NA overflow was
comparable.
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Figure 3.2 Neuronal NA overflow during 60 mins of 90% and 95% coronary flow reduction to 0.48
and 0.24 mllminlg, respectively. GS (5Hz for 30 sees) was applied once before andfour times during
ischaemia. Coronary effluent was collected for over 1 min during normoxia and over 4 mins during
ischaemia. P values indicate the difference of the curves by two-way analysis of variance. DM1
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Figure 3.3 Relation between the severity of ischaemia and neuronally-mediated NA overflow in
innervated perfused rat hearts. NA overflow was induced by GS applied before ischaemia (SI) and
during the final minute ofa period of ischaemia (S2). Results are presented as S2/S1 ratio. There was
no significant difference in SI-induced NA overflow between the 9 groups (p>0.4). The progressive
decline ofS2/Sl ratio during 95% and 100% ischaemia is statistically significant (p<0.01). Each spot
represents mean (±SEM) of5-9 observations. Open symbols denote normoxic values.
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In comparison with pre-ischaemic values, reperfusion did not enhance
spontaneous NA overflow after 60 mins low-flow ischaemia of 90% (0.4±0.1 and
0.6±0.2 pmol/min/g, NS) or 95% (1.2±0.5 and 2.9±0.5 pmol/min/g, NS), or after 10
min stop-flow ischaemia (1.1 ±0.3 and 0.910.4 pmol/min/g, NS), except after 40 min
stop-flow ischaemia (1.410.3 and 104.5124.0 pmol/min/g, p<0.001).
3.3.3. Severity of Ischaemia and Presynaptic Inhibitory Mechanisms
In normoxia, NA overflow was increased over 2-fold by the a-adrenergic
antagonist phentolamine from 41.018.5 to 96.8110.8 pmol/min/g (p<0.01), but was
not significantly affected by the adenosine receptor antagonist, 8-phenyltheophylline
(54.719.4 to 49.913.5 pmol/min/g, NS, Figure 3.4). In the absence of these drugs, 10
mins stop-flow or 60 mins low-flow ischaemia reduced NA overflow from 54.416.4
to 12.411.8 pmol/min/g (p<0.001) or from 47.115.3 to 14.910.8 pmol/min/g
(p<0.001), respectively. There was no significant difference in S2/S1 ratio between
the two groups (0.2410.03 vs 0.3210.03, NS). Both phentolamine and 8-
phenyltheophylline failed to increase neuronal NA overflow in the hearts with 10
mins stop-flow ischaemia (NS, Figure 3.4). In contrast, with 60 mins 95% flow
reduction, NA overflow was partly restored to the pre-ischaemic levels by
phentolamine (26.414.9 vs 45.514.0 pmol/min/g, p<0.05) and 8-phenyltheophylline
(34.117.8 vs 45.719.3 pmol/min/g, NS). Both drugs caused significantly higher S2/S1
ratios than measured in the hearts without drug treatment (p<0.05 and 0.01,
respectively; Figure 3.4). Meanwhile, S2-induced heart rate increase was also greater
in the drug treated hearts than those without drug (+78113 vs +41111 beats/min,
p<0.05).
3.3.4. Low-flow Ischaemia, Myocardial Lactate Release and Acidosis
Ischaemia resulted in flow-dependent changes in the coronary effluent levels of
lactate, pH and Pco2 (Figure 3.5). During the first 5 mins of reperfusion following a
60 min period of 95% flow reduction, LDH overflow was 3.8410.92 U/g. In the
hearts subjected to a 65-min period of 90% or 95% flow reduction, the incidence of
ventricular fibrillation within the first 2 mins of reperfusion was 15% (3/20) and 51%
(29/57, p<0.01), respectively.
























Figure 3.4 Effect ofseverity of ischaemia (95% and 100% reduction of coronary flow on presynaptic
a-adrenergic and purinergic inhibition of nerve stimulation-mediated NA overflow. GS (5 Hz for 1
min) was performed twice. The first GS (SI) was to determine neuronal NA overflow during
normoxic, control conditions. The second GS (S2) was made in the absence (control) or presence of
phentolamine or 8-phenyltheophylline, to determine whether the presynaptic receptor antagonists
could restore neuronal NA overflow to pre-ischaemic levels (SI, 100%) and the results of NA
overflow are presented as S2/S1 ratio. No significant difference in SI-evoked NA overflow was found
between the 9 groups (p>0.2). Each column represents the mean (±SEM) of5-10 observations.
* p<0.05 and ** p<0.01 vj SI; + p<0.05 and #p<0.01 vs group without drug
3.4 Discussion
Our study demonstrates the importance of the severity of ischaemia for neuronal
NA release and its controlling mechanisms. In the hearts subjected to 60 mins low-
flow ischaemia, reduction of NA overflow is more pronounced in the hearts with 95%
than in those with 90% flow reduction. In the ischaemia/reperfusion series, the most
severe ischaemia (stop-flow) largely suppressed neuronal NA overflow within 10
mins. When coronary flow was reduced by 95%, decline of NA overflow increased
with time. In contrast, a higher residual flow (0.48 ml/min/g) prevented this
progressive reduction although NA overflow remained significantly depressed. This


















Figure 3.5 Changes in lactate,
pH and Pco2 levels in
coronary venous effluent from
normoxic and ischaemic rat
hearts. The average flow rate
was 4.8 mllminlg for normoxia
and 0.48 or 0.24 mllminlg for
90% and 95% ischaemia,





flow-dependent phenomenon is important for the understanding of the patho¬
physiology of the ischaemic heart. An inhibited neuronal NA release may protect the
ischaemic myocardium from excessive adrenergic stimulation. However, as the
severity of ischaemia is heterogeneous in vivo [Bolli et al 1986, Reimer et al
1987, Pirk and Pecker 1988], it is likely that this suppression is not uniform.
Marked metabolic disturbances, such as acidosis, accumulation of lactate and carbon
dioxide, intracellular enzyme leakage, and a high incidence of reperfusion VF show
that 95% flow reduction is rather severe for the myocardium. However, sympathetic
neurotransmission i.e. GS-evoked increases in NA overflow and heart rate, is still
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preserved, although depressed, at least within the observation period of 90 mins. It
would then seem that adrenergic nerve terminals would be more resistant to ischaemia
than the myocardium. Indeed, a more efficient glycolytic ATP production and a low
ATP demand for adrenergic nerve fibres to maintain a normal function has been
described in the perfused heart and cultured neurons [Dart et al 1987, Carlsson 1988,
Wakade and Wakade 1985].
In the hearts with 95% flow reduction, inhibition of neuronal reuptake by
desipramine doubled NA overflow throughout the 60-min period of ischaemia
although the difference in NA overflow during normoxia is significant. This may be
due to a prolonged exposure of released NA to the reuptake process during ischaemia.
In the present study, we did not compare the effectiveness of desipramine with
increasing severity and duration of ischaemia. However data is avaliable from the rat
heart with stop-flow ischaemia. There is a progressive reduction in the efficiency of
this reuptake mechanism during anoxia and metabolic blockade [Schomig 1988]. Dart
et al [1984b] have shown that the effectiveness of this drug in restoring neuronal NA
overflow is significantly lower during 9-10 mins than that during 0-1 min of stop-
flow ischaemia. When stop-flow ischaemia extends to 15 mins, this reuptake
mechanism will reverse its normal transport direction to initiate a "carrier-mediated
NA efflux", a process independent of neuronal activity [Schomig 1988, Dart et al
1987]. Therefore, the neuronal reuptake mechanism is also influenced by the severity
of ischaemia and, as shown in our study, remains effective in limiting NA
accumulation during prolonged ischaemia, provided a small residual flow is
maintained.
Another important observation in this study is that neuronal NA release maintains
its sensitivity to the presynaptic inhibition up to 60 mins of 95% flow reduction, but
not during the first 10 mins of stop-flow ischaemia. Although neuronal NA overflow
was similarly reduced in both experimental conditions, the underlying mechanisms
may be different. After 60 mins of 95% flow reduction, phentolamine partially and 8-
phenyltheophylline almost completely restored NA overflow to normoxic control
levels. Unfortunately, we were not be able to analyse the levels of adenosine in the
effluent at this stage. Recently, Headrick et al [1989] have shown that the increase of
adenosine levels in the coronary effluent correlates well with the extent of flow
reduction in the isolated perfused rat heart. Using the in situ perfused rat heart model,
Richardt et al [1987] have also found that within a few minutes of stop-flow
ischaemia, effluent concentrations of adenosine increase to levels that inhibit neuronal
NA release. Therefore, the effectiveness of 8-phenyltheophylline during prolonged
low-flow ischaemia in our study indicates a high interstitial adenosine concentration.
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In contrast, blocking adenosine receptors has no detectable effect during normoxia.
probably due to a low prevailing level of adenosine [Richardt et al 1988, Headrick et
al 1989]. Failure of adenosine receptors to modulate NA release within the first 10
mins stop-flow ischaemia has been reported [Richardt et al 1987], Two possibilities
are postulated by the authors: high interstitial concentration of adenosine which
competes with 8- phenyltheophylline for the presynaptic purinergic receptors, and
failure of neurotransmission as a result of ATP depletion. Thus the previous and the
present studies show that the presynaptic modulatory mechanisms, mediated by a-
adrenergic and purinergic receptors, all fail within 10 mins of stop-flow ischaemia,
suggesting a common phenomenon during most severe ischaemia [Dart et al 1984b,
Richardt et al 1987]. This is also true for cholinergic presynaptic inhibition [Chapter
4]. Therefore, in the present study carried out in the presence of desipramine, ATP
depletion may be the major reason for the failure of NA release after 10 min stop-
flow ischaemia and also for the onset of the carrier-mediated NA efflux soon
afterwards [Schomig et al 1984a, Dart et al 1987]. Presynaptic modulation is of
minor importance after 10 mins stop-flow ischaemia but is largely responsible for a
reduced NA release during prolonged low-flow ischaemia.
Our observations may have some implications for the understanding of cardiac
sympathetic activity in the in vivo ischaemic heart. Myocardial blood flow reduction
is heterogeneous [Reimer et al 1987, Piek and Becker 1988, Meesmann 1982]. In
moderate ischaemic regions, neuronal NA release is limited by both presynaptic
inhibition and enhanced reuptake. Carrier-mediated NA efflux may not occur. In
regions with severe ischaemia, energy depletion is mainly responsible for a profound
failure of neuronal NA release followed by carrier-mediated NA release soon
afterwards. Thus, the resultant spatial and temporal diversity in the adrenergic
stimulation of the ischaemic myocardium would contribute to arrhythmia
development. The observed dependence of sympathetic nerve function on the severity
of ischaemia may be involved, at least in part, in the salutary impact of collateral
circulation on early ischaemic arrhythmias [Bolli et al 1986, von Mutius et al 1988,
Meesmann 1982, Webster et al 1974, Section 1.1.3]. Critical amount of collateral
flow maintains a normal neuronal uptake function, thereby preventing the onset of
carrier-mediated NA efflux [Schomig 1988]. NA release via this pathways has been
demonstrated to be arrhythmogenic [Riemersma et al 1986b, Dietz et al 1989].
Chapter 4
Cholinergic Modulation ofNoradrenaline
Release during Acute Myocardial Ischaemia
4.1 Introduction
The autonomic nervous system plays an important role in the pathogenesis of
malignant arrhythmias during acute myocardial ischaemia [Verrier 1988, DeSilva
1982]. The arrhythmogenic effects of enhanced sympathetic stimulation, whether
produced by electrical, pharmacological or psychological means are well known.
Chronic sympathetic denervation with depletion of noradrenaline (NA) content is
protective against subsequent ischaemic arrhythmias [Schwartz and Stone 1980,
Puddu et al 1988]. The influence of parasympathetic activation is less clearly defined
and some studies have shown an inhibitory effect on early ischaemic arrhythmias
[Schwartz and Stramula-Badiale 1988, Verrier 1988, Corr and Gillis 1978], which is
believed to be due largely to antiadrenergic mechanisms, including the presynaptic
inhibition of exocytotic NA release [Corr et al 1987, Levy 1984]. Recent clinical and
experimental studies have demonstrated that an autonomic imbalance may be critical
for the occurrence of lethal ischaemic arrhythmias [La Rovere et al 1988, Schwartz et
al 1988a, Section 1.2.4].
Exocytotic NA release within the heart is largely affected by myocardial
ischaemia [Dart et al 1984b]. Although presynaptic sympathetic- parasympathetic
interactions, mediated by a-adrenergic and muscarinic cholinergic receptors, have
been well recognized in normoxic preparations [Levy 1984, Loffelholz and Pappano
1985], and speculated to contribute to the vagal protection against ischaemic
arrhythmias [Zuanetti et al 1987, Corr et al 1986], little is known about how this
aspect of sympathetic nerve function may be affected by ischaemia. Coexistence of
efferent sympathetic and parasympathetic overactivity may be a frequent
pathophysiological event during early myocardial ischaemia [Pantridge 1978, Corr
and Gillis 1978]. This study was designed to examine the influence of acute




4.2.1 Animals, Drugs and Model Characteristics
Male Wistar rats were used for this study. The experimental model was the in situ
retrogradely perfused, innervated heart model (Section 2.2). All experiments were
performed in the presence of 0.1 pM desipramine to inhibit neuronal reuptake of NA.
Choline chloride (10 pM), physostigmine (1 pM), phentolamine (1 pM) and
methacholine were also used as specified in Section 2.6. Coronary effluent was
collected for 1 min in normoxically perfused hearts starting with the GS, and for 1.5
min in ischaemic-reperfusion experiments as little effluent was collected during the
first 30 sec of reperfusion.
To define the concentration of methacholine to be used, we examined the relation
between methacholine concentration and exocytotic NA overflow in seven normoxic
hearts. After a control sympathetic nerve stimulation (SI, 30 sec duration),
methacholine was infused into the perfusate giving final concentrations of 0.1, 1, 5
and 10 pM respectively. Four more consecutive sympathetic nerve stimulations (30
sec duration with 12 min intervals) were then performed at each concentration of
methacholine. NA overflow evoked by S2-S5 was significantly inhibited in a dose
dependent manner (p<0.01-0.001 vs 16.5±1.3 pmol/g/min by SI, Figure 4.1). On the
basis of these results methacholine was used for all studies, except specified, at a dose
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Figure 4.1 Effects of various concentrations of methacholine on stimulation-mediated NA overflow
in normoxic rat hearts (n=7). Left sympathetic ganglion was stimulated five times (30 sec duration)
separated by 15 min intervals. Methacholine was added before each of the last four stimulations.
Neuronal NA overflow was significantly inhibited by each concentration of methacholine. Points
and vertical bars indicate MeaniSEM.
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In 35 normoxic hearts, sympathetic stimulation resulted in a significant increase
in heart rate (209±7 to 257±8 beats/min), -t-dP/dt (1587±28 to 2196±35 mm Hg/sec)
and -dP/dt (769±22 to 1175±27 mm Hg/sec). A profound reduction in heart rate and
±dP/dt were recorded during vagal nerve stimulation: heart rate (235±5 to 90±7
beats/min), -t-dP/dt (1640±35 to 857±32 mm Hg/sec) and -dP/dt (863±39 to 456±18
mm Hg/sec). When combined sympathetic and vagal nerve stimulation was
performed, all the functional parameters showed marked reduction from pre-
stimulation levels: heart rate (229±16 to 77±14 beats/min), 4dP/dt (1589±28 to
904±42 mm Hg/sec), -dP/dt (812±26 to 437±15 mm Hg/sec).
In 12 normoxically perfused hearts with heart rate controlled by pacing at 300-
350 beats/min with a pacemaker (APC type E4162, Welwyn Garden City, UK), a
significant and stable increase in ±dP/dt and ventricular pressure was achieved by
sympathetic stimulation at 2 Hz. Vagal nerve stimulation (15 Hz) superimposed on



















Figure 4.2 A typical recording of the effect of vagal nerve stimulation on ventricular contractility of
a perfused rat heart. Heart rate was kept constant during nerve stimulation by pacing at 330
beats/min. GS (2 Hz) increased LVSP and ±dP/dt and concomitant bilateral vagal nerve stimulation
(15 Hz) reduced those parameters.
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Spontaneous NA overflow (in the absence of nerve stimulation) was always
found to be very low (about 1 pmol/g/min). To check if vagal nerve stimulation alone
could contribute to NA overflow, we collected coronary effluent from six normoxic
hearts immediately before and during vagal nerve stimulation (15 Hz for 1 min).
Spontaneous NA overflow was 1.41±0.13 pmol/g/min and vagal nerve stimulation
did not affect this value (1.43±0.19 pmol/g/min).
4.2.2 Protocols
Vagal nerve stimulation and NA overflow
The effect of vagal nerve stimulation on neuronal NA overflow was examined
during normoxia and during either low-flow (0.25 ml/g/min) or stop-flow ischaemia
of varying duration.
In 14 hearts, sympathetic or combined sympathetic and vagal nerve stimulation
(1 min duration) were each performed, in random order, during normoxic perfusion.
In ischaemic experiments each heart was subjected to two equal periods of low-
flow ischaemia separated by a 15 min recovery period of normoxic perfusion. GS or
combined sympathetic and vagal stimulation was applied during the final 1 min of
each ischaemic period. The order of stimulation was random. The duration of low-
flow ischaemia was 3 (n=8) or 10 mins (n=8), and of stop-flow ischaemia was 1
(n=12), 3 (n=8), or 5 mins (n=9). In all experiments physostigmine (1 p.M) was
added to the perfusate to minimize ACh hydrolysis by cholinesterase, and choline
chloride (10 |0.M) was added as a substrate for ACh resynthesis. Physostigmine at this
dose potentiated the heart rate-lowering effect of vagal nerve stimulation (15 Hz for
1 min) from -97±7 to -170±8 beats/min (n=13-16, p<0.01).
In order to examine if the effect of ischaemia on vagally-mediated modulation of
NA release is reversible, 1 min GS (5 Hz) was given during normoxic perfusion, then
a 10-min period of stop-flow ischaemia was made followed by 10 mins reperfusion
(n=8/group). A combined sympathetic and vagal stimulation was then applied. In
another group (serving as a control), two GS were applied separated by 10 mins stop-
flow ischaemia followed by 10 mins reperfusion.
Effect of a-adrenoceptor antagonist on cholinergic inhibition ofNA overflow
In eight normoxic hearts the effect of phentolamine on vagally-induced inhibition
of NA release was assessed. After an initial 1 min sympathetic nerve stimulation,
phentolamine was continuously infused (final concentration 1 |iM). Sympathetic or
combined sympathetic and vagal nerve stimulation (1 min) were then performed, in
random order, separated by a 15-min recovery period. The same protocol was
followed during stop-flow ischaemia of 1 (n=8), 3 (n=8), or 5 mins (n=9).
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Physostigmine (1 (iM) and choline chloride (10 (iM) were present throughout.
It is well known that a-blockade increases NA release [Dart et al 1984b, Section
1.3.4]. However, it is unclear if cholinergic inhibition of NA release could be
potentiated when NA release is enhanced. In order to examine this possibility, GS
was performed twice in normoxic hearts in the absence and presence of 0.01 |iM (
n=5) or 0.1 |iM methacholine (n=5). The same protocol was followed in another two
groups of hearts (n=6/group) in the presence of 1 |iM phentolamine.
Muscarinic agonist andNA overflow
The effect of exogenous muscarinic agonist methacholine (10 jiM) on GS-
induced NA overflow was examined during normoxia (n=6), low-flow ischaemia of 3
(n=6) and 10 mins (n=5), and stop-flow ischaemia of 1 (n=6), 3 (n=9), and 5 mins
(n=8). GS was given twice (1 min duration) in the presence or absence of
methacholine.
Methacholine can also be hydrolysed by cholinesterase. Therefore, to exclude this
possibility, nine hearts were subjected to two periods of 3 min stop-flow ischaemia in
the presence of physiostigmine (1 |iM). GS (1 min duration) was given twice with
and without methacholine (10 (J.M). The sequence was randomized.
4.3 RESULTS
4.3.1 Ischaemia and Vagal Inhibition of NA Release
Vagal stimulation reduced exocytotic NA release to approx 75% of control in
normoxic hearts (p<0.01, Table 4.1 and Figure 4.3). NA overflow was similarly
reduced by vagal stimulation during the last minute of a 3-min period of low-flow
ischaemia (p<0.01), but not if vagal nerves were stimulated during the last minute of
a 10-min period of low-flow ischaemia even though the sympathetic stimulation-
induced increase in heart rate (12±12 to 74±8 beats/min, p<0.01) was prevented
(11±11 to 7±7 beats/min, p=NS). During 1 min stop-flow ischaemia, vagal
stimulation tended to reduce NA overflow, although this reduction was no longer
statistically significant (p<0.06). If the duration of stop-flow ischaemia was extended
to 3 or 5 minutes, vagal stimulation had no effect on the neuronally mediated NA
overflow (Table 4.1 and Figure 4.3), yet a suppression of the chronotropic effect of
GS was achieved in the 3-min ischaemic group (sympathetic stimulation 73±18 to
99±8 beats/min, p<0.01; combined nerve stimulation 65±9 to 4±4 beats/min,
p<0.001). At 5 mins stop-flow ischaemia, most hearts were in asystole and heart rate
did not significantly change by GS (0±0 to 19±7 beats/min, NS) or combined nerve
stimulation (5±5 to 0±0 beats/min).
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Table 4.1 Effects of vagal nerve stimulation (VS) on left sympathetic ganglion stimulation (GS)
evoked NA overflow (pmollglmin) during normoxia, low flow ischaemia and stop-flow ischaemia
n GS GS+VS
Normoxia 14 30.9±4.1 22.313.0**
Low-flow ischaemia
3 min 8 29.8±2.3 19.411.9**
10 min 8 32.8±5.0 31.014.3
Stop-flow ischaemia
1 min 12 36.6±7.2 27.816.0
3 min 8 31.3±5.1 29.215.1
5 min 9 24.7±2.5 27.914.0




















Figure 4.3 Effects of vagal nerve stimulation (VS) on NA overflow evoked by sympathetic ganglion
stimulation (GS) during normoxia, low-flow ischaemia and stop-flow ischaemia. 1 |xM physostigmine
was used to prevent the hydrolysis of acetylcholine. The NA overflow produced by combined nerve
stimulation (GS+VS) has been expressed as a percentage of the overflow produced by GS alone.
Group numbers are shown in Table 4.1. Mean±SEM. ** p<0.01 for GS+VS vs GS and If p<0.05 for
% ofNA overflow vs control (0 min group).
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In the hearts subjected to 10 mins stop-flow ischaemia followed by 10 mins
reperfusion, NA overflow was well maintained (48.0±6.2 vs 46.117.8 pmol/g/min,
p=NS) with a S2/S1 NA overflow ratio of 0.9810.12. After ischaemia/reperfusion
vagal nerve stimulation still significantly reduced NA overflow from 41.514.0 to
34.212.6 pmol/g/min (p<0.05) yielding a reduced S2/S1 ratio of 0.8510.06.
4.3.2 Effect of Phentolamine on Vagal-Sympathetic Interactions
In normoxic hearts phentolamine resulted in a 136% increase in NA overflow
(p<0.001) corresponding to higher levels of +dP/dt during sympathetic stimulation
(18501253 vs 21451354 mm Hg/sec, p<0.05) and increased -dP/dt (8001102 vs
10641115 mm Hg/sec, p<0.05). Vagal stimulation in the presence of phentolamine
reduced NA release to 74% of control (GA + Phent, p<0.02, Table 4.2 and Figure
4.4). This vagally mediated % reduction in NA overflow was similar to that observed
under normoxic perfusion conditions in the absence of phentolamine 75%, (see
Figure 4.3). In 1-, 3- and 5-min ischaemic groups phentolamine resulted in a 139%
(p<0.001), 55% (p<0.01) and 45% (p=0.07) increase in NA overflow. The values
were reduced by vagal stimulation to 71% (1 min ischaemia, p<0.02), 72% (3 min
ischaemia, p<0.01) and 88% (5 min ischaemia, p=0.16) respectively(Table 4.2 and
Figure 4.4). In the presence of phentolamine, sympathetic nerve stimulation increased
heart rate from 58118 to 111113 beats/min (p<0.001) in 3 min ischaemic group , and
from 1219 to 71112 beats/min (p<0.001) in the 5-min ischaemic group; this
chronotropic effect was prevented by concomitant vagal stimulation (3 mins
ischaemia, 96112 to 010 beats/min, p<0.001; 5 mins ischaemia, 30114 to 918
beats/min, p=NS).
Table 4.2 Effects of the a-adrenergic antagonist phentolamine (1 \iM) on vagal stimulation induced
inhibition ofneuronal NA overflow (pmol/glmin) during normoxia and stop-flow ischaemia
n GS GS+Phent GS+VS+Phent
Normoxia 8 26.413.1** 62.518.8 42.815.2*
Stop-flow ischaemia
1 min 8 24.613.0*** 58.715.6 41.614.4**
3 min 8 25.814.4** 40.113.7 28.712.6**
5 min 9 21.012.7 30.413.6 26.814.7
























Figure 4.4 Effect of the a-adrenoceptor antagonist phentolamine (1 |iM) on vagally-induced
inhibition ofNA overflow in rat hearts undergoing normoxic perfusion or various periods of stop-
flow ischaemia. Neuronal uptake of NA was inhibited by desipramine (0.1 \\M) and 1 |xM
physostigmine was used to prevent the hydrolysis of acetylcholine. The NA overflow produced by
GS+VS has been expressed as a percentage of the overflow produced by GS alone. Group numbers
are shown in Table 4.2. Mean±SEM. * p<0.02 and ** p<0.01 for GS+VS vs GS.
The effect of phentolamine on methacholine-induced inhibition of NA overflow
is shown in Figure 4.5. A dose-dependent suppression of NA release was observed in
the hearts without phentolamine (methacholine 0.01 p.M, 40.1±8.5 to 30.2±5.6
pmol/g/min, p<0.07; 0.1 jiM, 44.8±9.3 to 22.8±3.8 pmol/g/min, p<0.025). Although
the amount of neuronal NA overflow was significantly increased (p<0.01) by
blocking the a-adrenoceptors, the effect of methacholine appeared not to be
affected (methacholine 0.01 (iM, 92.8±10.0 to 113.1±18.5 pmol/g/min, p=NS; 0.1
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Figure 4.5 Effect of a-adrenoceptor antagonist phentolamine (1 \xM) on the muscarinic receptor
agonist methacholine-mediated inhibition of NA overflow in the normoxically perfused rat hearts
(n=5-6 per group). GS (5 Hz for 1 min) was performed twice with a 15 min recovery period and
methacholine (0.01 or 0.11iM) was infused at least 12 min before the second GS. * p<0.025
4.3.3 Ischaemia and Methacholine-induced Inhibition of NA Overflow
In normoxic hearts, NA overflow was reduced to 17% of control by 10 (iM
methacholine (p<0.001) (Table 4.3 and Figure 4.6). In all the ischaemic experiments
NA overflow was also significantly reduced by 10 jiM methacholine but with less
effectiveness (p<0.05), depending on the degree of flow reduction and duration of
ischaemia (Table 4.3 and Figure 4.6). Addition of the cholinesterase inhibitor
physostigmine to the perfusate did not increase the methacholine-induced inhibition
of NA overflow after 3 min stop-flow ischaemia. The net increase in the heart rate by
GS were similar between the two groups of 3 mins stop-flow ischaemia without
(51 ±12 and 128±18 beats/min, p<0.01) and with physostigmine (0±0 vs
66±10beats/min, p<0.01), although the heart rate immediately before nerve
stimulation was significantly lower in the group with physostigmine (p<0.01).
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Table 4.3 Effects of the muscarinic agonist methacholine (MCh 10 \\M) on sympathetic ganglion
stimulation (GS) evoked NA overflow (pmollglmin) during normoxia, low-flow ischaemia and stop-
flow ischaemia.
n GS GS+MCh
Normoxia 6 42.6±6.4 7.4±1.9**
Low-flow Ischaemia
3 min 6 29.3±3.0 9.2±2.1**
lOmin 5 33.6±7.8 15.5±5.3*
Stop-flow Ischaemia
1 min 6 45.7±12.5 17.9±7.6*
3 min 9 32.6±5.8 18.8±6.0*
3 min it 9 32.7±5.5 18.1±2.8*
5 min 8 25.2±2.7 13.6±2.3*
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Figure 4.6 Effects of methacholine (MCh, 10 ytM) on stimulation-evoked NA overflow during
normoxia, low-flow ischaemia and stop-flow ischaemia. NA overflow produced by GS+MCh has
been expressed as a percentage of the overflow produced by GS. Desipramine (0.1 \xM) was present
throughout the experiments. Group numbers are shown in Table 4.3. Mean±SEM. * p<0.05, **
p<0.01 and *** p<0.001 for GS+MCh vs GS; it p<0.05 for % ofNA overflow vs 0 min group.
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4.4 Discussion
These experiments document for the first time that short periods of ischaemia
attenuate vagally induced inhibition of exocytotic NA overflow in the rat heart. The
results show: (1) that the longer the period of ischaemia the less effective is vagal
stimulation in inhibiting NA overflow, and (2) that vagally induced inhibition of NA
overflow though still detectable after 3 mins low-flow ischaemia is abolished by 3
mins stop-flow ischaemia. Thus, an essential feature of this ischaemia-induced
attenuation is a dependency on the duration and severity of ischaemia. Although
vagally induced inhibition on NA release fails within only a few minutes of stop-flow
ischaemia. This is a reversible process, as in the hearts subjected to 10 mins stop-flow
ischaemia vagal nerve stimulation during reperfusion period still significantly
suppressed NA overflow. Two important mechanisms for the clearance of released
ACh, namely washout from synaptic clefts and hydrolysis by cholinesterase [Section
1.3.3], are no longer effective in our experimental conditions due to very low or zero
flow and the administration of cholinesterase inhibitor. Therefore, a pronounced
presynaptic inhibition of exocytotic NA release might have been expected, but the
reverse was found.
Several mechanisms could account for this ischaemia-induced failure of vagally-
mediated presynaptic inhibition of exocytotic NA release. Hydrolysis of ACh in the
ischaemic heart appears not to be responsible because an enzyme inhibitor
(physostigmine) was present throughout. In addition, physostigmine did not reverse
the diminished inhibitory effect of methacholine on NA overflow observed during 2-
3 mins of stop-flow ischaemia. It has been found that cholinesterase activity in
normoxic mammalian hearts is low [Loffelholz and Pappano 1985], but nothing is
known of the effect of ischaemia on the activity of this enzyme.
A reduction in ACh release from vagal nerve terminals during ischaemia could be
a possible mechanism. In principle, at least three factors may cause a reduction in
ACh release in the present model:
(1) Ischaemia may directly interfere with exocytotic release of ACh according to
the results of studies that used rat brain slices or synaptosomes [Duner-Engstrom and
Fredholm 1988, Gustafsson et al 1978]. Ten minutes of hypoxia or anoxia reversibly
inhibited K+-evoked ACh release and that with concomitant acidosis (pH=6.2), this
impairment became irreversible [Gustafsson et al 1978]. Lack of ATP may be
particularly important in the heart because efferent vagal neurotransmission is
dependent on two synapses (i.e. between pre-ganglionic and post-ganglionic neurons
and between post-ganglionic neurons and effectors). The main biochemical events in
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the vagal nerve terminals, including choline uptake, ACh synthesis, transport and
exocytotic release, depend on energy supply and ionic homeostasis [Loffelholz and
Pappano 1985, Section 1.3.3]. Indeed, reduced ATP supply has been suggested as a
major cause for the failure of sympathetic neurotransmission during ischaemia [Dart
et al 1984b and 1987] although a concomitant acidosis seems not to contribute to
this failure [Dart and Riemersma 1989].
(2) Electrically-evoked ACh release from brain tissue or peripheral vagal
terminals can be partly inhibited by micromolar levels of adenosine or the adenosine
analogue phenylisopropyladenosine [Jalife et al 1980, Halvorsen and Nathanson
1981]. Adenosine may well play a similar role in the present heart model. Within a
few minutes of stop-flow ischaemia [Richardt et al 1987] micromolar adenosine
levels were observed in coronary venous effluent, obtained by reperfusion. Recently
using the changes of the effective refratory period by vagal nerve stimulation as an
end point, a presynaptic suppression of cholinergic neuro- transmission by 12 mM
K+, low pH of 6.4 or 10 |iM adenosine has been documented in the in vivo dog heart
[Miyazaki and Zipes 1990].
(3) ACh release from cholinergic nerve terminals in the heart can be reduced by
6
exogenous NA via activation of the presynaptic a-adrenoceptors [Loffelholz and
Pappano 1985, McGrattan et al 1987, Section 1.3.4]. However there has been no
study to show that exocytotic NA release inhibits exocytotic ACh release. During
early ischaemia, a high concentration of NA may accumulate in the synaptic cleft due
to the combined effects of sympathetic nerve stimulation, inhibition of neuronal
reuptake of NA, and ineffectiveness of washout from the synaptic clefts. Therefore
this inhibitory modulation of ACh release is expected to be more pronounced than
during normoxia. This possibility is supported by the present results that during 1 and
3 mins stop-flow ischaemia, phentolamine restored the inhibitory efficacy of vagal
stimulation on NA overflow to the control level. This is probably by removal of this
enhanced transaxonal inhibitory modulation, although NA release is greatly
potentiated by the drug at the same time. However, this effect of phentolamine was
no longer significant after 5 mins stop-flow ischaemia. As the inhibition of NA by
lower doses of methacholine seems not to be changed by phentolamine in our model,
the reversibility of vagally-mediated inhibition by a-blockade could not be explained
by interactions between a-adrenergic and muscarinic receptors, as suggested by
others [Roeske and Yamamura 1983].
Another mechanism contributing to the reduced vagal effect may be ischaemia-
induced dysfunction of the presynaptic muscarinic receptors, is suggested by the fact
that the modulatory effect of methacholine is similarly attenuated during ischaemia.
In an in vivo dog study, the number of muscarinic receptors in the ischaemic
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myocardium did not change within one hour coronary artery occlusion although the
number of ^-adrenoceptors doubled [Mukherjee et al 1979]. In various cardiac
preparations, both the number and affinity state of postsynaptic muscarinic receptors
can be modulated by multiple factors, including muscarinic agonists or antagonists,
ionic activity, guanine nucleotides and binding state of adjacent non-muscarinic
receptors [Watanabe 1984, Jalife et al 1980, Birdsall et al 1979]. The present study
suggests that ischaemia alters the function of presynaptic muscarinic receptors. No
effort was made in the present study to examine the mechanism, but an increase in
extracellular potassium concentration may be involved. Extracellular K+
concentration will double or even triple within the first few minutes of myocardial
ischaemia [Kleberl984, Hill and Gettes 1980, Miyazaki and Zipes 1990]. Potassium
is capable of reducing the affinity state of muscarinic receptors for agonists
[Loffelholz and Pappano 1985, Birdsall et al 1979]. The results from vagal
stimulation and methacholine, although quantitatively similar, were not identical.
This could be due to a lower prevailing concentration of ACh than of methacholine
in the synaptic cleft. However until ACh levels are measured, the mechanisms
whereby ischaemia interferes with vagal inhibition of NA overflow remains
speculative.
An interesting finding in the current studies is that when vagal stimulation no
longer reduces NA overflow its negative chronotropic effect is still maintained. This
may be explained by a denser vagal innervation in atria and conducting system than
in ventricles [Lund et al 1986] whereas nerves located in the ventricles are probably
the source of most NA overflow. In addition, it is not known if there is any
difference between presynaptic and postsynaptic muscarinic receptors in their
agonist affinity or their sensitivity to ischaemia. However, neuropeptide Y, a co-
transmitter released with NA by sympathetic nerve stimulation, inhibits vagal
neurotransmission but does not alter the postsynaptic cholinergic action on heart rate
[Potter 1987, Warner and Levy 1989, Section 1.3.4]. Similarly, adenosine inhibits
ACh release at the presynaptic level, whilst it potentiates the effects mediated by
postsynaptic muscarinic receptors [Pelleg et al 1988, Belloni et al 1989, Potter
1986]. This mechanism may also be involved in our aforementioned dissociation of
pre- (inhibition of NA release) and post-synaptic muscarinic effects (reduction in
heart rate) by vagal nerve stimulation.
Clinical and experimental observations suggest a simultaneous sympathetic and
vagal activation during the very early phase of myocardial ischaemia [Webb et al
1972, Lombardi et al 1983, Verrier 1988, Corr and Gillis 1978]. If our findings from
the perfused rat heart can be extrapolated to the in vivo situation, then the presynaptic
inhibition of vagal activity on NA release will vary within the ischaemic heart,
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the severity and duration of ischaemia. This condition may lead to an
autonomic activity within the ischaemic region. Thus, electrical
nd arrhythmias may occur as a result of heterogeneous adrenergic
These events may happen within the first few minutes of myocardial
time when sudden cardiac death frequently occurs [Fraser 1986]. Indeed,
experimental studies have also suggested that withdrawal of vagal
I lead to ischaemia-induced ventricular fibrillation and sudden cardiac
ir 1988, Schwartz et al 1988a, La Rovere et al 1988, Section 1.2.2].
imulation of cardiac sympathetic and vagal nerves during ischaemia
,'her incidence of serious arrhythmias than either alone in an in vivo study
ti 1978].
aucii- asion, these results demonstrate that cholinergic presynaptic inhibition of
1A release in the rat heart is impaired during acute ischaemia, and suggest
d ACh release and/or dysfunction of the presynaptic muscarinic
3rs could be responsible. The resulting autonomic imbalance within the
myocardium could lead to the development of serious ventricular
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Chapter 5
Gender Difference in Presynaptic Adrenergic Inhibition
ofNA Release during Normoxia and Ischaemia
5.1 Introduction
Clinical studies have suggested a gender-related difference in the adrenergic
reactivity to various stressful conditions, including mental stress [Frankenhaeuser et
al 1976, Lenders et al 1987], head-up tilt [Lenders et al 1987], lower-body negative
pressure [Frey and Hoffler 1988] exercise [Frankenhaeuser et al 1976, Lenders et al
1987, Claustre et al 1980], and insulin-induced hypoglycaemia [Claustre et al 1980].
When exposed to these stressful conditions, men show a more marked sympatho¬
adrenal activation than women with higher plasma catecholamine concentrations and
a higher urinary catecholamine output [Lenders et al 1987, Frey and Hoffler 1988,
Sanchez et al 1980]. Under resting conditions, plasma concentrations of adrenaline
and NA are higher in males [Lenders et al 1987, Frey and Hoffler 1988, Sanchez et al
1980].
Results from experimental studies support this sex difference. In rats, cardiac
sympathetic activation by drug-induced hypotension is more pronounced in males
than in females [Bunag et al 1975]. Furthermore, the female cardiovascular system is
more tolerant to several pathological conditions, such as circulatory shock [Altura
1976], isoprenaline-induced myocardial necrosis [Wexler et al 1974], myocardial
ischaemia and infarction [Siegmund et al 1979, Lu et al 1984, Du et al unpublished].
These pathological stimuli could certainly activate the sympatho-adrenal system.
The mechanisms responsible for these sex differences in the adrenergic activation
by stressful factors are largely unknown. A lower central sympathetic activity in
females has been proposed [Lenders et al 1987, von Eiff et al 1971]. Catecholamine
content and metabolism in the central nervous system and adrenal medulla may also
differ [Crowley et al 1978, Fernandez-Ruiz et al 1989]. Many studies have
demonstrated that females have a higher density and activity of a-adrenoceptors in
various tissues [Jones et al 1983, Morita et al 1987, Colucci et al 1982], It is unclear
if presynaptic a2-adrenoceptors are higher in females, as one study may suggest
[Wiechman and Borowitz 1979]. Oestrogen treatment increases, and ovariectomy
decreases a2-adrenoceptors [Roberts et al 1981, Larsson et al 1984, Levin et al 1980].
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However, testosterone treatment has no such effect [Colucci et al 1982]. One clinical
study showed that oestrogen attenuated the pressor response to mental stress [von Eiff
et al 1971].
On account of these findings, it is logical to hypothesize a sex difference in the
mechanisms controlling sympatho-adrenal function. One particular possibility is a
increased presynaptic inhibition of NA release from sympathetic nerves in females.
We therefore examined the sex differences in sympathetic nerve stimulation-induced
NA release from the perfused rat heart and the effects of oc2- adrenoceptor antagonist
and agonist both in normoxic and in ischaemic conditions. In addition we also
examined the effect of ovariectomy on these processes.
5.2 Methods
5.2.1 Animals, Drugs and Model
Male and female Sprague-Dawley rats (9-10 weeks old, 200-290 g) were used.
Experiments were performed alternately on male and female rats. No attempt was
made in these studies to ascertain the phase of the oestrous cycle of female rats at the
time of study. The in situ retrogradely perfused, innervated heart model (Section 2.2)
was used for this study. Hearts were heavier in male (0.77±0.07 g, n=73) than in
female rats (0.72±0.06 g wet weight, n=74, p<0.01). Perfusion flow rates were
carefully adjusted to the estimated heart weight and were 5.24±0.33 for males and
5.18±0.35 ml/g/min for females, Mean ±SD, NS).
The neuronal NA reuptake inhibitor, desipramine was added to the perfusate (0.1
pM) in all experiments [Dart et al 1984b, Iversen 1973]. Rauwolscine and clonidine
were used to block or stimulate the a2-adrenoceptors. Coronary effluent for NA
analysis was collected over a 2-min period starting with the nerve stimulation in
normoxic perfused hearts. Timolol (3 pM) and isoprenaline were used to block or
stimulate {3-adrenergic receptors. Coronary effluent was collected during the first 2.5
mins of ischaemic-reperfusion in the ischaemic hearts (as there was little effluent
collected during first 30 sees). NA overflow in the absence of nerve stimulation was
always low and similar in the two sexes (0.82±0.17 and 0.77±0.14 pmol/g/min, NS).
5.2.2. Protocols
Normoxic series
Experiment 1: Total content of NA, adrenaline and dopamine were measured in
eight male and eight female hearts. After 20 mins in situ perfusion, hearts were
excised, weighed and quickly frozen on solid C02 and stored at -40° C until assayed.
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Experiment 2: The effect of incremental doses of rauwolscine on neuronal NA
overflow was examined in 10 male and 10 female rat hearts. Sympathetic nerve
stimulation (30-sec duration) was applied five times (S1-S5) with 15-min intervals.
The first (SI) and the last (S5) nerve stimulations served as controls (no drug).
Concentrations of rauwolscine were 0.1 pM (S2), 1 pM (S3) and 10 pM (S4). release
Experiment 3: Presynaptic a2-adrenoceptor mediated inhibition of NAjwas studied
in 12 male and 12 female hearts using rauwolscine and clonidine. After an initial
control stimulation (SI, 60 sees), a second stimulation (S2, 60 sees) was performed in
the presence of rauwolscine (1 pM) and a third (S3, 60 sees) in the presence of
clonidine (3 pM).
Experiment 4\ p- and -adrenoceptor mediated inotropic response was examined
in male and female hearts. In five male and five female hearts GS (60 sees) was
performed three times in the absence (SI and S2) and presence of timolol (3 pM, S3).
In another five male and five female hearts, isoprenaline was infused at
concentrations of 2.5xl0'9, 10"8 and 2.7xl0"7 M and changes in dP/dt were
continuously monitored at each concentration.
Ischaemic series
Experiment 1: The effect of global ischaemia (by stopping coronary perfusion) on
nerve stimulation-induced NA release was studied in male and female hearts (n=9 per
group). A first nerve stimulation (SI, 30 sees) was used as an individual normoxic
control. Then hearts were subjected to three episodes of ischaemia in the sequence of
1-, 3- and 6-min duration and separated by 15-min periods of normoxic reperfusion.
Nerve stimulation (S2-S4) was applied during the final 30 sees of each ischaemic
period.
Experiment 2: Effect of the a2-adrenergic antagonist rauwolscine (1 pM) and the
agonist clonidine (3 pM) on NA release during ischaemia was studied in male (n=23)
and female hearts (n=24). Each heart underwent two episodes of 3 mins of ischaemia
separated by a 15-min recovery period. NA overflow was determined during an initial
nerve stimulation (60 sees) in the final minute of ischaemia (SI). The hearts were
then assigned to treatment with rauwolscine (male n=13, female n=13) or clonidine
(male n=10, female n=ll). Another nerve stimulation (S2) was performed in the final
minute of the second ischaemic period.
Experiment 3: After 20-40 mins of stop-flow ischaemia non-exocytotic NA
release occurs in the isolated rat heart and is inhibited by desipramine [Schomig
1988]. This ischaemia-induced NA release was examined in male and female hearts
(10 hearts per group). Desipramine was omitted from the perfusate. Hearts were
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subjected to 40 mins of ischaemia followed by reperfusion. Coronary effluent was
collected during the first 3 mins of reperfusion.
Gonadectomy series
Female Sprague-Dawley rats (6 weeks old) were gonadectomized or sham-
operated using the techniques described by Waynforth [1980]. Body weights were
measured weekly. The perfusion experiments were conducted during 7-8 weeks after
the operation. Adequacy of the gonadectomy was assessed by inspection of possible
residual ovarian tissue, atrophy of the uterus, and changes in body weight [Waynforth
1980, Scheuer et al 1987]. Nerve stimulation-induced NA overflow and the effects of
rauwolscine (1 |iM) and clonidine (3 (iM) were studied using the same protocol as
described for Experiment 3 of the normoxic series.
5.3 Results
5.3.1 GS during Normoxia and Myocardial Catecholamine Content
Sympathetic nerve stimulation (60 sees) caused a marked overflow of NA into the
coronary effluent in male and female hearts. This increase in catecholamine release
was reflected by an increased inotropic and chronotropic response (Table 5.1). None
of these measurements were different between male and female hearts. Myocardial
content of NA (7.7±0.8 vs 8.1±0.7 nmol/g) and dopamine (0.62±0.12 vs 0.63±0.06
nmol/g) were also similar in males and females. However the content of adrenaline
was higher in female than male hearts (0.14±0.01 vs 0.08±0.02 nmol/g, p<0.01).
Table 5.1 NA overflow andfunctional response to left sympathetic ganglion stimulation (GS, 5 Hz for
60 sees) in normoxic perfused male and female rat hearts.
Male (n=12) Female (n=12)
Basal GS Basal GS
NA overflow (pmol/g) 0.7±0.3 86.317.9 1.110.2 85.3110.0
+dP/dtmax (mmHglsec) 1728±104 31281218 17841144 36261286
-dP/dtmax (mmHglsec) 946±68 19101100 908166 20921206
Heart rate (beats!min) 207118 233117 216+17 248115
All changes induced by nerve stimulation were significant (p<0.01) in both groups. No sex difference
was observed in any of these parameters.
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5.3.2 Gender and Presynaptic Modulation of NA Release during Normoxia
Rauwolscine increased NA overflow at each of the concentrations studied
(p<0.01) both in male and female hearts. The maximum effect of rauwolscine was
observed at 1 |iM (Figure 5.1). The increase in NA overflow by rauwolscine was
higher in female than in male hearts (p<0.05 by ANOVA).
Figure 5.1 Effect of the a2-adrenergic antagonist rauwolscine on nerve stimulation-evoked NA
overflow in perfused innervated male and female rat hearts (n=10 per group). Sympathetic nerve
stimulation (5 Hz for 30 sees) was applied 5 times (S1-S5) with 15 min intervals. The first (SI) was
used as a control. Rauwolscine was present before and during S2 (10~7M), S3 (KHM) and S4
(10~5M). Data are presented as a ratio of that obtained by SI. A second control nerve stimulation was
carried out 15 mins after washout of rauwolscine (S5). Similar amount ofNA overflow was obtained
by SI and S5 both in males andfemales (male: 40.9±4.9 and 42.2±5.7 pmollg; female: 43.5±7.4 and
48.9±8.6 pmollg).
At the optimum concentration of 1 (J.M, rauwolscine significantly enhanced NA
overflow during the second nerve stimulation in both sexes (p<0.01, Table 5.2). The
net increase in NA overflow by rauwolscine was significantly higher in females than
in males (+71.0±7.6 vs +39.9±7.8 pmol/g, p<0.01), and the ratio of NA overflow of
the second over the first nerve stimulation (S2/S1) was significantly higher in females
than in males (p<0.05, Figure 5.2).
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Table 5.2 NA overflow (pmollg) in male and female rat heart induced by sympathetic ganglion
stimulation (GS) during normoxia and ischaemia and effects of the a^-adrenergic antagonist














































































Male Female Male Female
Figure 5.2 Sex differences in the ratio ofNA overflow evoked by GS (5 Hz for 60 sees without (SI)
and with (S2) the a2-adrenoceptor antagonist rauwolscine (l\iM) in normoxic (n=12 in each group,
left panel) and ischaemic hearts (n=13 per group, right panel). Desipramine (0.1\lM) was used to
inhibit neuronal reuptake ofNA.
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Figure 5.3 Relationship between NA overflow and increases in left ventricular contractility
(A±dP/dt) and heart rate (AHR) induced by sympathetic nerve stimulation without (open symbols)
and with (closed symbols) the a2-adrenoceptor antagonist rauwolscine. NA overflow data are from
the normoxic series (panels A, B and C) in Table 5.2, from the ischaemic series (D) in Table 5.2 and
from gor.adectomy series (E) in the text. Triangles represent male or gonadectomized female groups,
and circles denote female or sham-operated female groups. Ten to 13 hearts in each group. The
inotropic and chronotropic effects of rauwolscine are significant (p<0.05 or <0.01), except for the
rise in heart rate in male rats (panelD) and in gonadectomized female rats (panel E).
Gender Difference in NA Release 93
The pre-stimulation levels of ±dP/dt and heart rate were similar between and
within groups (p>0.6). In the female group, rauwolscine significantly potentiated the
inotropic and chronotropic responses to the second (S2) compared with that of the
first (SI) nerve stimulation (changes in heart rate and ±dP/dt, all p<0.01), but this
effect was only of borderline significance in males (Figure 5.3). However, all these
sex-related differences in rauwolscine-induced potentiation of functional responses to
sympathetic stimulation in normoxic hearts were basically related to differences in
NA overflow (Figure 5.3 A, B and C).
In comparison to the effect of the antagonist rauwolscine, the agonist clonidine
had little effect on NA overflow in normoxic perfused hearts. A small reduction in
NA overflow was observed in females (p<0.05) but not in males (Table 5.2). This
difference between the two sexes was not significant whether expressed in absolute
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Figure 5.4 Effect of the a2-adrenoceptor agonist clonidine (3 \\M) on NA overflow induced by
sympathetic ganglion stimulation in male and female rat hearts during normoxia and during the final
minute of ischaemia (3 mins). Results are presented as the ratio of individual control values
measured during normoxia or during ischaemia without clonidine (SI, open bars). Desipramine (0.1
[iM) was used to inhibit neuronal NA uptake. Ten to 12 hearts per group.
*p<0.05 vs SI-inducedNA overflow.
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In male and female hearts the (3-receptor antagonist timolol (3 |iM) equally
inhibited most of the inotropic and chronotropic responses to GS (p<0.01) but a small
and significant increase in ±dP/dt was still measured, which usually appeared in the
final 20 sees during a 1 min stimulation period in contrast to the earlier appearance
(usually in the first 20 sees) of the maximum inotropic response to control stimulation
(Figure 5.5). Infusion of concentrations of isoprenaline resulted in a dose-dependent
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Figure 5.5 Nerve stimulation-
induced increase of ±dPldt in
the absence (SI and S2) and
presence of 0-adrenoceptor
antagonist timolol (3 pAf, S3)
in normoxically perfused male
and female rat hearts. (NS by
ANOVA n=5 per group). *
p<0.05 and #p<0.0005 vs pre-










Figure 5.6 Inotropic responses
of perfused male and female
rat hearts to different doses of
isoprenaline. A similar dose-
dependent increase in ±dP/dt
is observed in male and female
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5.3.3 Gender and NA Overflow during Ischaemia
A progressive decline in NA overflow was observed within the first 6 mins of
ischaemia in male and female hearts (p<0.001 by ANOVA). In males this reduction
was not significant at 1 min of ischaemia compared with the pre-ischaemic control
value (32.5±7.6 vs 40.4±6.2 pmol/g, NS), but it was at 3 and 6 mins of ischaemia
(27.0±5.5 and 20.1±3.0 pmol/g, respectively, both p<0.01). An identical pattern
emerged when the results were expressed as the ratio of the pre-ischaemic overflow
(Figure 5.7). In females, NA overflow was significantly inhibited by ischaemia at all
times examined (1, 3 and 6 mins of ischaemia vs the pre-ischaemic control value:
19.8±3.8, 14.9±2.6 and 10.8±1.5 v$ 39.315.5 pmol/g, p<0.001). The ratio of NA
overflow during ischaemia relative to the pre-ischaemic control was significantly
lower in females than in males (p<0.01 by ANOVA, Figure 5.7). Meanwhile, nerve
stimulation-induced increase in heart rate was also lower during ischaemia in females
than in males (combined data: +3515 vs +5216 beats/minute, p<0.05 by ANOVA).
0.2 H 1 1 i 1 1 1 > 1 ■ \ ■ 1
0 1 2 3 4 5 6
Iscbaemic duration (minute)
Figure 5.7 NA overflow from male and female rat hearts induced by sympathetic ganglion
stimulation (5 Hz for 30 sees) during normoxia and during 1, 3 and 6 mins of stop-flow ischaemia.
NA overflow during ischaemia is expressed as the ratio of individual normoxic values (SI =1).
Desipramine (0.1 \iM) was used to inhibit neuronal NA uptake. Sex difference was significant
(overall p<0.001 by ANOVA and at 3 and 6 mins as indicated by t-test). Nine hearts in each group.
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NA overflow was also significantly increased by rauwolscine in male and female
groups during ischaemia and the initial difference in both sexes in ischaemic NA
overflow was no longer significant (Table 5.2). The net increase of NA overflow by
rauwolscine tended to be higher in female than male hearts (+32.8±5.7 vs +16.1±6.2
pmol/g, p=0.054). The ratio of NA overflow in the presence and absence of
rauwolscine was significantly higher in the female group (p<0.05, Figure 5.3), an
effect mainly attributable to the difference in NA overflow between males and
females in the absence of this drug. Like in the normoxic experiments, changes in
heart rate induced by nerve stimulation with and without rauwolscine were also
related to the changes in NA overflow during ischaemia (Figure 5.3 D).
During ischaemia, the effect of clonidine differed from that during normoxia.
Clonidine increased NA overflow in male hearts with an increased ratio of NA
overflow (Table 5.2 and Figure 5.4), whilst no change in NA overflow had been
observed during normoxia. In contrast to the clonidine-mediated reduction in NA
overflow in normoxic female hearts, an insignificant increase in the ratio of NA
overflow (S2/S1) was observed (Figure 5.4). The ischaemia-induced difference in
neuronal NA overflow between both sexes was not affected by clonidine (Table 5.2).
Reperfusion after 40 mins of ischaemia evoked spontaneous NA overflow in both
male and female hearts (186±21 vs 183±31 pmol/g, NS). Overflow of lactate and
LDH were also observed in male and female hearts (lactate: 19.6±0.7 vs 19.7±1.2
pM/g, LDH: 214±46 vs 208±32 pU/g). No sex difference was found in all these
changes.
5.3.4 Gonadectomy Series
Gonadectomy was associated with an increase in body weight, which was
discernable starting from the second week after the operation. At the time of sacrifice,
gonadectomized rats had a higher body weight (320±7 vs 258±5 g, p<0.001), heart
weight (1.02±0.03 vs 0.86±0.02 g, p<0.001) and a marked uterine atrophy (83±3 vs
463±26 mg, p<0.001) than sham-operated female rats. The perfusion flow rate was
similar in the two groups (4.93±0.13 vs 4.7310.11 ml/g/min, NS).
NA overflow evoked by a control nerve stimulation (SI) did not differ between
sham-operated and gonadectomized females. NA overflow was significantly
increased by rauwolscine in sham-operated controls (from 70.518.4 to 164.7+22.7
pmol/g, p<0.001) and in gonadectomized rats (from 88.7113.2 to 140.5118.7 pmol/g,
p<0.01). However, the potentiation of NA overflow by rauwolscine was reduced after
gonadectomy as the S2/S1 ratio was significantly lower (p<0.02, Figure 5.8).
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NA overflow was not significantly affected by clonidine in gonadectomized and
sham- operated animals and S3/S1 ratios were similar (0.94±0.17 vs 1.0410.15, NS).
FSH FGX pSH FGX
Figure 5.8 Effect of female gonadectomy (FGX, n=14) or sham-operation (FSH, n=13) on net
increase in NA overflow (left panel) and on the ratio of NA overflow (right panel) evoked by
sympathetic ganglion stimulation (5 Hz for 60 sees) without (SI) and with (S2) the a2-adrenoceptor
antagonist rauwolscine (1 \xM) in normoxic perfused hearts.
Pre-stimulation heart rate (195111 vs 183113 beats/min, NS), +dP/dt (1573194 vs
15441166 mmHg/sec, NS) and -dP/dt (751163 vs 746140 mmHg/sec, NS) were
similar in sham-operated and gonadectomized rat hearts. Inotropic response to control
GS was significantly lower in gonadectomized rat hearts (+dP/dt: 25091152 vs
33231277 mmHg/sec, p<0.05; -dP/dt: 1421178 vs 19341231 mmHg/sec, p<0.05).
The chronotropic response to nerve stimulation was not significantly affected by
gonadectomy. Changes in heart rate with and without rauwolscine were related to the
changes in the amount of NA overflow (Figure 5.3 E).
5.4 DISCUSSION
Gender and Presynaptic a2-Adrenergic Inhibition of NA Release
The present study has demonstrated, for the first time, a stronger a2-adrenergic
presynaptic inhibition of exocytotic NA release in female than in male rat hearts. In
the presence of the a2-adrenoceptor antagonist rauwolscine, NA overflow was
increased proportionally more in female rat hearts. These sex differences are not due
to a leftward shift in the dose-response curve of rauwolscine in female rat hearts. The
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maximum effect of rauwolscine on NA overflow was achieved at 1 pM concentration
in both male and female rats. Clonidine, an a2-adrenergic agonist, significantly
reduced NA overflow in females, but not in males.
One may argue that the gender differences in NA release could simply be caused
by a denser sympathetic innervation in female rat hearts. However, if this had been
the case then we would have expected NA overflow in females also to be higher in
the absence of rauwolscine, and the ratio of NA overflow with and without
rauwolscine to remain unchanged. This was not so. Myocardial NA and dopamine
levels were also not different in both sexes. Another possibility is a less efficient NA
reuptake system in females. Our studies were always carried out in the presence of the
neuronal reuptake inhibitor, desipramine, and therefore a gender difference in
neuronal reuptake of NA, if it exists, seems an unlikely explanation. There are no
published data to support this possibility and one clinical study actually found a
higher clearance of catecholamine from the circulation in females [Lenders et al
1988]. We found a significantly higher content of adrenaline in female than in male
rat hearts. As adrenaline can not be synthesized by adrenergic neurones (Section
1.3.2), this difference is most probably due to sex-related difference in the neuronal
uptake of adrenaline. The implication of this difference, however, is unclear as
adrenaline constitutes only about 1-2% of total catecholamines in the heart. In
addition, oestrogen could inhibit the extraneuronal NA uptake in rat heart in vitro
[Iversen 1973]. However, since this uptake mechanism plays a minor role in NA
clearance from the synaptic cleft in our model [Dart et al 1984b], the magnitude of
the gender difference in NA overflow seems too large to be explained this way.
Our evidence on the gender difference of presynaptic control of NA release do not
rely on the results of NA overflow only. The inotropic and chronotropic potentiation
by rauwolscine was also more marked in female than in male hearts. We excluded the
possibility that this was due to a difference in postsynaptic adrenergic responsiveness
between the sexes. The inotropic response to nerve stimulation is predominantly
mediated by ^-adrenoceptors and the inotropic effects of increasing concentrations of
between
the (3-adrenergic agonist isoprenaline were similar)!males and females. When the (3-
antagonist timolol (3 pM) was used to unmask any a-adrenergic response, the greatly
reduced inotropic and chronotropic responses to nerve stimulation did not differ
between the two sexes. Thus, neither postsynaptic (3- nor a-adrenoceptors in the rat
heart are functionally different according to the sex of the animal. Therefore, the sex
differences in functional responses to nerve stimulation by rauwolscine can only be
explained by the alteration in NA overflow due to this drug. In gonadectomized rats
the inotropic state of the heart is reduced, as observed in this nerve stimulation
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experiment and other detailed haemodynamic studies [Schaible et al 1984, Scheuer et
al 1987]. Therefore, a difference in the response to nerve stimulation between sham-
operated and ovariectomized rat hearts cannot simply reflect NA overflow under
these circumstances. Taken together, our results suggest that the presynaptic a2-
adrenergic inhibition of NA release plays a more important role in female than in
male rat heart.
Mechanism
Both the increase in NA overflow and the associated greater chronotropic
response by rauwolscine was attenuated after gonadectomy, indicating a less effective
a2-adrenergic presynaptic inhibition after removal of the ovaries. The adequacy of
gonadectomy was documented by a marked uterine atrophy which has been attributed
to the fall in oestrogen levels [Scheuer et al 1987]. Therefore, a female hormone-
mediated modulation of presynaptic a2-adrenoceptors is indicated. To the best of our
knowledge, this is the first study to suggest such modulation in the heart.
Gender differences in a-adrenoceptors have been extensively studied using
pharmacological and radioligand techniques. In various tissues (blood vessels,
neurones, platelets, uterus, bladder and urethra), a higher sensitivity and density of a-
adrenoceptors has been found in females than in males [Stone et al 1989, Jones et al
1983, Colucci et al 1982, Roberts et al 1981, Levin et al 1980]. Some studies show
that this sex difference in a-adrenoceptors is restricted to the a2-subtype [Morita et al
1987, Hoffman et al 1981, Roberts et al 1981], but others found that acceptors also
differed between the sexes [Stone et al 1989, Colucci et al 1982]. Where this was
studied ^-adrenoceptors were found to be similar in the two sexes [Roberts et al 1981,
Levin et al 1980]. Furthermore, this gender difference in a-adrenoceptors does not
persist after ovariectomy [Colucci et al 1982], Conversely, elevating oestrogen levels
in males and females increases the density of a2-receptors, but has no such an effect
on (3-receptors [Roberts et al 1981, Colucci et al 1982, Hoffman et al 1981].
Progesterone prevents the oestrogen-induced rise in myometrial a2-adrenoceptors
[Roberts et al 1981]. Testosterone treatment does not affect a-adrenoceptors [Colucci
et al 1982].
Sex Difference in NA Release during Ischaemia
A reduction in neuronal NA overflow during acute ischaemia has been
documented and is explained by presynaptic inhibition, enhanced neuronal reuptake
and energy depletion of sympathetic nerves [Dart et al 1984b, Dart and Riemersma
1985, Schomig 1988].
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Another important observation in our study is that ischaemia reduces neuronal NA
release to a greater extent in females than in males. In contrast, no sex difference
exists in non-exocytotic NA release induced by a 40-min period of ischaemia.
Interestingly, at 3 mins of ischaemia, administration of the a2-adrenoceptor antagonist
rauwolscine led to a higher net increase in NA overflow in females and the initial
difference in the total amount of NA overflow between the two sexes was no longer
observed. Thus, the lower NA release during ischaemia in female hearts is largely due
to the greater a2-adrenoceptor-mediated presynaptic inhibition in female than in male
hearts. This gender difference is only observed during ischaemia but not during
normoxia. It is probably the result of a higher prevailing NA level in the synaptic
cleft due to the ineffectiveness of washout during stop-flow ischaemia. Our clonidine
data also support this proposition. As clonidine is a partial agonist with an efficacy of
about 1/5 of that of NA [Medgett et al 1978], it will show an antagonistic effect when
NA concentrations are high. Indeed, during ischaemia, neuronal NA overflow was
increased in males by clonidine. Although the rise in the female group was not
significant, it was also not different from the male group. However, the overall effect
of clonidine during ischaemia is to enhance neuronal NA overflow (p<0.01,
combined data from both groups).
The observed sex difference in presynaptic inhibition of neuronal NA release
during ischaemia may be an explanation for the early loss in catecholamines from
adrenergic nerves after coronary ligation in one study using male rats (0.5 hour)
[Abrahamsson et al 1982] but not in two other studies of female rats (3-8 hours)
[Paessens and Borchard 1980, Ahonen et al 1975]. In Chapter 3, we have
demonstrated that neuronal NA release is maintained for at least 90 mins of low-flow
ischaemia, along with an efficient adrenergic presynaptic inhibition.
Implications
The sympathetic nervous system plays an important role in the development of
serious ventricular arrhythmias during acute myocardial ischaemia [Corr et al 1986].
Gender may affect the risk of severe ischaemic arrhythmias both in man and
experimental animals [Section 1.1.3]. In the anaesthetized rat, the onset of ventricular
arrhythmias is delayed and arrhythmia-induced death within the first 20 mins of
coronary ligation is less frequent in females than males [Siegmund et al 1979]. In the
Framingham Study, sudden cardiac death rates are higher for men than for women
[Kannel and Schatzkin 1985, Dahlberg 1990]. However, sudden cardiac death, as a
percentage of total mortality from coronary heart disease, is not significantly lower in
women (46% vs 34%, p<0.1). Although ventricular tachyarrhythmias are more likely
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to be induced in electrophysiological testing in men than in women [Freedman et al
1988, Schoenfeld et al 1985], these studies were not controlled for differences in the
extent of coronary artery disease or extent of impairment of ventricular function. In
addition, the majority of women in all these studies were of post-menopausal age.
Thus, adequate clinical studies comparing the vulnerability to arrhythmias or sudden
cardiac death in men and women appear not to have been conducted. The difference
in presynaptic inhibition shown in this study might lead to a reduced adrenergic
stimulation and fewer serious arrhythmias and/or a reduction in sudden cardiac death




of the Heart: Effect ofGender
6.1 Introduction
We have observed a more potent a-adrenergic presynaptic control of neuronal
NA release in female than in male rats (Chapter 5). NA exocytosis is also under
modulation of vagal nerve activity [Levy 1984, Lavallde et al 1978, Chapter 4].
Although no study has been conducted to test whether gender influences vagal-
mediated presynaptic and postsynaptic effects in the heart, several indirect
observations indicate that gender may have such effect. The cardiovascular response
to stress differs according to gender. An increase in heart rate (HR), blood pressure,
peripheral vascular resistance, ventricular contractility and plasma level of
catecholamines in response to various stress (e.g. exercise, lower body negative
pressure, mental stress, or insulin-induced hypoglycaemia) are common in man.
Women usually show an increase in HR only with a less marked increase in plasma
catecholamines [Claustre et al 1980, Bunag et al 1975, Brooks et al 1990]. It has been
suggested therefore that stress leads to a sympathetic activation in males and a
withdrawal of vagal activity in females [Frey and Hoffler 1988, Sanchez et al 1980].
Gonadal hormones modulate the activity of choline acetyltransferase (ChAT) and
acetylcholine (ACh) content in central nervous system [Muth et al 1980, Luine 1985,
Luine et al 1986]. Oestrogen treatment may increase muscarinic receptors in nervous
tissue [Olsen et al 1988, Egozi et al 1982] and smooth muscle [Levin et al 1980]. It is
unclear if these effects also occur in the heart, but oestrogen and androgen receptors
do exist in myocardium [Stumpf et al 1977, McGill et al 1980]. Moreover, using
ligand binding technique, Williams et al demonstrated an increased affinity of
muscarinic receptors to 3H-QNB in female than in male rat hearts [1984].
Parasympathetic activation protects against ventricular arrhythmias during acute
ischaemia both in man and in experimental animals [Schwartz and Stramba-Badiale
1988, Schwartz et al 1988a, Corr et al 1986, Section 1.2.2]. A difference may exist
between the sexes in the severity of ischaemic arrhythmias or incidence of sudden
cardiac death [Dahlberg 1990, Siegmund et al 1979, Puddu et al 1988, Section 1.1.3].
The mechanisms for this gender difference is largely unclear.
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Therefore, the effect of gender on vagal nerve stimulation mediated inhibition of
neuronal NA release (presynaptic action) and reduction in HR (postsynaptic action)
was examined in the in situ perfused and innervated rat heart model (Section 2.2).
The influence of gonadectomy on these aspects was also studied.
6.2 Methods
6.2.1 Animals, Drugs and Model
Sprague-Dawley male and female rats (9-10 weeks of age) were used for this
study. All experiments were carried out alternatively on male and female rats.
Coronary flow rate was adjusted at about 5 ml/g/min. Drugs used were desipramine
(0.1 pM, neuronal reuptake inhibitor), choline chloride (10 pM, precursor for ACh
synthesis), physostigmine (1 pM, cholinesterase inhibitor), methacholine (0.01-50
pM, muscarinic agonist) and atropine (10 pM, muscarinic antagonist). Desipramine,
choline chloride and physostigmine were present throughout the experiment and other
drugs were infused as described in Section 2.6. Coronary effluent for the
measurement of NA was collected for 2 mins starting from the onset of left stellate
ganglion stimulation (GS) in normoxic experiments, or for 2.5 mins in ischaemic-
reperfusion experiments.
6.2.2 Protocols
Cholinergic inhibition ofNA release during normoxia and ischaemia
Presynaptic inhibition of NA overflow either by bilateral vagal nerve stimulation
(VS) or by methacholine was studied in male and female rat hearts.
In 13 male and 14 female normoxically perfused rat hearts, GS (5 Hz for 1 min)
was performed three times. The first GS served as a control, followed by GS plus VS
(15 Hz for 1 min) or GS in the presence of methacholine (10 pM). The sequence of
the last two nerve stimulations were randomized.
Another 10 male and 10 female hearts were subjected to two episodes of 3-min
stop-flow ischaemia separated by a 15-min period of normoxic perfusion. GS (5 Hz
for 1 min) or combined GS and VS (5 and 15 Hz for 1 min, respectively) was applied,
in random order, during the final minute of ischaemia, immediately followed by
reperfusion.
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Cholinergic postsynaptic effects in normoxic hearts
The effects of endogenous (VS) and exogenous (methacholine) cholinergic
stimulation on HR, coronary perfusion pressure were examined in male and female
rat hearts.
In 19 male and 22 female hearts, six VS were performed (30 sec duration) at
frequencies of 1, 2.5, 5, 10, 15 and 20 Hz, separated by 10-min recovery periods.
Epicardial ECG and ventricular pressure were continuously recorded. Ten mins after
the last VS, 21 (8 male and 13 female ) out of the 41 rat hearts were infused with
increasing concentrations of methacholine (0.01, 0.1, 1, 5, 10, 20 and 50 (iM). Each
dose was maintained for 3 mins. Epicardial ECG and perfusion pressure were
continuously recorded. In order to eliminate an effect of myocardial contraction on
perfusion pressure recorded during methacholine administration, in another 11 hearts
(6 male and 5 female) VF was induced and maintained by electrical stimulation of the
left ventricle (1.5 mA, 10-20 Hz) and the effect of concentrations of methacholine
(0.01-50 (iM) on coronary perfusion pressure was examined as described above. In
another 4 preparations, the influence of atropine (10 |J.M) on the vasoconstrictive
effect of 50 (iM methacholine was examined.
Gonadectomy and the effects of vagal nerve stimulation
The possibility that gonadal hormones modulate the effects of VS on the heart
was examined. Gonadectomy (GX) or sham-operation (SH) were performed in 4
week old male and female rats [Waynforth 1980]. Heart perfusion experiments were
carried out 8-9 weeks after the operation (i.e. at 12-13 weeks of age). At the time of
sacrifice, effective gonadectomy was verified by visual inspection of residual gonadal
tissues and uterine atrophy in ovariectomized female rats (Section 2.4).
GS (5 Hz for 1 min) or combined GS and VS (5 and 15 Hz for 1 min,
respectively) were applied separated by a 15-min recovery period. Coronary effluent
for the measurement of NA was collected for 2 mins. Afterwards, VS was given for 6
times (30 sec duration with 10-min recovery periods between the nerve stimulations).
The frequencies used were 1, 2.5, 5, 10, 15 and 20 Hz, respectively and changes in
HR were measured.
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6.3 RESULTS
6.3.1 Presynaptic Cholinergic Effects
Hearts of male rats were heavier than those of females (0.80±0.01 vs 0.71±0.01 g,
p<0.01). Perfusion flow was adjusted to the estimated heart weight and did not differ
between male and female groups (5.04±0.09 vs 5.0410.05 ml/g/min).
In normoxic hearts, GS-induced NA overflow was similar in the two sexes. Both
vagal nerve stimulation and 10 |iM methacholine significantly inhibited NA overflow
from male and female rat hearts. In female hearts, inhibition of NA overflow by VS
was more marked than in male hearts with a bigger net reduction of NA overflow
(-38.014.8 vs -21.914.3 pmol/g, p<0.05). As a result the ratio of NA overflow in the
presence and absence of VS was also lower in females (p<0.05, Figure 6.1).
Methacholine (10 (J.M) induced a similar reduction in neuronal NA overflow both in
absolute terms or when expressed as a ratio of control NA overflow (Table 6.1 and
Figure 6.1). During ischaemia NA overflow by GS was lower in female hearts and
VS did not significantly reduce NA overflow in both groups (Table 6.1). However, a
tendency of a reduction was noticed in females (p=0.06, Figure 6.1).
Table 6.1 Effects of vagal nerve stimulation (VS, 15 Hz) and methacholine (MCh, 10 ]xM) on
sympathetic ganglion stimulation (GS, 5 Hz) induced NA overflow (pmol/g) in male and female rat
hearts in normoxia or in 3 min stop-flow ischaemia
Male Female *
Normoxia (n=13) (n=14)
GS 83.4 ± 12.0 88.5 ± 11.9 NS
GS+VS 61.5 ± 11.0* 50.5 ± 9.1** NS
GS+MCh 18.7 ± 4.8# 22.0 ± 4.9# NS
Ischaemia (n=10) (n=10)
GS 53.5 ± 12.9 26.9 ± 4.5 <0.05
GS+VS 58.3 ± 12.9 18.7 ± 2.3 <0.01
§ unpaired t-test for gender difference.
*comparison vs GS by paired t-test: *p<0.05 ** p<0.01 #p<0.001.
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6.3.2 Postsynaptic Cholinergic Effects
Basal HR before each VS was similar in males and females (p>0.8). Frequency-
dependent reduction in HR by VS was observed in male and female hearts. At each
frequency, the HR-lowering effect was greater in females than in males (Figure 6.2).
At a frequency of 20 Hz, 50% of female hearts stopped beating whilst asystole was
observed only in 3 male hearts (16%). Coronary perfusion pressure was not
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Figure 6.2. Heart rate-lowering effect of vagal nerve stimulation (1-20 Hz) in normoxically perfused
male (n-19) and female rat hearts (n=22). Overall difference p<0.001 by ANOVA and significance
at individual frequencies *p<0.05 **p<0.01.
Male
-£> Female
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Administration of methacholine led to a dose-dependent decrease in HR and an
increase in perfusion pressure (Figure 6.3). These changes were identical in male and
female hearts. In male and female hearts, perfusion pressure before (40±2 vs 45±2
mm Hg) and after 3 mins methacholine infusion (40±2 vs 46±1 mm Hg) was similar.
The changes in coronary perfusion pressure induced by methacholine (>106 M) were
significantly lower (p<0.01) in the hearts with induced ventricular fibrillation.
Atropine at 10 |iM largely blocked the methacholine-induced (50 pM) increase in
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Figure 6.3. The effect of
methacholine on heart rate
(HR, upper panel) and
coronary perfusion pres¬
sure (CPP, lower panel) in
male and female rat hearts.
No gender difference was
observed by ANOVA, either
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6.3.3 Gonadectomy and Vagal Effects
Body and heart weights increased after ovariectomy and decreased after castration
(Figure 6.4). These results and those of uterine weight and perfusion flow rate at the
time of sacrifice are presented in Table 6.2.
Table 6.2 Body, heart, and uterus weights and coronary flow rate (CFR) in sham-operated and
gonadectomized rats
Body Heart Uterus CFR
(8) (8) (mg) (ml/glmin)
FSH (n=12) 248 ±5 0.81 ±0.02 5121 18 4.910.1
FGX (n=12) 312 ±7* 0.92 ± 0.03* 6013* 5.010.1
MSH (n-7) 418 ±11 1.2710.04 - 4.810.1
MGX (ri=ll) 368 ± 7* 1.09 1 0.02* - 5.110.1
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Figure 6.4. Growth curves in sham-operated and gonadectomized male or female rats. Sham-
operated: male (MSH), female (FSH); gonadectomized: male (MGX), female (FGX).
*p<0.05 for MSH vs MGX or FSH vs FGX.
There was no significant difference in control GS-induced NA overflow between
the 4 groups (FSH: 59.9±7.8, FGX: 61.0±10.3, MSH: 71.5±8.6, and MGX: 63.6±5.2
pmol/g). VS significantly reduced this value in FSH group (p<0.05), but not in the
other three groups (Figure 6.5). Ratios of NA overflow with and without VS did not
differ between the four groups.
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GS FSH FGX MSH MGX
Figure 6.5. Effect of vagal nerve stimulation (VS, 15 Hz) on NA overflow induced by sympathetic
ganglion stimulation (GS, 5 Hz) in hearts of sham-operated and gonadectomized male and female
rats. Results are expressed as the ratio ofNA overflow induced by a control GS. * p<0.05 vs GS by
paired t-test.
Basal HR was not influenced by gender or gonadectomy (p<0.6). The frequency-
dependent reduction in HR was demonstrated in male and female hearts of rats
whether gonadectomized or not, with similar slopes of the frequency-response curves.
However, the extent of HR reduction by VS varied between the four groups and
followed the sequence: FSH > FGX > MGX > MSH (p<0.05 by ANOVA for the
difference between FSH vs FGX and MGX vs MSH, Figure 6.6).
Frequency of vagal nerve stimulation (Hz)
Figure 6.6. The effect of gonadectomy on HR-lowering response to vagal nerve stimulation
(1-20 Hz). p<0.05 for the difference between FSH vs FGX or between MSH vs MGX groups by
ANOVA.
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6.4 DISCUSSION
Results from the present study show a more potent vagal effect in the perfused
female heart. Vagal nerve stimulation reduced neuronal NA overflow and HR more in
female than in male hearts during normoxic perfusion. A failure of vagal-mediated
inhibition of NA overflow by a few minutes of stop-flow ischaemia in male hearts has
been demonstrated (Chapter 4). In the present study, after 3 mins stop-flow
ischaemia, vagal stimulation again did not reduce neuronal NA overflow in male
hearts, but a tendency of reduced NA overflow in female hearts was observed. This
occurs despite the fact that neuronal NA overflow during ischaemia was significantly
lower in females than in males, a finding similar to that presented in Chapter 5.
Mechanisms responsible for this gender difference are not clear. Clearance of
released ACh in the heart is achieved via two mechanisms: hydrolysis by
acetylcholinesterase and washout from the biophase [Loffelholz and Pappano 1985].
The response to VS would change if a gender difference in the capacity of ACh
clearance exists. In this study, coronary flow rate was controlled and the studies were
performed in the presence of physostigmine. Effectiveness of this drug in preventing
hydrolysis of ACh seems reasonable as there was a significant potentiation of HR-
lowering response to VS (Chapter 4). Dieterich et al [1976] have demonstrated that
physostigmine increases evoked output of ACh by 2-3 fold in mammalian hearts.
Thus, under our experimental conditions a gender difference in the clearance of ACh
seems irrelevant.
Another possibility is a gender difference in the functional status of pre- and post¬
synaptic muscarinic receptors. It has been demonstrated that oestrogen treatment
increases muscarinic receptors in the central nervous tissue of rats [Olsen et al 1988,
Egozi et al 1982]. Oestrogen may also exert a similar effect in smooth muscle and
myocardium [Levin et al 1980, Williams et al 1984]. However, inspection of
methacholine-mediated effects, i.e., changes in NA overflow, HR and coronary
vasoconstriction, do not suggest a gender difference in muscarinic receptors localized
on sympathetic nerve endings, myocytes and smooth muscle cells of coronary
arteries.
As ACh overflow by vagal nerve stimulation was not measured in this study, we
can not exclude the possibility that the speed of ACh resynthesis is higher in females,
thereby leading to a higher degree of ACh pool replenishment during repeated vagal
stimulations. In all experiments, 10 (J.M choline was present to ensure a continuous
supply of the precursor for ACh resynthesis. A high affinity choline uptake system
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transfers choline into the cholinergic nerve ending [Ducis 1988, Section 1.3.3]. The
supply of choline via this system meets the demand even under condition of a
markedly increased neuronal activity [Ducis 1988, Lindmar et al 1980, Wetzel and
Brown 1983]. We observed in five separate male hearts that vagal nerve stimulation
(15 Hz for 1 min separated by 15-min intervals) reduced HR equally well (%
reduction from control: 71±3%, 67±6%, 66±6%, 65±4%, and 63±5%, NS). In the in
vivo male rats, there is no reduction in ACh content in various parts of the heart after
20 mins intensive vagal stimulation (15 Hz, 0.5 mA and 2 ms) [Lund et al 1986].
These observations suggest an efficient ACh resynthesis even in the male rat heart.
Results from the gonadectomy study show that both male and female hormones
are involved in the observed gender difference in the HR-lowering effect of vagal
nerve stimulation. The frequency-response of HR was attenuated by ovariectomy but
strengthened after castration. These opposite effects of gonadectomy in female and
male rat hearts seem to indicate that female hormones enhance, and male hormone
inhibits the effect of the vagus on the heart. However, an effect of gonadectomy on
vagally-mediated inhibition of neuronal NA release was not found. We have no
simple explanation for this discrepancy and it is perhaps due to a large individual
variation in this specific experiment. Nevertheless, reduced NA overflow by vagal
nerve stimulation was only observed in the sham-operated female group.
Modulation of cholinergic nerve function by gonadal hormones has been
described for central nervous tissue. The activity of cholinergic enzymes differ
between males and females [Luine et al 1986. Muth et al 1980]. Oestrogen treatment
increases ChAT activity and ACh content in certain regions which are sensitive to
gonadal hormones [Luine 1985]. Increased ChAT activity may lead to an increased
cholinergic function although ChAT may not be the rate-limiting step for ACh
synthesis [Ducis 1988, Section 1.3.3]. However, there has been no data to show a
gender difference in cardiac content of ACh or ACh overflow evoked by vagal nerve
stimulation. We tried to pre-label hearts with 3H-choline (1 pM) and measured
radioactive overflow before and during vagal nerve stimulation. The high basal level
of radioactivity in coronary effluent and a small increase in overflow of the 3H-
radioactivity by nerve stimulation made it unsuitable for quantitative studies. Now,
we are setting up a radioenzymatic method for ACh analysis. Data on ACh content in
myocardium and release are critical if we wish to explain the mechanism underlying
the observed sex difference.
Chapter 7
Sympathetic-Parasympathetic Interactions, Gender and
Ischaemic-Reperfusion Arrhythmias
7.1 Introduction
Acute myocardial ischaemia is a potent stimulus for the activation of autonomic
nervous system, both in man and in animals [Pantridge 1978, Lombardi et al 1983].
Within the first 30 mins after the onset of acute myocardial infarction, 83% of
patients show clinical signs of sympathetic and/or parasympathetic activation
[Pantridge 1978]. Direct recording of afferent and efferent nerve activity
demonstrated enhanced cardiac sympathetic and vagal nerve impulses after coronary
ligation [Lombardi et al 1983, Corr et al 1986].
The role of sympathetic activation in the genesis of ischaemic and reperfusion
arrhythmias has been documented by a large body of clinical and experimental studies
[Section 1.2.2]. Cardiac sympathetic activation, either by electrical, pharmacological
or psychological means, increases the vulnerability of the heart to arrhythmias. On the
contrary, chronic sympathectomy or adrenergic antagonists reduce the incidence of
ischaemic-reperfusion arrhythmias [Corr et al 1986, Verrier 1988, Schwartz and
Zuanetti 1988]. Most studies suggest that vagal activation during ischaemia protects
the heart from arrhythmias [Verrier 1988, Schwartz and Stramba-Badiale 1988]. A
similar salutary effect of vagal activity in the modulation of reperfusion arrhythmias
has been suggested by a few recent studies [Schwartz and Zuanetti 1988]. The
mechanisms responsible for the vagal protection against ischaemic and reperfusion
arrhythmias are considered mainly to be due to its anti-adrenergic effects, including
presynaptic inhibition of NA release [Levy 1984, Corr et al 1986]. But the
contribution by this inhibitory mechanism during ischaemia is largely unknown.
A few studies suggest less severe ischaemic arrhythmias or early mortality in
female than in male rats [Siegmund et al 1979, Du et al unpublished, Lu et al 1984]
and dogs [Puddu et al 1988]. We have found sex differences in the autonomic control
of the heart (Chapter 5 and 6). It would then be of interest to examine if these
differences affect the severity of arrhythmias during acute ischaemia.
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The rat is a commonly used model for the study of ischaemic and reperfusion
arrhythmias [Curtis et al 1987]. However, the relation between neuronal activity and
the genesis of arrhythmias has apparently not been examined in this model.
Therefore this study was designed to examine: 1) modulation of sympathetic and
cholinergic stimulation on the pathogenesis of reperfusion arrhythmias linked to NA
release, and 2) sex difference in the severity of ischaemic arrhythmias in models
without (isolated perfused heart) and with neuronal influence (intact animal).
7.2 Methods and Protocols
The effect of nerve stimulation on reperfusion ventricular fibrillation (VF) was
studied using male Wistar rats (9-10 weeks old). Male and female Sprague-Dawley
rats (10-12 weeks old) were used for in vitro and in vivo arrhythmia studies.
7.2.1 Reperfusion Arrhythmia Experiment
The in situ perfused innervated rat heart model, described in Section 2.2. was used
in this study. Neuronal reuptake inhibitor desipramine (0.1 pM) was present
throughout.
After a 30-min stabilization period, low-flow ischaemia (10 mins) was induced by
reducing perfusion flow from 5 ml/g/min to 0.25 ml/g/min. Coronary effluent was
collected on ice during ischaemia for lactate and NA measurements. At the end of
ischaemia perfusion flow was restored to the pre-ischaemic level. Epicardial ECG
was recorded during ischaemia and on reperfusion to monitor heart rate (HR) and VF.
Four groups were included:
1) control (n=12), no nerve stimulation;
2) GS (n=ll), sympathetic ganglion stimulation (GS, 5 Hz) was performed during
1-10 mins of ischaemia;
3) combined nerve stimulation (n=14), sympathetic (5 Hz) and bilateral vagal
nerve stimulation (15 Hz) were applied during 1-10 mins of ischaemia;
4) GS + methacholine (n=12), methacholine (1 |iM) was added to perfusate at
least 12 mins before ischaemia and maintained throughout the ischaemic
period. GS was performed during the last 9 mins of ischaemia.
The end point for these studies was VF occurring within the first 2 mins of
reperfusion.
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7.2.2 In vitro Arrhythmia Experiment
An isolated Langendorff-perfused rat heart model (see Section 2.3.1) was used.
After stabilization, coronary artery was occluded and maintained for 20 mins
followed by 5 mins of reperfusion. ECG was continuously recorded throughout the
ischaemic-reperfusion period. Coronary effluent was collected every 5 mins during
ischaemia and during the 5 mins reperfusion. Lactate concentrations were measured
in all the samples and NA levels were analysed in the samples collected during the
reperfusion.
7.2.3 In vivo Arrhythmia Experiment
An anaesthetized open-chest animal model, previously described in Section 2.3.2,
was used for this experiment. After stabilizing the preparation and recording of blood
pressure and ECG (chest lead), left coronary ligation was induced and maintained for
20 mins. In a pilot experiment, 12 hearts were reperfused 20 mins after coronary
ligation according to the technique described by Himori and Matsuura [1989]. A low
incidence of reperfusion-induced VF was found (8%). Therefore reperfusion was not
routinely performed in this study. ECG and blood pressure were continuously
monitored during ischaemia. At the end of 20 mins of ischaemia, those rats without
sustained VF received a bolus injection of Evans blue solution intravenously for the
determination of non-perfused myocardium (Section 2.3.2).
7.2.4 Verification of Coronary Artery Ligation
In the in vitro perfused hearts reduction of coronary effluent by coronary ligation
was used to assess the severity of the ischaemic insult. In the in vivo study, the
unstained ischaemic area was carefully dissected from the blueish non-ischaemic zone
and weighed. The percentage of the ischaemic region was expressed as a percentage
of left and right ventricular weight (atria were trimmed off before weighing). The
extent of reduction in arterial blood pressure immediately after coronary occlusion
was also used to estimate the severity of ischaemic insult to the heart.
Two in vitro preparations were rejected as the reduction in coronary flow by
coronary ligation was less than 20%. Three in vivo preparations were discarded due to
a failure to occlude the left coronary artery.
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7.3 Results
7.3.1 Reperfusion VF and NA Overflow
In the control group, NA levels during the first 10 mins of low-flow ischaemia
were less than 1 pmol/ml. Sympathetic nerve stimulation increased NA
concentrations to about 30 pmol/ml, and this level was maintained during the 9 mins
of nerve stimulation (Table 7.1). In the hearts with combined sympathetic and vagal
nerve stimulation, NA level in the effluent collected during the first period (1-4 mins)
tended to be lower compared with that measured afterwards, although this difference
was not statistically significant (p=0.06). During low-flow ischaemia nerve
stimulation induced NA overflow was not affected by 1 |lM methacholine (Table 7.1
vs GS), in contrast to its 50% inhibition of neuronal NA overflow during normoxia
(Chapter 4).
Reperfusion VF was 8% in the control group. Sympathetic nerve stimulation
significantly increased the incidence of VF during reperfusion (p<0.05) accompanied
by an enhanced NA overflow during ischaemia (Figure 7.1). Both endogenous and
exogenous cholinergic stimulation abolished the sympathetic stimulation-triggered
VF during reperfusion (p<0.05) but failed to inhibit NA overflow during ischaemia
(Table 7.1 and Figure 7.1).
Table 7.1 NA levels in coronary venous effluent during the first 10 mins of low-flow ischaemia (0.25
ml/g/min) and the effect ofnerve stimulation and methacholine.
During ischaemia there was a marked increase in the concentrations of lactate
in coronary effluent and this was similar in the groups with and without nerve
stimulation (Figure 7.2). In the control group ischaemia led to a progressive reduction
in HR within the first few minutes. GS resulted in a transient and small increase in





(g) 1-4 mins 4-7 mins 7-10 mins
0.78±0.02 0.6±0.1 0.9±0.2 0.8±0.2
0.79±0.02 30.3±7.3 32.1±5.3 23.8±4.6
0.81±0.03 17.4±2.6 30.7±5.8 30.7±5.6
0.81±0.02 28.8±4.6 40.4±6.5 28.1±3.0
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(1/12) (6111) (0/14) (0/12)
Figure 7.1 The effect of vagal nerve stimulation (VS, 15 Hz) or methacholine (MCh, 1 \xM) on NA
overflow induced by sympathetic nerve stimulation (GS) during the first 10 mins of low-flow
ischaemia (left panel) and the incidence ofVF during reperfusion (right panel). *p<0.05 vs GS group
(right panel) and ** p<0.01 vs control group (left panel)
HR during the first 3 mins of nerve stimulation (p<0.05). Combined sympathetic and
vagal nerve stimulation significantly reduced HR during the first period of nerve
stimulation (1-4 mins, p<0.05 vs control and GS groups). Afterwards no difference
existed between the three groups (Figure 7.2). Arrhythmias were not found during
ischaemia except bradycardia. In the group with methacholine, HR before ischaemia
was significantly lower than in the other three groups (136±15 beats/min, p<0.01),
and did not differ from the GS group during low-flow ischaemia (data not shown).
7.3.2 Gender and Ischaemic Arrhythmias
Coronary ligation in vitro resulted in a 40% reduction in coronary flow rate
(p<0.001) and a significant decrease in HR (p<0.05). Lactate concentration in the
coronary effluent was higher during ischaemia (p<0.01) and further enhanced during
the first 5 mins of reperfusion (p<0.01). During the first 5 mins of reperfusion, NA
overflow was 28.6±6.1 pmol/g in males and 25.1±4.3 pmol/g in females. All these
changes were similar in the male and female groups (NS, Table 7.2).
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Figure 7.2 The effect of nerve
stimulation on lactate product¬
ion (upper panel) and heart
rate during 10 mins of low-
flow ischaemia (lower
panel). *p<0.05 vs control and
GS groups.
Table 7.2 Changes in HR, coronary flow rate (CFR) and lactate levels before and during ischaemia
(20 mins) and reperfusion (5 mins) in isolatedperfused male andfemale rat hearts.
HR (beats/min) CFR (ml/min/g) Lactate QiM)
Male Female Male Female Male Female
Control 284±7 272±8 9.11.23 9.115.0 3514 3214
Ischaemia
0.5 min 260±8 249±8 - - - -
5 min 247±6 243±9 5.41.26 5.51.27 240117 217113
10 min 251±6 247±9 4.81.27 6.01.49 355145 260130
15 min 243±9 240110 4.51.31 5.01.34 326169 226141
Reperf - - - - 567167 519136
All parameters were not significantly different between males (n=24) andfemales (n=24).
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In the in vivo experiment, the weight of ventricles (0.83±0.01 and 0.72±0.01 g,
p<0.01) and of the ischaemic myocardium (0.27±0.01 vs 0.2410.02 g, p<0.05) was
greater in males than in females. The ischaemic myocardium as percentage of total
ventricular mass was similar in both sexes (32.711.5% vs 33.712.3%, p=NS).
The development of ventricular arrhythmias during ischaemia and reperfusion in
both in vitro and in vivo studies is summarized in Table 7.3. In these two different
experimental models, no sex-related difference was observed in the frequency of
ventricular premature beats (VPB), ventricular tachycardia (VT) or VF.
Table 7.3 Ventricular arrhythmias during 20 mins of coronary occlusion and during reperfusion in in
vitro and in vivo hearts from male andfemale Sprague-Dawley rats.
In vitro In vivo
Male Female Male Female
(n=24) (n=24) (n=26) (n=24)
VPB (beats/20 min) 80112 64119 162149 118122
VT % 95.8 87.5 100 83
Onset time (sec) 437122 439126 330126 314116
Duration (sec) 3516 2919 4318 65120
VF % 62.5 62.5 28 33
Onset time (sec) 581123 623146 473181 482151
Duration (sec) 320183 298181 84150 77139
Reperfusion VF % 93 100 - -
Onset time (sec) 55119 4318 - -
No significant differences were observed between male andfemales.
7.3.3 Gender and Haemodynamic Response to Ischaemia
There was no sex difference in both HR and mean arterial pressure (MAP) before
coronary ligation in the anaesthetized rats. A small but significant increase in HR
between 0.5 and 5 mins after coronary ligation was observed in male rats (p<0.05 or
<0.02, Figure 7.3). In female rats, however, HR was significantly reduced 1 min after
coronary occlusion (p<0.001 vs pre-ischaemic value, Figure 7.3). As a result there
was a highly significant difference in HR between the two groups during 3-20 mins
period (Figure 7.3). A profound drop in MAP (p<0.001) was found immediately after
coronary ligation. There was no difference in the extent of this acute hypotension in
male and female groups (0.5 min: -3014 vs -3313 mm Hg, NS; Figure 7.3). Males
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showed a significant partial recovery in MAP over the first 5 mins of ischaemia and
MAP increased by 10 mm Hg compared with the 0.5 min ischaemia level (p<0.01,
Figure 7.4). In female rats, however, there was a further reduction in MAP (p<0.05)
within the first minutes of coronary occlusion, although some recovery was observed
after 10 mins of ischaemia. The early recovery in MAP during the first 5 mins after
coronary occlusion in males was highly significantly different from the decrease in
MAP in females (pcO.OOl Figure 7.4).
-5 0 5 1# IS 20 min
Figure 7.3 The effect of left coronary ligation on HR (upper panel) and MAP (lower panel) in
anaesthetized male and female rats.
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Figure 7.4 The effect of gender on ischaemia-induced changes in HR (upper panel) and MAP (lower
panel) in anaesthetized rats during the first 5 mins of coronary artery ligation. HR results are
presented as net changes (AHR) from the pre-ischaemic control. MAP data are presented as net
changes (AMAP) from the level measured at 0.11 min after coronary ligation. *p<0.05 and **p<0.01
vs 0 min values ofHR or 05 min values ofMAP.
7.4 Discussion
Neuronal Mechanisms and Reperfusion VF
The present study demonstrates that the sympathetic and parasympathetic nerve
system exert an opposite influence on the development of reperfusion VF. An
enhanced neuronal NA release in the preceding period of ischaemia triggered
reperfusion VF. This finding is in agreement with a number of in vivo and in vitro
studies [Section 1.2.2]. In those studies suppression of sympathetic activity by
adrenergic antagonists or by sympathectomy reduces the incidence of reperfusion VF
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[Penny 1984, Schwartz and Zuanetti 1988, Abrahamsson et al 1985]. In an in vivo
dog study, the amount of spontaneous NA overflow from ischaemic hearts is
correlated with the severity of arrhythmias during early reperfusion [Yamaguchi et al
1990]. However, a number of other studies also suggest that adrenergic mechanisms
are not necessarily involved the arrhythmogenesis during ischaemia and reperfusion
in the rat heart [Curtis et al 1987, Daugherty et al 1986, Botting et al 1983]. But none
of these studies examined the effect of sympathetic nerve stimulation-induced NA
release on the genesis of VF.
An antiarrhythmic effect of cholinergic stimulation (whether by electrical
stimulation or using an agonist) on reperfusion VF is observed in the present study.
This observation is in keeping with a few existing studies [Schwartz and Zuanetti
1988]. The mechanisms responsible for the salutary impact of cholinergic stimulation
on reperfusion VF are considered to be multifactorial, including reduction in HR,
presynaptic inhibition of NA release and direct electrophysiological influences
[Zuanetti et al 1987, Levy 1984, Verrier 1988]. Cholinergic presynaptic inhibition of
NA release fails during early ischaemia (Chapter 5). Using a different protocol, a
similar failure of cholinergic inhibition of NA release was again observed. Thus in
this experiment prevention of reperfusion VF by cholinergic stimulation is associated
with a failure of cholinergic presynaptic inhibition of NA release. Therefore, this
protection could only be explained by the post-synaptic muscarinic actions. We did
find a significant reduction in HR by combined nerve stimulation during 1-4 mins of
ischaemia. However, it is uncertain if this early and temporary reduction in HR is
important in the suppression of reperfusion VF. This question could be answered by
further experiments with HR controlled by pacing. A difference in glycolytic flux,
which may be associated with an anti-arrhythmic effect seems not to be involved as
lactate levels in coronary effluent during ischaemia were not affected by cholinergic
stimulation.
We did not examine the electrophysiological effects of cholinergic stimulation. It
has been well documented that vagal stimulation or cholinergic agonists reduce
myocardial automaticity, prevent the onset of the delayed after-depolarization, and
elongate the effective refractory period [Loffelholz and Pappano 1985, Section 1.2.3].
All these effects may explain the reduced vulnerability to arrhythmias observed.
Interestingly, some studies have demonstrated that postsynaptic vagal effects to the
heart are potentiated by hypoxia and acidosis, due to increased levels of adenosine
[Potter et al 1986, Verlato and Borgdorff 1990]. Increased adenosine production
during low-flow and stop-flow ischaemia in the perfused rat heart has been well
documented [Richardt et al 1987, Headrick et al 1989]. A negative chronotropic
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effect of vagus may also be enhanced by exogenous administration of adenosine
[Pelleg et al 1988, Belloni et al 1989].
Gender and Ischaemic Arrhythmias
In both in vitro and in vivo experiments, severity of ischaemic arrhythmias during
the first 20 mins after coronary artery occlusion was similar in both sexes. As
neuronal NA release during ischaemia (Chapter 5) and the function of the vagus
(Chapter 6) differ between the sexes, a sex difference in ischaemic arrhythmias in the
in vivo study was expected. In the in vitro study the incidence of VF was sufficiently
high to document an anti-arrhythmic effect, but there was none. In the in vivo
preparation the incidence of VF was generally too low to demonstrate a significant
anti-arrhythmic effect with the numbers used [Walker et al 1988]. This value is also
lower than reported (96-100%) [Curtis et al 1987, Johnston et al 1983].
The well-defined determinants of VF are infarct size [Curtis et al 1987, Bolli et al
1986, Coromilas et al 1985], heart rate [Bolli et al 1986, Lederman et al 1987], and
potassium level [Curtis and Hearse 1989, Nordrehaug and Vander-Lippe 1983]. In the
present study, percentage of ischaemic myocardium, pre-ischaemic HR and MAP are
similar in males and females. We did not measure plasma K+ level. But as all animals
were kept on the same laboratory chow, it seems unlikely that the plasma K+ would
differ between the two sexes. Sympathetic nerve stimulation is potent in initiating
arrhythmia during ischaemia [Schwartz and Vanoli 1981, Corr and Gillis 1978].
However, direct evidence supporting a causal effect of neuronal NA release on
arrhythmogenesis is still limited [Section 1.2.2]. Myocardial NA release during
ischaemia may be mediated by efferent sympathetic impulses (exocytosis) or by
neuronal reuptake carrier reversing its normal transport direction (non-exocytosis)
[Schomig 1988]. We have found a sex difference in neuronal NA release but not in
NA non-exocytosis during ischaemia (Chapter 5). In the isolated perfused heart,
which is devoid of sympathetic drive, NA release after 20 mins of coronary ligation
was also similar in both sexes. If our result from the in vivo experiment is a genuine
reflection of the arrhythmic vulnerability, it may support the view that the non-
exocytotic release of NA is important in initiating VF during ischaemia [Schomig
1988, Dietz et al 1989, Riemersma et al 1986b]. It is also well-known that chronic
sympathectomy with a profound reduction in myocardial catecholamine content is
antiarrhythmic but acute sympathectomy is less effective [Corr et al 1986, Euler et al
1985, Section 1]. However, further studies are required to test whether gender has any
significant effect on the development of ischaemic arrhythmias under the condition
of enhanced neuronal activity.
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Gender and Autonomic Activation After Coronary Ligation
Immediately after coronary occlusion, male rats showed a trans-ient but
significant increase in HR and a partial recovery in MAP. A progressive reduction in
HR and a further drop in MAP were observed in females during this period. The
percentage of ischaemic myocardium and the initial extent of hypotension by
coronary ligation are similar in both sexes. In our study, ischaemic area was always
restricted to the free anterior wall of the left ventricle. Therefore, differences in these
haemodynamic responses to ischaemia can not be explained by differences in the
extent or localization of ischaemic area [Curtis et al 1987, Billman and Marsh 1989,
Corr and Gillis 1978, Section 1.2.1].
Simultaneous increases in HR and MAP are probably due to a sympathetic
activation although a withdrawal of parasympathetic tone also lead to an increase in
HR. On the other hand, reduction in HR and MAP in females can only be explained
by a parasympathetic activation. Sympathetic activation during ischaemia could be
triggered by local ischaemia or disturbance in cardiovascular function via cardio-
cardiac reflex and baroreflex [Shepherd 1985, Section 1.2.1]. Direct stimulation on
unmyelinated vagal afferent fibres in the ventricle may ensue an increased
parasympathetic activity [Shepherd 1985, Corr et al 1986]. Other authors have found
an increase in HR and an earlier recovery in blood pressure after coronary ligation in
male rats [Johnston et al 1983, Siegmund et al 1979, Macleod et al 1983]. Siegmund
et al [1979] found a stable but not reduced HR in female rats within the first 20 mins
after coronary occlusion, perhaps due to a small group size (n=8). In the present
experiment, we included data from all animals (n=24 and 26) in which HR and MAP
were reliable within the first 5 mins of coronary ligation, as arrhythmias are rare
during this period in this model [Curtis et al 1987]. Therefore, the possible distortion
by arrhythmias or a chance finding seem unlikely. Additionally, the type of
anaesthesia may modify the haemodynamic response to ischaemia [Siegmund et al
1979, Macleod et al 1983]. But the different response pattern was observed using the
same anaesthesia. Thus, result from this study indicate a sex difference in the pattern
of autonomic responses to acute myocardial ischaemia, with a relatively sympathetic
dominance in males and vagal dominance in females. Interestingly, using the in vitro
innervated perfused heart model, we have observed a higher neuronal NA release
during early ischaemia in males and a more potent cardiac effect of vagal stimulation
in females (Chapter 5 and 6).
Men and women may differ in their autonomic response to stress with a more
marked sympathetic activation in men (see Section 5.1 and 6.1). Clinical studies also
indicate a higher vulnerability to ischaemic arrhythmias in men [Kannel and
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Schatzkin 1985, Dahlberg 1990, Freedman et al 1988, Section 1.1.3] and a higher
incidence of heart failure in women with acute MI [Kimmelstiel and Goldberg 1990].
Sympathetic activation during acute MI provides an acute compensation to maintain
haemodynamic stability. But an enhanced sympathetic drive to the heart may increase
also the risk of ventricular arrhythmias. On the other hand, vagal activiation may
improve the electrical stability of the ischaemic heart at the expense of an incomplete
haemodynamic compensation. It would be of interest to examine if the observed sex
difference in the autonomic nervous control of the heart is involved in these sex-
related differences in humans.
Chapter 8
Dietary Fats and Cardiac Sympathetic
Neurotransmission
8.1 Introduction
Epidemiological studies have identified an inverse relation between dietary
consumption of n-6 or n-3 polyunsaturated fatty acids (PUFA) and the incidence of
ischaemic heart disease [Wood et al 1987, Connor and Connor 1990]. A number of
factors are believed to be involved in this protection. Systematically, dietary
supplement with PUFA can change the profile of plasma lipids, reduce the thrombotic
activity, and delay the development of atherosclerosis [Connor and Connor 1990]. As
the result of a modified fatty acid composition of cellular membranes, direct
influences on the heart may also play an important role [Katz 1986, Lammers et al
1987]. Experimentally, diets enriched with PUFAs may reduce prostanoid production
[Hartog et al 1986], improve coronary circulation [Kenny et al 1990, Force et al
1989, Hartog et al 1986], ameliorate ischaemic damage [McLennan et al 1985,
Bruckner et al 1987, Hock et al 1987 and 1990, Black et al 1984, Culp et al 1980],
and reduce the severity of ischaemic arrhythmias both in vivo and in vitro [McLennan
et al 1985 and 1989, Hock et al 1990, Culp et al 1980, Riemersma et al 1988, Sargent
1990].
In cardiac tissue, effects mediated by a-, and perhaps (3-adrenoceptors are found
to be attenuated by diets rich in n-3 and n-6 PUFA [McLennan et al 1987, MacLeod
and Riemersma 1990, Reibel et al 1988, Wince et al 1987], although an enhancement
of the a-receptor mediated vasoconstriction in dogs has also been reported [Kenny et
al 1990, Panek et al 1985].
Effect of dietary PUFA on catecholamine release has seldomly been investigated.
In the atrium of adult rats, both NA content and field stimulation-evoked 3H-NA
release are not significantly altered by long-term feeding of sunflower oil (rich in n-6
PUFA) compared with coconut oil (rich in saturated fatty acids). (^-Adrenoceptor
mediated presynaptic inhibition of 3H-NA release was attenuated by n-6 PUFA diet
[Semafuko et al 1987]. But an enhanced a-adrenergic presynaptic control of 3H-NA
release in the perfused rat tail artery is also reported by the same group [Semafuko et
al 1989]. Another study has found that supplementation with saturated fats reduced
neuronal NA release from tail arteries of the rat [Panek et al 1985]. Influence of
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dietary n-3 PUFA on NA release from the heart during normoxia and ischaemia is
unknown.
Sympathetic activation and endogenous NA release play an important role in the
pathogenesis of ischaemic arrhythmias [Corr et al 1986, Schomig 1988]. As dietary
PUFA may modulate both ischaemic arrhythmias and NA release, a modified
sympathetic neurotransmission could be involved in this antiarrhythmic effect.
Therefore, the purpose of this study was to examine the influence of realistic dietary
supplements with n-6 and n-3 PUFA on neuronal NA release and its presynaptic
controlling mechanisms in the perfused rat heart. The control diet was rich in fats
with a polyunsaturated/saturated ratio (P/S ratio) of 0.3 , as commonly consumed by
the average Scottish man [Thomson et al 1985]. As several studies suggested that n-3
PUFA supplement could modify vasoactivity [Kenny et al 1990, Shimokawa and
Vanhoutte 1989, Force et al 1989, Hartog et al 1986], the effect of n-3 PUFA
supplement on coronary vasoconstriction induced by muscarinic agonist was also
studied [Kalsner 1989].
8.2. Methods
8.2.1 Dietary Fats, Drugs and Model
Male Lew rats were used for this study. Rats (6 weeks of age) were fed semi¬
synthetic diets as detailed in Section 2.5. Heart perfusion experiments were carried
out 10-11 weeks later. Using the in situ perfused, innervated heart model (Section
2.2), effects of dietary fats on neuronal NA release and its presynaptic modulation
were examined. Hearts were perfused at a constant flow rate of about 5 ml/g/min
except in ischaemic series, in which the flow rate was reduced by 90% to 0.5
ml/g/min. Drugs used were desipramine (0.1 |iM), phentolamine (3 |iM), isoprenaline
(10 nM), froben (10 (i.M), and methacholine (1-100 |iM). Desipramine was added to
the perfusate and was present throughout the experiment. Other drugs were infused
into the heart via a pump (Section 2.6). Coronary effluent was collected for 1 min
during nerve stimulation in normoxic experiments, or for 3 mins during low-flow
ischaemia starting from onset of nerve stimulation. At the end of experiments, hearts
were excised, weighed, frozen and stored in liquid N2 for fatty acid analysis by
gaschromatography (Section 2.8.3).
8.2.2 Protocols
Dietary PUFA andNA release during normoxia
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The effects of experimental diets on NA release and its presynaptic control were
examined during normoxic perfusion. In the first series, the effect of n-6 PUFA was
examined. After 20 mins perfusion to stabilize the hearts, sympathetic ganglion
stimulation (GS, 5 Hz for 1 min) was given (SI) as an individual control. The second
and third GS were performed in the presence of phentolamine (3 |iM, S2) or
isoprenaline (10 nM, S3), respectively. In the second series, oral dosing technique
was necessary to prevent auto-oxidation of n-3 PUFAs. The control and n-3 PUFA
groups each received daily oral dosing of olive oil or Maxepa mixed in olive oil
(Section 2.5). The same protocols as used in the first series were followed and drugs
presented in S2 and S3 were phentolamine (3 |iM) and flurbiprofen (Froben, 10 |iM),
respectively.
Dietary n-6PUFA and NA overflow during prolonged ischaemia
In another 2 groups of rats fed control and n-6 diets, the first GS (5 Hz for 30 sec)
was performed during normoxic perfusion as a control. Afterwards, coronary flow
rate was reduced by 90% to 0.5 ml/g/min and maintained at this level for 60 mins.
Another four consecutive GS (5 Hz for 30 sec) were delivered at 8, 18, 28 and 58
mins of ischaemia, respectively. Coronary effluent was collected for 3 mins starting
with each nerve stimulation for the analysis of NA overflow. NA and lactate levels in
ischaemic venous effluent were also measured before each nerve stimulation.
Dietary n-3 PUFA on methacholine-induced vasoconstriction
In the hearts of rats fed n-3 diet (n=9) and their controls (n=10), a 10-min period
was allowed to re-stabilize the preparation after the completion of nerve stimulation
experiment. Then, methacholine-induced coronary vasoconstriction was studied. In
order to avoid the effect of myocardial contracture on the resistance of coronary
vasculature, ventricular fibrillation was induced and maintained by electrical
stimulation of the left ventricle (10-20 Hz and 1.5 mA). Accumulating doses of
methacholine (1, 5, 10, 20, 50 and 100 |iM) were infused into the heart. Each dose
was maintained for 3 mins. Froben (10 (iM) was present throughout the experiment.
8.3. Results
Body weights of rats fed control, n-3 or n-6 PUFA diets were monitored on a
weekly and found to be similar. At the time of sacrifice, body and heart weights were
not significantly different between n-6 or n-3 and the respective control groups (Table
8.1).
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Table 8.1. Body and heart weights of rats fed experimental diets
n Bodya (g) BodyB (g) Heart (g)
Control 16 160±4 324±12 1.07±0.03
n-6 16 164±6 346±10 1.09±0.03
Control 12 148±8 366±6 1.04±0.03
n-3 10 148±8 370±8 1.07±0.03
A: begining ofdietary feeding; B: end of the dietary feeding
8.3.1 Fatty Acid Composition ofMyocardial Phospholipids
N-6 or n-3 PUFA enriched diets resulted in a different fatty acid profile of total
phospholipids of the myocardium in comparison to that of controls. Supplementation
with n-6 PUFA significantly increased 18:2n-6, 20:2n-6, 22:4n-6 and total n-6 fatty
acids. N-3 PUFA supplement led to a significant increase in n-3 fatty acids
(especially 20:5 and 22:6) accompanied by a decrease in n-6 fatty acids (mainly 20:4,
22:4, and 22:5, Table 8.2). PUFA rich diets, whether n-3 or n-6, did not significantly
change the total amount of saturated fatty acids.
Table 8.2. Fatty acid composition of total phospholipids in hearts of rats fed experimental diets rich
in n-3 or n-6 polyunsaturatedfatty acids (\ig!g wet weight) and their controls
Control (n=9) N-6 (n=12) Control (n=8) N-3 (n=8)
16:0 795±80 870157* 947164 989147
18:0 2317±236 24191149 26701171 24391149*
18:1 n-9 785±72 851142* 908139 804139#
18:2 n-6 1381±205 1949il57# 18901156 1774193
20:2 n-6 7±1 1813# 711 911*
20:4 n-6 25851229 25441137 29641198 22571124#
22:4 n-6 130116 152120* 11719 5215#
22:5 n-6 372174 164125# 198115 3615#
18:3 n-3 311 1111# 511 511
20:5 n-3 212 111 615 3015#
22:5 n-3 158127 173125 218127 256119#
22:6 n-3 7791115 10441198** 1087194 17211103#
Total sats 31281314 33051199 36331232 34441194
Total n-6 45161444 48611259* 52221337 41831206#
Total n-3 9431114 12291184** 13161120 20111116#
* p<0.05 **p<0.01 # p<0.001 vs the respective control.
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8.3.2 Diets, NA Overflow and Its Presynaptic Modulation
Spontaneous NA overflow was low (<1.5 pmol/g/min) and did not differ between
the four dietary groups. Control sympathetic nerve stimulation-evoked NA overflow
was similar in dietary n-6 or n-3 PUFA group versus the respective control group
(Figure 8.1). In the presence of phentolamine, neuronal NA overflow was
significantly enhanced in all groups and this increase was not affected whether
animals were supplemented with n-6 or n-3 PUFA. The ratio of NA overflow (S2/S1)
was 2.6±0.6 vs 1.9±0.3 for n-6 vs control (NS) and 2.2±0.2 vs 2.1±0.1 for n-3 vs
control (NS, Figure 8.1). In the presence of isoprenaline (10 nM) or froben (10 jiM),
neuronal NA overflow was not significantly changed and no diet-related differences




GS GS +Phent. GS+Isop.
GS GS +Phent. GS+ Fitoben
Figure 8.1. Effect of dietary fat on neuronal NA overflow and its presynaptic controlling
mechanisms. The first sympathetic ganglion stimulation (GS) served as control. * p<0.05 vs GS in
the same group by paired t-test. Note NA overflow was not changed by feeding rats n-6 or n-3 PUFAs
(all p>0.05 vs controls). Froben= flurbiprofen.
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Heart rate and ±dP/dt did not differ between n-6 or n-3 PUFA and their control
dietary groups (NS) during basal conditions and during nerve stimulation either with
or without a-adrenergic blockade. In the hearts from rats on control diet, there was a
higher increase in ±dP/dt in response to GS in the presence of phentolamine
compared with that in its absence (p<0.05). This effect of phentolamine was not
observed in the two PUFA dietary groups (NS, Table 8.3).
Table 8.3 Effect of dietary fatty acids on basal and sympathetic ganglion stimulation-mediated
haemodynamic responses in perfused hearts and the influence of the a-adrenergic antagonist
phentolamine (phent., 3 pM). n=8-12 per group.
HR (b/min) + dP/dt (mm Hg/s) ■dP/dt (mm Hg/s)
-Phent. +Phent. -Phent. +Phent. -Phent. +Phent.
Basal
Control 256±17 239118 15831104 16081104 887176 875181
n-6 241±17 244111 1464178 1464189 621124 614139
Control 203114 196120 1665154 1722151 921150 990147
n-3 19018 17619 1584167 1521145 895137 890144
Stimulation
Control 287116 281112 20751126 24921180* 12171103 1425180*
n-6 27119 271110 18641120 20791122 907161 979154
Control 263114 24218 26051114 29181150* 16591113 19101128*
n-3 249116 24415 26641236 26411241 16851167 17211149
1) All changes induced by GS were significant at p<0.01.
2) No significant differences were observed between n-6 or n-3 diets and their controls.
3) *p<0.05 vs the stimulation values without phentolamine in the same group by paired t-test.
8.3.3 N-6 Diet and Neuronal NA Overflow during Ischaemia
The control nerve stimulation during normoxia resulted in similar amount of NA
overflow in n-6 PUFA dietary animals and their controls (34.4±4.0 vs 35.416.1
pmol/g, NS). During 60 mins of 90% flow reduction, spontaneous NA overflow was
maintained and did not differ between the two groups (Figure 8.2). Lactate
concentration in coronary effluent was significantly increased by ischaemia and did
not differ according to the diet of the rats. Each nerve stimulation applied during
ischaemia evoked an over 10-fold increase in NA overflow accompanied by a
significant increase in HR (Figure 8.2 and Table 8.4). During ischaemia,
concentrations of lactate in the ischaemic venous effluent increased from 0.4 ±0.1 to
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2-3.5 mM (pcO.Ol) in control animals and from 0.5±0.1 to 2.6-3.3 mM (p<0.01) in
n-6 PUFA animals. No diet-related differences were found in these observations.
Figure 8.2. Effect of n-6
PUFA diet on spontaneous and
nerve stimulation-induced NA
overflow during normoxia (0
nun) and during 60 mins of
90% flow reduction. The
neuronal reuptake inhibitor
desipramine (0.1 \\M) was
present throughout the
experiment. (n=8lgroup). The
increase in NA concentration
during GS is highly significant
(p<0.001) and did not vary
according to the diet: control





Table 8.4 The effect ofsympathetic ganglion stimulation (GS, 30 sec duration) on heart rate before
and during 60 mins low-flow ischaemia.
Duration of Ischaemia (min)
Diet Condition Normoxia 8 18 28 58
Control Basal 215±28 55±11 54±17 37±11 43±11
GS 289±19 133±17 109±18 93±8 106±16
n-6 Basal 219±15 66±17 45±8 47±9 65±12
GS 268±34 132±12 97±12 104±11 116±16
p<0.01 for the increase in heart rate by each GS ; n-8 per group.
Dietary Fats andAdrenergic Transmission 132
8.3.4 N-3 PUFA and Methacholine-Induced Coronary Vasoconstriction
Under our experimental conditions (5 ml/g/min perfusion flow, inhibition of
prostanoid production by flurbiprofen , and minimizing the effect of contraction by
induced VF), there was no significant difference in basal coronary perfusion pressure
of the hearts from animals fed n-3 PUFA or control diets. A dose-dependent increase
in perfusion pressure was observed during methacholine infusion. The extent of this


















Methacholine concentration (-Log M)
Figure 8.3. The effect of the muscarinic agonist methacholine on coronary perfusion pressure of
hearts from rats fed n-3 PUFA (n=9) or their control (n=10) diet.
8.4. Discussion
The present study shows that 10 weeks feeding rats on diets enriched with PUFA
resulted in significant changes in fatty acid composition of myocardial total
phospholipids. The n-6 PUFA enriched diet increases the total n-6 PUFA, which is
mainly due to a 40% increase in 18:2. Dietary supplementation with Maxepa leads to
about 50% increase in total n-3 fatty acids, especially 22:5 and 22:6, accompanied by
a significant reduction in n-6 fatty acids. All these changes are in agreement with
previous reports [Flock et al 1987, Reibel et al 1988, Sargent 1990].
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As the cell membrane plays a central role in the exitation-secretion coupling and
agonist-receptor interactions [Katz 1986], concomitant change in sympathetic
neurotransmission was expected, but was not observed. Spontaneous and control
nerve stimulation-evoked NA overflow were similar in the control and dietary PTJFA
groups. Nor was the presynaptic modulation of NA release mediated by a- and p-
adrenoceptors or by prostaglandin receptors affected by diets. This can not be
explained by an insensitivity of the model, since the increase in NA overflow by
blocking presynaptic a-receptors with phentolamine is highly significant.
Postsynaptic effects of sympathetic nerve stimulation were also not significantly
affected by the diets. Stimulation of sympathetic ganglion at 5 Hz equally increase
heart rate and ±dP/dt in all groups. In control rat hearts, ±dP/dt response to
sympathetic stimulation is potentiated by blocking a-adrenoceptors with
phentolamine which is in accordance with a significantly increased NA overflow by
this drug. However, this was not observed in hearts of the rats fed PUFA enriched
diets although neuronal NA overflow is similarly enhanced as in controls. It may
indicate an attenuation of the P-adrenoceptor-mediated inotropic response to
enhanced endogenous adrenergic stimulation by dietary PUFA, as demonstrated by
others [Wince et al 1987, McLennan et al 1987]. However, a between-group
difference is not observed. Several studies have demonstrated that arterial
vasodilation can be enhanced by dietary PUFA [Kenny et al 1990, Panek et al 1985,
Shimokawa and Vanhoutte 1989]. In this study, the dose-response curve of perfusion
pressure to methacholine was not shifted by dietary n-3 PUFA. Taking all these
findings together, this study provides no evidence to suggest that dietary fatty acid
composition affects sympathetic neurotransmission or the function of pre- and post¬
synaptic receptors in the normoxic heart of the rat.
Myocardial NA release is believed to be important for the genesis of ischaemic
arrhythmias [Lombardi et al 1984, Schomig 1988, Section 1.2.2]. Neuronal NA
overflow during prolonged low-flow ischaemia is under the effective presynaptic
modulation (Chapter 3). Differences in this modulation would be reflected by a
different NA overflow level. However, during a 60-min period of low-flow
ischaemia, increases in NA overflow and HR by nerve stimulation do not differ in
hearts of rats fed n-6 or their control diet. In another study from this laboratory,
neuronal activity-independent NA release during ischaemic-reperfusion is also not
altered by n-3 or n-6 dietary PUFA compared with the control diet [Sargent 1990].
Semafuko and co-workers [1987] have demonstrated that dietary supplementation
with sunflower oil (rich in n-6 PUFA) attenuates the a-adrenergic presynaptic
modulation of NA release in isolated rat atrium of adult rats vs a supplement of
saturated fat. Meanwhile, control 3H-NA release and NA content are not affected.
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Interestingly, this dietary modulation seems to be organ-dependent as they have also
reported an enhanced a-adrenergic inhibition of NA release in the tail artery of rats
[Semafuko et al 1989]. There are several methodological differences in their studies
compared with the present one. 3H-NA labelling technique and field stimulation were
used by Semafuko et al [1987, 1989] to study NA release and its modulation, whilst
we measured endogenous NA overflow evoked by electrical nerve stimulation in the
presence of neuronal reuptake inhibitor. Another important issue may be the feeding
period. In their study, dietary feeding started from pregnancy period until adulthood
[Semafuko et al 1987, 1989]. Central and peripheral sympathetic nerves develop very
rapidly within the first 2-3 weeks [De Champlain et al 1970, Semafuko et al 1987].
Therefore, it is possible that an earlier supplementation with dietary PUFA may lead
to a higher incorporation of PUFA into the nervous membranes. Obviously, it is
difficult to know to what degree our measured alteration in fatty acid composition in
myocardial phospholipids reflect the fatty acid profile in the nerve membranes.
In summary, the results from this study indicate that dietary feeding of n-6 and n-
3 PUFA results in major changes in fatty acid composition of membrane
phospholipids in the heart. However, these changes are not accompanied by a
significantly modified sympathetic neurotransmission or function of the receptors
examined. Therefore, any protective effects of dietary PUFA in myocardial ischaemia
may be mediated by factors which are independent of efferent sympathetic
neurotransmission. However, a possible modulation of the central nerve activity by




The principle aim of this project was to examine the effect of acute myocardial
ischaemia on neuronal NA release and its modulation.
The severity and duration of ischaemia is an important determinant for changes of
the function of the sympathetic nerve terminal (Chapter 3). During stop-flow
ischaemia, NA exocytosis is reduced and fails within 10 mins, accompanied by the
loss of presynaptic modulation and neuronal reuptake mechanism. However,
exocytosis, presynaptic modulation and neuronal reuptake are all maintained for at
least 60-min period of low-flow ischaemia (residual flow similar to collateral flow in
vivo). Carrier-mediated NA efflux does not occur during low-flow ischaemia. The
presynaptic parasympathetic inhibitory mechanism appears even more sensitive to
severe ischaemia. A rapid failure of vagally-mediated inhibition of neuronal NA
release is observed after 1 min of stop-flow ischaemia, in contrast to a maintained
inhibitory effect at 3 mins of low-flow ischaemia (Chapter 4 and 7). Thus, this study
demonstrates a dependency of NA release on the severity of ischaemia, a conclusion
which is critical for the understanding of local sympathetic nerve function during
acute ischaemia.
In the perfused rat heart, inhibition of NA release by vagal nerve stimulation is
abolished within a few minutes of low-flow ischaemia (Chapter 4 and 7) due to a
reduced ACh release, which in turn is at least partly due to an adrenergic presynaptic
inhibition, and dysfunction of presynaptic muscarinic receptors. Therefore, ischaemia
affects the sympathetic-parasympathetic interactions in such a way which is in favour
of NA release. Despite this failure, sympathetic stimulation-triggered ischaemic-
reperfusion VF in this model is prevented by superimposed cholinergic stimulation
(Chapter 7). Thus, under conditions of simultaneous vagal and sympathetic activation
during acute myocardial ischaemia, cholinergic presynaptic inhibition of NA
release may no longer exist within the ischaemic area shortly after the interruption of
coronary flow. Cholinergic postsynaptic actions, however, are maintained during
longer periods of ischaemia and are responsible for the antiarrhythmic effect by vagal
nerve activation.
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During normoxic perfusion, presynaptic inhibition of cardiac NA release by <x-
adrenoceptors or vagal nerve stimulation is more potent in female than in male rat .
This mechanism leads to a lower exocytotic NA release during early stop-flow
ischaemia in females than in males (Chapter 5). Meanwhile, neuronal NA release and
heart rate in the female heart are under stronger parasympathetic influence than that
in the male (Chapter 6). These gender related differences may be responsible for the
different heart rate and blood pressure responses to acute coronary artery occlusion in
male and female rats in vivo (Chapter 7). Gonadectomy studies indicate that gonadal
hormones, especially oestrogen, may be responsible for these differences (Chapter 5
and 6). Thus, the autonomic control of the heart is also influenced by gender.
In contrast, feeding rats diets enriched with n-6 or n-3 polyunsaturated fatty acids
for 10 weeks does not exert a significant effect on sympathetic neurotransmission,
despite major changes in fatty acid composition of myocardial phospholipids (Chapter
8).
9.2 Limitations of the Study
A flow rate of 5 ml/min/g, which is close to coronary blood flow measured in vivo
[Malic et al 1976], was used to perfuse the innervated heart "normoxically".
Nevertheless, hearts under such perfusion produced more lactate (about 2-3
jiM/g/min) than those receiving the higher flow rate of 9 ml/g/min (<0.5 |lM/g/min).
This is due to the low oxygen capacity of the perfusate, despite the fact that Po2 is as
high as 600 mm Hg. The implication of this higher lactate production by myocytes is
not entirely clear, as this level is still much lower than that observed during
ischaemia-reperfusion. The main purpose of this project is to study the autonomic
nerve function in the heart and cardiac nerves are rather resistant to hypoxia [Carlsson
1988, Dart et al 1987, Wakade and Wakade 1985]. The myocardial contractility in
such perfused hearts may be low due to the limited oxygen supply. However, there
are no signs of declining ventricular contractility and response to sympathetic or
vagal nerve stimulation over a 2-hour perfusion period (Section 2.10).
The perfused rat heart, compared to the in situ dog heart, is a suitable model for
quantitative study of NA release [Dart 1989]. However, this study and also previous
studies [Schomig 1989, Dart et al 1983] show a wide individual variation in NA
overflow by control sympathetic nerve stimulation. This limits the sensitivity to
detect a difference between groups and a larger group size is required to show such a
difference statistically. In contrast, the variation in the amount of NA overflow from
the same heart by repeated nerve stimulations is relatively small [Section 2.10,
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Schomig 1988]. Therefore, in this study between-group comparisons were made
using both absolute values and the Sn/Sl ratio of NA overflow by a test stimulus (Sn)
over that obtained by a control nerve stimulation (SI).
In preparations subjected to stop-flow ischaemia, reperfusion is necessary to
washout NA released by nerve stimulation during ischaemia. The effect of
reperfusion per se on neuronal function can not be excluded but is difficult to
estimate, although assumed to be small [Dart et al 1987]. Non-exocytotic NA
overflow occurs when stop-flow ischaemia extends to 15-20 mins [Schomig 1988], or
perhaps during prolonged low-flow ischaemia, although not observed in these studies.
This restricts the duration of severe ischaemia that can be applied to study the
neuronal release of NA.
Due to the limitations of time and laboratory facilities, it was not possible to
measure some important parameters, i.e., myocardial content and neuronal release of
acetylcholine in Chapter 4 and 6, and adenosine concentration in coronary venous
effluent in Chapter 3. Thus, some of our findings are not fully explained and some of
the conclusions depend in part on data from others, and therefore remain somewhat
speculative.
Finally, the relation between neuronal NA release/presynaptic modulatory
mechanisms and arrhythmogenesis during ischaemia has been explored little.
Nevertheless, the preliminary results indicate that neuronal NA release is associated
with an increased incidence of VF and that the vagus also plays an important role.
Therefore, the innervated perfused rat heart is a suitable model for such studies.
9.3 Presynaptic Modulation of NA Release during Ischaemia
Three different types of presynaptic inhibitory mechanisms were examined:
automodulation by a-adrenoceptors (Chapter 3-5 and 8), axo-axonal modulation by
vagal nerve stimulation (Chapters 4, 6 and 7), and trans-synaptic modulation by
purinoceptors (Chapter 3). These inhibitory mechanisms differ in some aspects during
normoxia and during ischaemia.
Firstly, the inhibition of NA release mediated by vagal nerve stimulation is the
most sensitive to ischaemia and fails within 10 mins of low-flow ischaemia (Chapter
4 and 7). In contrast, both a-adrenergic and purinergic inhibitory mechanisms remain
effective for at least 60 mins of low-flow ischaemia (Chapter 3). Obviously,
sensitivity of presynaptic inhibitory process to ischaemia reflect to some extent the
complexity of the mechanisms involved. Inhibition by vagal nerve stimulation
requires more steps than that by a-adrenergic or purinergic receptors, e.g. ACh
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exocytotic release, diffusion and binding of ACh to presynaptic muscarinic receptors
on sympathetic nerve endings, and an effective intraneuronal signal transmission.
Each of these links may be affected by ischaemia, thereby rendering vagally induced
inhibitory mechanism more vulnerable to ischaemia than automodulation of NA
release.
Secondly, presynaptic mechanisms also differ in their relatively contribution to
the suppression of neuronal NA release. In normoxically perfused rat hearts, the most
important influence is mediated by a-adrenoceptors (Chapter 3-5, 8). Vagal activity
may also play a role (Chapter 4 and 6) but less so. Blocking purinergic receptors or
inhibiting prostanoid production was without significant effect in this model (Chapter
3 and 8). During low-flow ischaemia, however, vagal inhibitory mechanism fails
rapidly (Chapter 4 and 7). The potency of a-adrenoceptor mediated inhibition is not
changed for at least 60 mins (Chapter 3). In contrast, purinergic inhibition becomes
the most important mechanism during ischaemia (Chapter 3), presumably due to
increased prevailing concentrations of adenosine [Richardt et al 1987]. The
presynaptic facilitatory modulation of NA release in the ischaemic heart, like those
mediated by p-adrenoceptors, angiotensin II receptors, serotonin receptors, have not
been studied. It would be of interest to do comparative studies on the effects of
ischaemia on both inhibitory and facilitatory modulations.
Intervention at the level of presynaptic receptors is accompanied not only by
modified NA release, but also by parallel changes in the functional response,
i.e.±dP/dt and heart rate, to sympathetic nerve stimulation both in normoxia and
ischaemia (Chapter 3-5, 8). Therefore, the functional significance of the presynaptic
modulation of NA release, especially inhibitory, is stressed.
9.4 NA Release in Ischaemia in Relation to Arrhythmogenesis
An important feature of myocardial ischaemia in vivo is heterogeneity in flow
reduction across the ischaemic area [Bolli et al 1986, Piek and Becker 1988, Reimer
et al 1987]. It is assumed that the dependency of sympathetic nerve function on the
severity of ischaemia, demonstrated in the present study, may also pertain in vivo.
Therefore, in regions with near zero blood flow, rapid failure of neuronal NA release
may occur followed by "carrier-mediated NA efflux" [Schomig 1988]. In non-
ischaemic or mildly ischaemic regions NA release is preferentially via exocytosis.
Meanwhile, in regions with severe but incomplete cessation of blood flow, excytosis
is maintained but inhibited presynaptically. Non-exocytotic NA efflux may not
happen or be substantially postponed. Consequently, a spatially and chronologically
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inhomogeneous NA release results in uneven adrenergic stimulation in closely related
myocardial regions with unequal flow. In the very early stage, adrenergic stimulation
is probably stronger in non-ischaemic and mildly ischaemic areas. At a later stage of
ischaemia, non-exocytotic release of NA in regions with the most severe ischaemia
may cause a reversal of this gradient in adrenergic stimulation with intense
stimulation in central ischaemic areas but not in non- and mild-ischaemic
areas (Figure 9.1). This may favour the induction of electrophysiological dispersion
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Figure 9.1 Schematic representation of the different intensity of adrenergic stimulation to ischaemic
and non ischaemic myocardium in vivo due to various sources ofcatecholamines.
It is generally believed that acute myocardial ischaemia is associated with an
enhanced adrenergic stimulation to ischaemic myocardium [Corr and Gillis 1978,
Verrier 1988]. The effectiveness of adrenergic blockade during myocardial ischaemia
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in vivo supports this view (see Section 1.2.2). However, using nerve stimulation
technique, a reduced amount of NA overflow has frequently been observed during
early ischaemia in previous in vitro and in vivo studies [Dart 1989, Forfar et al 1984]
and also in the present study (Chapter 3-6).
The intensity of adrenergic stimulation is dependent on NA concentration in the
synaptic space which is difficult to estimate. Assuming that neuronal reuptake is
largely inhibited by desipramine in our study, then the amount of NA overflow equals
roughly to that released. During low-flow ischaemia (0.25 ml/g/min), neuronal NA
release is reduced to 30-50% of normoxic control value (Chapter 3). In contrast, NA
concentration in the coronary effluent during nerve stimulation is much higher during
ischaemia (10-25 pmol/ml) than during normoxic perfusion at 5 ml/g/min (5-10
pmol/ml, Chapter 3, 7, 8). A higher synaptic concentration of NA in ischaemic than
in normoxically perfused myocardium is also indicated by clonidine's facilitation of
NA release, which was only observed during ischaemia (Chapter 5). In normoxia, NA
released into the extracellular space (about 0.2 ml/g wet weight) [Frank and Langer
1974] may diffuse into capillary blood flow and thus removed. In other words,
capillary blood flow constitutes a pool, which "buffers" increased NA levels in the
synaptic cleft. During ischaemia however, this buffering and washout mechanism is
markedly impaired. Therefore, a "concentrating effect of ischaemia" may exist by
which NA levels in the biophase are increased in myocardial ischaemia, despite a
reduced quantity of neuronal NA release. Thus, postsynaptic adrenergic stimulation
of the ischaemic myocardium may be enhanced during the early period. The neuronal
reuptake mechanism could attenuate this NA accumulation in ischaemic myocardium
during early phase of ischaemia. However, this protective mechanism may fail
quickly under anoxic and stop-flow ischaemic conditions [Schomig 1989, Dart et al
1984b], or be interfered with in vivo by a number of drugs [Goldstein et al 1988,
Docherty and McGrath 1980, Iversen 1973].
Arrhythmogenic effect of sympathetic nerve stimulation during myocardial
ischaemia has been well-documented in various animal species [Corr and Gillis 1978]
except in the rat. Using the perfused and innervated rat heart model, it was
demonstrated that sympathetic nerve stimulation during ischaemia enhances both NA
release and incidence of VF during early reperfusion (Chapter 7).
Several factors that influence ischaemic arrhythmogenesis (Section 1.1.3) may do
so via an effect on sympathetic neurotransmission, as indicated by data from this
project.
Firstly, our results on the effect of severity of ischaemia on neuronal NA
release and the controlling mechanisms (Chapter 3) may explain the salutary effect of
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collateral flow in the development of severe ventricular arrhythmias (Section 1.1.3).
It is suggested that a critical amount of residual flow preserves normal nerve function
with inhibited neuronal NA release by presynaptic mechanisms. Under these
conditions, carrier-mediated NA efflux is prevented for at least 60 mins of ischaemia
well beyond the electrically vulnerable period after acute coronary ligation in the rat
heart model [Curtis et al 1987].
Secondly, clinical and experimental data suggest that females may be less
susceptible to severe ventricular arrhythmias and sudden cardiac death (Section
1.1.3). In the present study, it has been demonstrated that neuronal NA release in the
female rat heart is under a more tonic presynaptic a-adrenergic control, thereby
leading to a lower NA release during early ischaemia (Chapter 5). Vagal influence on
the heart at pre- and post-synaptic sites is also stronger in female than in male rats
(Chapter 6). The different haemodynamic response to coronary ligation in vivo in
male and female rats with coronary artery occlusion supports a gender difference in
the autonomic response to acute myocardial ischaemia (Chapter 7). All these
observations may help to explain the gender difference in the severity of arrhythmias
and early mortality after experimental myocardial ischaemia and infarction
[Siegmund et al 1979, Lu et al 1984].
Thirdly, the incidence of VT and VF is found to be higher in Sprague-Dawley
than in Wistar rats during the first 30 mins of coronary artery occlusion in vivo
[Curtis et al 1987, Johnston et al 1983]. One possible mechanism may be a higher
neuronal NA release in hearts of Sprague-Dawley rats than that of Wistar rats, as
demonstrated in Section 2.10.
However, negative data were also obtained. For example, there is no significant
influence of dietary PUFA on efferent sympathetic neurotransmission in the heart
(Chapter 8). Thus, the well-defined antiarrhythmic effect of dietary PUFA (see
Section 1.1.3 and 8.1) can not be explained this way. Moreover, VF triggered by
sympathetic nerve stimulation is prevented by simultaneous cholinergic stimulation,
despite the fact that NA release is unchanged (Chapter 4, 7). Therefore, under certain
circumstances, arrhythmogenic effect of adrenergic activation may be less important,
or antagonized by other coexisting factors. These results underline the multifactorial
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